US20100048762A1 - Composition and dental material - Google Patents

Composition and dental material Download PDF

Info

Publication number
US20100048762A1
US20100048762A1 US12/523,591 US52359108A US2010048762A1 US 20100048762 A1 US20100048762 A1 US 20100048762A1 US 52359108 A US52359108 A US 52359108A US 2010048762 A1 US2010048762 A1 US 2010048762A1
Authority
US
United States
Prior art keywords
group
mass
parts
polymerizable monomer
polymerizable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/523,591
Inventor
Hiroshige Ishino
Takahiro SEKIGUCHI
Koichi Okada
Naoki Nishigaki
Ai Hinamoto
Mariko Sugiura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Noritake Dental Inc
Original Assignee
Kuraray Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Medical Inc filed Critical Kuraray Medical Inc
Assigned to KURARAY MEDICAL INC. reassignment KURARAY MEDICAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NISHIGAKI, NAOKI, OKADA, KOICHI, SUGIURA, MARIKO, HINAMOTO, AI, ISHINO, HIROSHIGE, SEKIGUCHI, TAKAHIRO
Publication of US20100048762A1 publication Critical patent/US20100048762A1/en
Assigned to KURARAY NORITAKE DENTAL INC. reassignment KURARAY NORITAKE DENTAL INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: KURARAY MEDICAL INC.
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/26Esters containing oxygen in addition to the carboxy oxygen
    • C08F20/28Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen

Definitions

  • the present invention relates to compositions that are particularly suitable for dental materials and that contain polymerizable monomers and polymerization initiators.
  • the present invention also relates to dental materials using the compositions, such as dental primers, bonding materials, composite resins, and cements.
  • a known dental adhesive is one containing a polymerizable monomer having a polymerizable group and a hydroxyl group.
  • a known dental adhesive is one containing a polymerizable monomer having a polymerizable group and a hydroxyl group.
  • WO 2004/047773 describes a dental adhesive composition characterized by containing a polyfunctional polymerizable monomer that is an ester compound of polyhydric alcohol having 3 to 6 carbon atoms and a plurality of (meth)acrylic acids and that has one to two hydroxyl groups, a monofunctional (meth)acrylate having no hydroxyl group in the molecule, a polymerizable monomer having an acidic group in the molecule, an organoboron compound as a curing agent, and a filling material.
  • the dental adhesive When such a dental adhesive is allowed to act on dentin, it is important for the dental adhesive to have an decalcifying effect that allows a dentin surface to be dissolved with an acidic component, a penetration effect that allows a monomer component to penetrate into a collagen layer of dentin, and a curing effect that allows the monomer component thus penetrated to solidify to form a hybrid layer (hereinafter also referred to as a “resin-impregnated layer”) with collagen.
  • a hybrid layer hereinafter also referred to as a “resin-impregnated layer”
  • the present invention is intended to provide a composition that exhibits excellent adhesive properties to a tooth structure (particularly dentin) when it is applied as a dental material.
  • the present invention also is intended to provide a dental material that is excellent in adhesive properties to a tooth structure (particularly dentin).
  • composition including a polymerizable monomer (A) having an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups, and a bisacylphosphine oxide (B) represented by formula (1):
  • R 4 indicates an alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group
  • R 5 to R 14 are each independently a hydrogen atom, halogen atom, alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group.
  • the polymerizable monomer (A) includes a group represented by formula (2):
  • G is a hydroxyl group or polymerizable group and “*” indicates a bond.
  • the polymerizable groups each are a group represented by formula (3), (4), or (5):
  • R 1 indicates a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and “*” indicates a bond.
  • the polymerizable monomer (A) is a compound represented by formula (6):
  • Gs are hydroxyl groups or polymerizable groups
  • n is an integer of 2 or more, at least two of the Gs are hydroxyl groups, and at least two of the Gs are polymerizable groups.
  • An example of more preferable polymerizable monomers (A) is a compound represented by formula (7):
  • R 1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms
  • m denotes an integer of 2 or more
  • k denotes an integer of 1 or more
  • the sequence order of m units having an ester group and k units having a hydroxyl group is arbitrary. In this case, it is preferable that m be 2 to 5 and k be 1 to 5.
  • Another example of more preferable polymerizable monomers (A) is a compound represented by formula (8):
  • R 1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and p denotes an integer of 2 or more. In this case, it is preferable that p be 2 to 4.
  • R 1 be a hydrogen atom or methyl group.
  • R 4 be an alkyl group or aryl group
  • R 5 to R 14 be each independently a hydrogen atom, halogen atom, alkyl group, or alkoxy group.
  • the composition of the present invention further includes, as a polymerizable monomer component, at least one polymerizable monomer selected from the group consisting of a polymerizable monomer (C) having one polymerizable functional group and at least one hydroxyl group, a polymerizable monomer (D) having an acidic group, and a crosslinkable polymerizable monomer (E).
  • the composition of the present invention includes at least one selected from the group consisting of a solvent (F), a polymerization accelerator (H), and a filler (I).
  • the composition of the present invention further includes at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxides.
  • G polymerization initiator
  • the composition of the present invention contains 0.01 to 20 parts by mass of bisacylphosphine oxide (B) with respect to 100 parts by mass of the whole amount of polymer monomer components.
  • composition of the present invention is suitable for dental applications.
  • the present invention includes a dental primer, dental bonding material, dental composite resin, and dental cement, each of which contains the above-mentioned composition.
  • composition of the present invention contains a polymerizable monomer having a plurality of polymerizable groups and hydrophilic groups as well as a polymerization initiator having excellent performance, it is useful for the applications that require curability and those that require hydrophilicity and it is particularly suitable for dental applications.
  • Dental materials such as a dental primer, bonding material, composite resin, and cement
  • the compositions of the present invention exhibit excellent curability and are exceptionally excellent in adhesive properties to tooth structures.
  • the polymerizable monomer (A) has an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups.
  • polymerizable monomers that satisfy such a definition can be used independently or two or more of them can be used in combination.
  • the polymerizable monomer (A) has at least two polymerizable groups.
  • these polymerizable groups are polymerized and thereby the composition is cured to be able to function as, for example, a primer, bonding material, composite resin, or cement.
  • the polymerizable monomer (A) has crosslinkability. Accordingly, the composition has high curability and the cured product has high mechanical strength.
  • the polymerizable group denotes a group including a radical polymerizable functional group and examples thereof include a group including a vinyl group.
  • the group represented by the following formula (3), (4), or (5) is preferable as the polymerizable group.
  • a group represented by formula (3) is most preferable.
  • R 1 , R 2 , and R 3 each indicate a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and “*” indicates a bond.
  • the aliphatic hydrocarbon group having 1 to 10 carbon atoms include an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, and an alkynyl group having 2 to 10 carbon atoms.
  • the alkyl group having 1 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include a methyl group, ethyl group, n-propyl group, isopropyl group, cyclopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, cyclobutyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, cyclopentyl group, n-hexyl group, isohexyl group, cyclohexyl group, n-heptyl group, cycloheptanyl group, n-octyl group, 2-ethylhexyl group, cyclooctanyl group, n-nonyl group, cyclononanyl group, and n-decyl group.
  • the alkenyl group having 2 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include a vinyl group, allyl group, methylvinyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, and cyclohexenyl group.
  • the alkynyl group having 2 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-hexynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl, and 1-
  • R 1 , R 2 , and R 3 each be a hydrogen atom or a methyl group.
  • the polymerizable group may be detached from the polymerizable monomer (A) by, for example, hydrolysis.
  • the polymerizable group include a methacryloyloxy group. Therefore, it is more preferable that R 1 , R 2 , and R 3 each be a methyl group.
  • the polymerizable monomer (A) includes at least two polymerizable groups, and the at least two polymerizable groups may be identical to or different from each other.
  • the polymerizable monomer (A) has at least two hydroxyl groups. These hydroxyl groups allow the polymerizable monomer (A) to be provided with high hydrophilicity to have high penetrability into a collagen layer of dentin, which results in high adhesive properties of the composition to a tooth structure.
  • the polymerizable monomer (A) has an unconjugated carbon chain with at least four carbon atoms bonded continuously.
  • this carbon chain composes the whole or a part of the skeleton of the polymerizable monomer (A), and the polymerizable groups and hydroxyl groups are bonded to the carbon chain.
  • polymerizable monomer (A) is a compound in which a part of hydroxyl groups of a tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously is substituted by polymerizable groups so that the number of each of the hydroxyl groups and the polymerizable groups is two or more.
  • examples of the tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously are not particularly limited. Preferable examples thereof include sugar alcohol, monosaccharides, disaccharides, and trisaccharides, each of which has 4 to 20 carbon atoms.
  • sugar alcohol examples include erythritol, a sugar alcohol having 4 carbon atoms, xylitol, ribitol, and arabinitol, each of which is a sugar alcohol having 5 carbon atoms, mannitol, sorbitol, and iditol, each of which is a sugar alcohol having 6 carbon atoms, and maltitol, a sugar alcohol having 12 carbon atoms.
  • glucamine a sugar alcohol containing an amino group, also is used preferably.
  • Examples of monosaccharides that are used preferably include xylose, ribose, arabinose, and lyxose, each of which is a monosaccharide having 5 carbon atoms, as well as glucose, mannose, galactose, sorbose, and fructose, each of which is a monosaccharide having 6 carbon atoms.
  • glucosamine, mannosamine, galactosamine, N-acetylglucosamine, N-acetylmannosamine, and N-acetylgalactosamine that are monosaccharides, each of which contains an amino group and a derivative thereof, also are used preferably.
  • disaccharides that are used preferably include trehalose, sucrose, maltose, lactose, and cellobiose.
  • trisaccharides that are used preferably include Coupling Sugar (registered trademark), lactosucrose, maltotriose, and isomaltotriose.
  • the composition of the present invention is used preferably as a dental composition and more preferably as a dental adhesive composition. From the viewpoint of adhesive properties to a tooth structure (particularly dentin), it is preferable that it have high penetrability into the tooth structure (particularly dentin). From such a viewpoint, the carbon number of the aforementioned alcohol compound is more preferably 4 to 15, further preferably 4 to 9, and particularly preferably 4 to 7.
  • the number of the hydroxyl groups of the alcohol compound is preferably 4 to 15, more preferably 4 to 9, and particularly preferably 4 to 7.
  • preferable alcohol compounds include: erythritol, mannitol, sorbitol, and maltitol as sugar alcohols; glucose and glucosamine as monosaccharides; trehalose and maltose as disaccharides; and maltotriose as trisaccharides.
  • erythritol, mannitol, glucose, and trehalose are further preferable and erythritol and mannitol are particularly preferable.
  • the polymerizable monomer (A) has a group represented by the following formula (2).
  • This group is a structure that is characteristic to the compounds indicated above as examples.
  • G indicates a hydroxyl group or polymerizable group and “*” indicates a bond.
  • the polymerizable monomer (A) is preferably a compound represented by formula (6).
  • Gs are hydroxyl groups or polymerizable groups
  • n is an integer of 2 or more
  • at least two of the Gs are hydroxyl groups
  • at least two of the Gs are polymerizable groups.
  • the polymerizable group or the hydroxyl group is bonded to each carbon atom of the carbon chain, and therefore the polymerizable groups and hydroxyl groups are closely-located with a high density. Accordingly, when a composition containing this polymerizable monomer (A) is applied as a dental material, it exhibits excellent curability and adhesive properties. Furthermore, it also has an advantage that it can be produced easily using sugar alcohol.
  • n is preferably an integer of 2 to 18, more preferably an integer of 2 to 9, and most preferably an integer of 2 to 4.
  • the polymerizable monomer (A) is preferably a compound represented by the following formula (7).
  • R 1 denotes the same as described above, m denotes an integer of 2 or more, k denotes an integer of 1 or more, and the sequence order of m units having an ester group and k units having a hydroxyl group is arbitrary.
  • m is preferably 2 to 5, more preferably 2 to 4, and most preferably 2.
  • k is preferably 1 to 5, more preferably 2 to 4, and most preferably 2.
  • the total of m and k is preferably 3 to 18, more preferably 3 to 9, further preferably 4 to 8, and most preferably 4.
  • the compound represented by formula (7) has at least three hydroxyl groups, two of which are primary hydroxyl groups. These primary hydroxyl groups are highly advantageous for interaction with a tooth structure (particularly dentin). Accordingly, when a composition containing a compound represented by formula (7) is applied as dental applications, a composition with particularly high adhesive properties to a tooth structure (particularly dentin) is obtained. Moreover, since at least two groups represented by formula (3) are included as polymerizable groups, curability also is excellent.
  • compounds represented by formulae (9) and (10) are preferable from the viewpoints of curability and adhesive properties to a tooth structure of the composition.
  • the polymerizable monomer (A) is preferably a compound represented by the following formula (8).
  • R 1 denotes the same as described above, and p denotes an integer of 2 or more.
  • the compound represented by formula (8) has polymerizable groups represented by formula (3) at the both ends of an unconjugated carbon chain with at least four carbon atoms bonded continuously and has particularly high polymerization performance due to a steric factor. Accordingly, when a composition containing a compound represented by formula (8) is applied as a dental application, it serves as a composition with particularly high curability. Moreover, since it has a plurality of hydroxyl groups, it has excellent penetrability into a collagen layer of dentin as well as excellent adhesive properties to a tooth structure.
  • p is preferably 2 to 4. This is because when a decomposition product is produced by an action such as hydrolysis inside an oral cavity, the decomposition product is a highly safe compound such as erythritol, xylitol, sorbitol, or mannitol. Examples of compounds in which p is 2 to 4 include erythritol di(meth)acrylate, xylitol di(meth)acrylate, and sorbitol di(meth)acrylate.
  • erythritol di(meth)acrylate in which p is 2 is more preferable, and when the aforementioned viewpoints of polymerizability and stimulativeness to a biological body also are taken into consideration, erythritol dimethacrylate represented by the following general formula (11) is most preferable.
  • the polymerizable monomer (A) can be obtained through production by a known method.
  • a carboxylic acid having a polymerizable group for instance, a carboxylic acid in which a hydrogen atom is bonded to a bond of a group represented by formula (3)
  • a derivative thereof and the tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously may be allowed to undergo an esterification reaction according to a conventional method and this may then be purified by a separation means such as chromatography.
  • the esterification reaction may be carried out after the carboxylic acid having a polymerizable group is converted into a derivative such as an acid halide.
  • the polymerizable monomer (A) is particularly a compound represented by formula (7), especially a compound represented by formula (9) or (10), it is preferable that the polymerizable monomer (A) be produced by performing a step (a) where using a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand, as a raw material, the compound and carboxylic acid having a polymerizable group (in this case, carboxylic acid in which a hydrogen atom is bonded to a bond of a group represented by formula (3)) or a derivative thereof are esterified, and a step (b) where the protecting groups of the primary hydroxyl groups of the resultant ester compound are deprotected.
  • a step (a) where using a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand, as a raw material, the compound and carboxylic acid having a polymerizable group (in this case, carboxylic acid in which a hydrogen atom is bonded to a bond of a group represented by formula (3)) or
  • the derivative of the carboxylic acid having a polymerizable group is not particularly limited but an acid halide or acid anhydride is used preferably.
  • an acid halide is used more preferably.
  • acid chloride is used particularly preferably when availability and storage stability of the compound are taken into account. The production process including these steps allows a polymerizable monomer to be obtained with high yield and therefore is suitable for industrial production.
  • the compound in which primary hydroxyl groups of the alcohol compound are protected beforehand can be obtained as a commercially available product, for example, 1,2:5,6-di-O-isopropylidene-D-mannitol and 1,3:4,6-di-O-benzylidene-D-mannitol. Furthermore, it also can be produced by carrying out a step of protecting the primary hydroxyl groups of the alcohol compound. In a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand, it is preferable that a part of hydroxyl groups other than the primary hydroxyl groups be protected while a plurality of hydroxyl groups are allowed to remain. In this manner, a structure having at least three hydroxyl groups is obtained easily.
  • the step of protecting the primary hydroxyl groups of the alcohol compound can be carried out by performing a known reaction for introducing protecting groups.
  • protecting groups that are used preferably are ether protecting groups, silyl ether protecting groups, and acetal protecting groups.
  • Ether protecting groups that are used more preferably are a 1-ethoxyethyl ether group and triphenylmethyl ether group.
  • Silyl ether protecting groups that are used more preferably are a triisopropylsilyl ether group, t-butyldimethylsilyl ether group, and t-butyldiphenylsilyl ether group.
  • Each of these protecting groups can be introduced preferentially into a primary hydroxyl group and can be deprotected under a mild acidic condition, and therefore it has an advantage that deprotection can be achieved without cleaving the ester bond.
  • acetal protecting groups that are used more preferably are an isopropylidene group, cycloheptylidene group, benzylidene group, and p-methoxybenzylidene group.
  • the acetal protecting group When using an acetal protecting group, it not only can be introduced preferentially into a primary hydroxyl group but also can protect two or more hydroxyl groups including the primary hydroxyl group at the same time. Accordingly, the acetal protecting group is especially suitable for synthesis of the polymerizable monomer (A). Therefore, among the ether protecting groups, silyl ether protecting groups, and acetal protecting groups, the acetal protecting groups are used further preferably. Moreover, from the viewpoints that deprotection is possible under a particularly mild acidic condition and a byproduct produced at the time of deprotection can be removed easily, an isopropylidene group is used particularly preferably.
  • the step of esterifying a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand and a carboxylic acid having a polymerizable group or a derivative thereof can be carried out according to a known method.
  • esterification reaction it is important to select suitable reaction conditions (particularly, the temperature condition and the type of catalyst) under which a deprotection reaction tends not to occur, with consideration given to the type of the protecting group.
  • reaction conditions particularly, the amounts of the compound in which primary hydroxyl groups of the alcohol compound are protected beforehand and the carboxylic acid having a polymerizable group or a derivative thereof to be used
  • the reaction conditions so that after the esterification reaction, a plurality of ester bonds are formed and the total number of the protected hydroxyl groups and unreacted hydroxyl groups is at least three, in one molecule.
  • the step of deprotecting the protecting groups of the primary hydroxyl groups of the resultant ester compound may be carried out according to a known method depending on the type of the protecting group. In this case, it is important to select reaction conditions (particularly, the temperature condition and the type of catalyst) under which the ester bond tends not to be cleaved. As described above, when the ether protecting groups, silyl ether protecting groups, and acetal protecting groups that are preferable as the protecting group of the primary hydroxyl group are used, all of them can be deprotected under mild acidic conditions and therefore deprotection can be performed without allowing the ester bond to be cleaved.
  • the silyl ether protecting groups can be deprotected with extremely high selectivity by the use of a fluorine-containing compound such as TBAF (tetrabutylammonium fluoride) and thus are highly useful.
  • a fluorine-containing compound such as TBAF (tetrabutylammonium fluoride)
  • TBAF tetrabutylammonium fluoride
  • mineral acids such as hydrochloric acid and sulfuric acid and aqueous solutions thereof
  • organic acids such as formic acid, acetic acid, and trifluoroacetic acid and aqueous solutions thereof
  • cation exchange resin are used preferably.
  • organic acids such as formic acid, acetic acid, and trifluoroacetic acid and aqueous solutions thereof are more preferable, and formic acid, acetic acid, and aqueous solutions thereof are further preferable.
  • the polymerizable monomer (A) Since the polymerizable monomer (A) has a plurality of polymerizable groups and a plurality of hydroxyl groups, it is excellent in crosslinking reactivity and can interact strongly with a compound having a hydrophilic group. Accordingly, when the polymerizable monomer is mixed with a suitable component into a composition, the composition thus obtained exhibits excellent curability and adhesive properties in various applications including dental applications. From the viewpoint of obtaining both curability and adhesive properties to a tooth structure of the composition in a balanced manner, compounds represented by the aforementioned formulae (7) and (8) can be used in combination.
  • the amount of polymerizable monomer (A) to be added may be determined appropriately according to the application of the composition. Preferably, 1 to 99 parts by mass of polymerizable monomer (A) is contained in 100 parts by mass of the whole amount of polymerizable monomer components (other polymerizable monomer components will be described later).
  • a composition in which the amount of the polymerizable monomer (A) to be added is in such a range is used as a dental composition, there are advantages that penetrability into a collagen layer of dentin is excellent and bond strength is high.
  • the amount of polymerizable monomer (A) to be added is less than 1 part by mass, bond strength may be reduced and bond durability also may be reduced.
  • the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass.
  • the amount of polymerizable monomer (A) to be added exceeding 99 parts by mass results in insufficient decalcification and sufficiently high bond strength may not be obtained. Therefore the amount is more preferably 98 parts by mass or less and further preferably 95 parts by mass or less.
  • R 4 indicates an alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group
  • R 5 to R 14 are each independently a hydrogen atom, halogen atom, alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group.
  • the bisacylphosphine oxide (B) acts as a photopolymerization initiator.
  • the bisacylphosphine oxide (B) acts as a photopolymerization initiator.
  • a composition containing a polymerizable monomer (A) has high penetrability into a collagen layer of dentin.
  • the bisacylphosphine oxide (B) makes it possible to cure the polymerizable monomer (A) sufficiently even in the portion where the polymerizable monomer (A) has penetrated into the collagen layer and as a result, adhesive properties improve surprisingly.
  • Alkyl groups having 1 to 10 carbon atoms are preferable as the alkyl groups indicated with R 4 to R 14 , and examples thereof include a methyl group, ethyl group, n-propyl group, isopropyl group, cyclopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, cyclobutyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 2,4,4-trimethylpentyl group, cyclopentyl group, n-hexyl group, isohexyl group, cyclohexyl group, n-heptyl group, cycloheptanyl group, n-octyl group, 2-ethylhexyl group, cyclooctanyl group, n-nonyl group, cyclononanyl
  • Alkenyl groups having 2 to 10 carbon atoms are preferable as the alkenyl groups indicated with R 4 to R 14 , and examples thereof include a vinyl group, allyl group, methylvinyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, and cyclohexenyl group.
  • Alkynyl groups having 2 to 10 carbon atoms are preferable as the alkynyl groups indicated with R 4 to R 14 , and examples thereof include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-hexynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl
  • Aryl groups having 6 to 30 carbon atoms are preferable as the aryl groups indicated with R 4 to R 14 , and examples thereof include a phenyl group, o-tolyl group, m-tolyl group, p-tolyl group, xylyl group, mesityl group, naphthyl group, and anthracenyl group. These aryl groups further may include an alkyl group, alkoxy group, alkenyl group, and alkynyl group.
  • Alkoxy groups having 1 to 10 carbon atoms are preferable as the alkoxy groups indicated with R 4 to R 14 , and examples thereof include a methoxy group, ethoxy group, n-propoxy group, isopropoxy group, cyclopropyropoxy group, n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group, cyclobutoxy group, and cyclohexyloxy group.
  • Acyl groups having 1 to 10 carbon atoms are preferable as the acyl groups indicated with R 4 to R 14 , and examples thereof include: formyl groups; alkylcarbonyl groups having 2 to 10 carbon atoms such as an acetyl group, propionyl group, butyryl group, isobutyryl group, valeryl group, pivaloyl group, hexanoyl group, heptanoyl group, octanoyl group, and decenoyl group; arylcarbonyl groups having 7 to 10 carbon atoms such as a benzoyl group; and arylalkylcarbonyl groups having 8 to 10 carbon atoms such as a benzylcarbonyl group.
  • Acyloxy groups having 1 to 10 carbon atoms are preferable as the acyloxy groups indicated with R 4 to R 14 , and examples thereof include groups in which one oxygen atom is bonded to each of the groups described above as examples of the acyl groups.
  • halogen atoms indicated with R 5 to R 14 include a fluorine atom, chlorine atom, and bromine atom. Among these, a chlorine atom is preferable.
  • Examples of the bisacylphosphine oxide (B) represented by formula (1) include bis-(2,6-dichlorobenzoyl)phenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-2,5-dimethylphenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-4-propylphenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-1-naphthylphosphine oxide, bis-(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis-(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, bis-(2,6-dimethoxybenzoyl)
  • bisacylphosphine oxide (B) is contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of bisacylphosphine oxide (B) to be added is less than 0.01 part by mass, polymerization may not proceed sufficiently, which may result in a reduction in bond strength. Accordingly, it is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass.
  • the amount of bisacylphosphine oxide (B) to be added exceeds 20 parts by mass, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Accordingly, it is more preferably 18 parts by mass or less, further preferably 15 parts by mass or less, and most preferably 10 parts by mass or less.
  • the composition of the present invention may contain components other than the polymerizable monomer (A) and bisacylphosphine oxide (B) depending on the application of the composition.
  • the composition of the present invention may contain, as a polymerizable monomer component other than the polymerizable monomer (A), polymerizable monomer components such as a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group, a polymerizable monomer (D) having an acidic group, and a crosslinkable polymerizable monomer (E).
  • the composition of the present invention may contain a solvent (F), a polymerization accelerator (H), and a filler (I).
  • the composition may contain at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxides.
  • G polymerization initiator
  • the phrase “the whole amount of polymerizable monomer components” denotes the total amount of the polymerizable monomer (A) and polymerizable monomers (C) to (E).
  • polymerizable groups are groups that are radical-copolymerizable with polymerizable groups of the polymerizable monomer (A).
  • the composition of the present invention contains a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group.
  • a polymerizable monomer (C) particularly when it is used as a dental composition, excellent bond strength is obtained. Since the polymerizable monomer (C) has a polymerizable group, not only radical polymerization can occur but also copolymerization with another monomer can occur.
  • the polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group is not particularly limited.
  • the polymerizable group of the polymerizable monomer (C) is preferably a group that is radical-copolymerizable with a polymerizable group of the polymerizable monomer (A).
  • the polymerizable group of the polymerizable monomer (C) is preferably a (meth)acrylic group or (meth)acrylamide group.
  • the polymerizable monomer (C) is used preferably as a component of a dental composition.
  • the polymerizable group may be detached by, for example, hydrolysis.
  • the polymerizable group of the polymerizable monomer (C) is preferably a methacrylic group or methacrylamide group.
  • the polymerizable monomer (C) has at least one hydroxyl group and therefore has excellent hydrophilicity, and it is a monofunctional polymer monomer having one polymerizable group. Accordingly, when a composition of the present invention containing a polymerizable monomer (A) and a polymerizable monomer (C) is used as a dental composition, an effect that the penetrability into a collagen layer of dentin is further excellent also is obtained.
  • Polymerizable monomers (C) can be used independently or two or more of them can be used in suitable combination.
  • Examples of the polymerizable monomers (C) include 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, 4-hydroxybutyl(meth)acrylate, 6-hydroxyhexyl(meth)acrylate, 10-hydroxydecyl(meth)acrylate, propylene glycol mono(meth)acrylate, glycerol mono(meth)acrylate, erythritol mono(meth)acrylate, N-methylol(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, and N,N-(dihydroxyethyl)(meth)acrylamide.
  • 2-hydroxyethyl(meth)acrylate 3-hydroxypropyl(meth)acrylate, glycerol mono(meth)acrylate, and erythritol mono(meth)acrylate are preferable and 2-hydroxyethylmethacrylate is particularly preferable.
  • the amount of polymerizable monomer (C) to be added is not particularly limited, but it is preferable that 1 to 90 parts by mass of polymerizable monomer (C) be contained in 100 parts by mass of the whole amount of polymerizable monomer components.
  • a composition in which the amount of polymerizable monomer (C) to be added is in such a range is used as a dental composition, both excellent penetrability into a collagen layer of dentin and excellent bond strength are obtained.
  • the amount of polymerizable monomer (C) to be added is less than 1 part by mass, contribution of the polymerizable monomer (C) to penetration into a collagen layer of dentin may not be obtained and the bond strength may be reduced.
  • the amount of polymerizable monomer (C) to be added is more preferably at least 3 parts by mass, further preferably at least 5 parts by mass, and particularly preferably at least 7 parts by mass.
  • the amount of polymerizable monomer (C) to be added is more preferably 80 parts by mass or less, further preferably 75 parts by mass or less, and particularly preferably 70 parts by mass or less.
  • the composition of the present invention contains a polymerizable monomer (D) having an acidic group.
  • a composition containing a polymerizable monomer (D) having an acidic group is used as a dental composition
  • the polymerizable monomer (D) itself that has an acidic group has an acid-etching effect and a primer treatment effect. Therefore, it has advantages that, for example, pretreatments such as an acid etching treatment and a primer treatment are not necessary. Accordingly, a combination with a polymerizable monomer (D) having an acidic group makes it possible to provide a bonding material that is simple to use and has high bond strength and excellent bond durability, particularly preferably a one-component bonding material.
  • Polymerizable monomers (D) having acidic groups can be used independently or two or more of them can be used in suitable combination.
  • the polymerizable monomers (D) having acidic groups are not particularly limited. Examples thereof include a monofunctional polymerizable monomer having one carboxyl group or an acid anhydride group thereof in the molecule, a monofunctional polymerizable monomer having a plurality of carboxyl groups or an acid anhydride group thereof in the molecule, and a monofunctional polymerizable monomer having a phosphinyloxy group or phosphonooxy group in the molecule (also referred to as a monofunctional radical polymerizable phosphoric acid ester).
  • Examples of the monofunctional polymerizable monomer having one carboxyl group or an acid anhydride group thereof in the molecule include (meth)acrylic acid, N-(meth)acryloylglycine, N-(meth)acryloylaspartic acid, N-(meth)acryloyl-5-aminosalicylic acid, 2-(meth)acryloyloxyethyl hydrogen succinate, 2-(meth)acryloyloxyethyl hydrogen phthalate, 2-(meth)acryloyloxyethyl hydrogen malate, 6-(meth)acryloyloxyethyl naphthalene-1,2,6-tricarboxylic acid, O-(meth)acryloyltyrosine, N-(meth)acryloyltyrosine, N-(meth)acryloylphenylalanine, N-(meth)acryloyl-p-aminobenzoic acid, N-(meth)acryloyl-o-a
  • Examples of the monofunctional polymerizable monomer having a plurality of carboxyl groups or an acid anhydride group thereof in the molecule include 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, 10-(meth)acryloyloxydecane-1,1-dicarboxylic acid, 12-(meth)acryloyloxydodecane-1,1-dicarboxylic acid, 6-(meth)acryloyloxyhexane-1,1-dicarboxylic acid, 2-(meth)acryloyloxyethyl-3′-methacryloyloxy-2′-(3,4-dicarboxybenzoyloxy)-propyl succinate, 4-(2-(meth)acryloyloxyethyl)trimeritate anhydride, 4-(2-(meth)acryloyloxyethyl)trimeritate, 4-(meth)acryloyloxyethyl trimeritate, 4-(meth)acryloy
  • Examples of the monofunctional polymerizable monomer having a phosphinyloxy group or phosphonooxy group in the molecule include 2-(meth)acryloyloxyethyl dihydrogenphosphate, 2-(meth)acryloyloxyethylphenyl hydrogenphosphate, 10-(meth)acryloyloxydecyl dihydrogenphosphate, 6-(meth)acryloyloxyhexyl dihydrogenphosphate, 2-(meth)acryloyloxyethyl-2-bromoethyl hydrogenphosphate, and 2-(meth)acrylamideethyl dihydrogenphosphate.
  • Examples of other monofunctional polymerizable monomer having an acidic group include a monofunctional polymerizable monomer having a sulfo group in the molecule such as 2-(meth)acrylamide-2-methylpropanesulfonic acid and 10-sulfodecyl(meth)acrylate.
  • the amount of polymerizable monomer (D) having an acidic group to be added is not particularly limited but it is preferable that 1 to 90 parts by mass of polymerizable monomer (D) having an acidic group be contained in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of polymerizable monomer (D) having an acidic group to be added is less than 1 part by mass, the acid-etching effect or primer treatment effect may not be obtained. Therefore, the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass.
  • the amount of polymerizable monomer (D) having an acidic group to be added exceeds 90 parts by mass, sufficiently high curability may not be obtained and therefore the adhesive properties may be deteriorated. Accordingly, the amount is more preferably 80 parts by mass or less and further preferably 70 parts by mass or less.
  • the composition of the present invention contains a crosslinkable polymerizable monomer (E).
  • a composition containing a crosslinkable polymerizable monomer (E) is used as a dental composition, it has advantages such as a further improvement in bond strength.
  • Crosslinkable polymerizable monomers (E) can be used independently or two or more of them can be used in suitable combination.
  • the crosslinkable polymerizable monomers (E) are not particularly limited. Examples thereof include an aromatic compound-based bifunctional polymerizable monomer, an aliphatic compound-based bifunctional polymerizable monomer, and trifunctional or higher polymerizable monomers.
  • aromatic compound-based bifunctional polymerizable monomer examples include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy)-2-hydroxypropoxyphenyl]propane (commonly known as “Bis-GMA”), 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytetraethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane, 2,2-bis(4-(meth
  • Examples of the aliphatic compound-based bifunctional polymerizable monomer include ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (commonly known as “UDMA”).
  • UDMA 2,2,
  • trifunctional or higher polymerizable monomers examples include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate, and 1,7-diacryloyloxy-2,2,6,6-tetraacryloyloxymethyl-4-oxyheptane.
  • the amount of crosslinkable polymerizable monomer (E) to be added is not particularly limited, but it is preferable that 1 to 90 parts by mass of crosslinkable polymerizable monomer (E) be contained in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of crosslinkable polymerizable monomer (E) to be added is less than 1 part by mass, sufficiently high bond strength may not be obtained. Therefore, the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass.
  • the amount of crosslinkable polymerizable monomer (E) to be added exceeds 90 parts by mass, the composition may not penetrate sufficiently into a collagen layer of dentin and thereby high bond strength may not be obtained. Therefore, the amount is more preferably 80 parts by mass or less and further preferably 70 parts by mass or less.
  • composition of the present invention may contain a polymerizable monomer other than the aforementioned (A), (C), (D), and (E) as required.
  • the composition of the present invention contains a solvent (F) depending on the specific embodiment.
  • the solvent include water (J), an organic solvent (K), and a mixed solvent thereof.
  • the composition of the present invention contains water (J), it exhibits both excellent bond strength and excellent bond durability.
  • the content of water (J) is 6 to 2000 parts by mass with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the content of water (J) is less than 6 parts by mass, the monomer may not penetrate sufficiently into a collagen layer and the bond strength may be reduced.
  • the content of water (I) exceeds 2000 parts by mass, the polymerizability of the monomer may be deteriorated and both the bond strength and bond durability may be reduced.
  • the content of water (J) is more preferably at least 7 parts by mass and further preferably at least 10 parts by mass.
  • the content of water (J) is more preferably 1500 parts by mass or less.
  • water (J) is free of impurities that have adverse effects, and distilled water or ion exchanged water is preferable.
  • Organic solvents (K) can be used independently or two or more of them can be used in suitable combination.
  • Examples of the organic solvent (K) include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-methyl-2-propanol, acetone, methyl ethyl ketone, tetrahydrofuran, diethyl ether, diisopropyl ether, hexane, toluene, chloroform, ethyl acetate, and butyl acetate.
  • the organic solvent (E) is preferably a water-soluble organic solvent.
  • organic solvent (K) is not particularly limited and the organic solvent (K) may not need to be added depending on the embodiment.
  • the preferable amount of the organic solvent (K) to be added varies considerably depending on the embodiment in which it is used. Therefore, preferable amounts of organic solvents (K) to be added according to respective embodiments are indicated together with description of specific embodiments of the composition of the present invention described later.
  • composition of the present invention further may contain a polymerization initiator (G) other than the bisacylphosphine oxide (B), preferably at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxide.
  • This polymerization initiator (G) may be either a photopolymerization initiator or a chemical polymerization initiator.
  • photopolymerization initiator examples include acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, and alpha-amino ketone compounds.
  • acylphosphine oxides used as the photopolymerization initiator include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, 2,6-dichlorobenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, 2,4,6-trimethylbenzoylethoxyphenylphosphine oxide, 2,3,5,6-tetramethylbenzoyldiphenylphosphine oxide, and benzoyl di-(2,6-dimethylphenyl) phosphonate.
  • the water-soluble acylphosphine oxides used as the photopolymerization initiator have alkali metal ions, alkaline earth metal ions, pyridinium ions, or ammonium ions in the acylphosphine oxide molecules.
  • the water-soluble acylphosphine oxides can be synthesized by the method disclosed in EP 0009348 or JP 57(1982)-197289 A.
  • acylphosphine oxides include sodium monomethylacetylphosphonate, sodium monomethyl(1-oxopropyl)phosphonate, sodium monomethylbenzoylphosphonate, sodium monomethyl(1-oxobutyl)phosphonate, sodium monomethyl(2-methyl-1-oxopropyl)phosphonate, sodium acetylphosphonate, sodium monomethylacetylphosphonate, sodium acetylmethylphosphonate, methyl-4-(hydroxymethoxyphosphinyl)-4-oxobutanoate sodium salt, methyl-4-oxophosphonobutanoate monosodium salt, acetylphenylphosphinate sodium salt, sodium (1-oxopropyl)pentylphosphinate, methyl-4-(hydroxypentylphosphinyl)-4-oxobutanoate sodium salt, sodium acetylpentylphosphinate, sodium acetylpentylphosphin
  • acylphosphine oxides and water-soluble acylphosphine oxides particularly preferable ones are 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, and 2,4,6-trimethylbenzoylphenylphosphine oxide sodium salt.
  • thioxanthones or the quaternary ammonium salts of thioxanthones that are used as the above-mentioned photopolymerization initiators include thioxanthone, 2-chlorothioxanthen-9-one, 2-hydroxy-3-(9-oxy-9H-thioxanthen-4-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(1-methyl-9-oxy-9H-thioxanthen-4-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(9-oxo-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride, 2-hydroxy-3-(3,4-
  • thioxanthones or the quaternary ammonium salts of thioxanthones a particularly preferable thioxanthone is 2-chlorothioxanthen-9-one, and a particularly preferable quaternary ammonium salt of thioxanthone is 2-hydroxy-3-(3,4-dimethyl-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride.
  • ketals used as the photopolymerization initiator include benzyl dimethyl ketal and benzyl diethyl ketal.
  • alpha-diketones used as the photopolymerization initiator examples include diacetyl, dibenzyl, camphorquinone, 2,3-pentadione, 2,3-octadione, 9,10-phenanthrenequinone, 4,4′-oxybenzyl, and acenaphthenequinone.
  • camphorquinone is particularly preferable from the viewpoint of having the maximum absorption wavelength in the visible light range.
  • Examples of the coumarin compound used as the aforementioned photopolymerization initiator include compounds described in JP 9(1997)-3109 A and JP 10(1998)-245525 A such as 3,3′-carbonylbis(7-diethylamino)coumarin, 3-(4-methoxybenzoyl)coumarin, 3-thienoyl coumarin, 3-benzoyl-5,7-dimethoxycoumarin, 3-benzoyl-7-methoxycoumarin, 3-benzoyl-6-methoxycoumarin, 3-benzoyl-8-methoxycoumarin, 3-benzoylcoumarin, 7-methoxy-3-(p-nitrobenzoyl)coumarin, 3-(p-nitrobenzoyl)coumarin, 3,5-carbonylbis(7-methoxycoumarin), 3-benzoyl-6-bromocoumarin, 3,3′-carbonylbiscoumarin, 3-benzoyl-7-dimethylaminocoumarin, 3-benzoylbenzo[f]coumarin, 3-
  • coumarin compounds particularly 3,3′-carbonylbis(7-diethylaminocoumarin) and 3,3′-carbonylbis(7-dibutylaminocoumarin) are suitable.
  • anthraquinones used as the aforementioned photopolymerization initiator include anthraquinone, 1-chloroanthraquinone, 2-chloroanthraquinone, 1-bromoanthraquinone, 1,2-benzanthraquinone, 1-methylanthraquinone, 2-ethylanthraquinone, and 1-hydroxyanthraquinone.
  • benzoin alkyl ethers used as the aforementioned photopolymerization initiator include benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether.
  • At least one selected from the group consisting of acylphosphine oxides, salts thereof, alpha-diketones, and coumarin compounds is used in combination with the aforementioned bisacylphosphine oxide (B).
  • B bisacylphosphine oxide
  • a chemical polymerization initiator that is used preferably is organic peroxide.
  • the organic peroxide used as the chemical polymerization initiator is not particularly limited and a known one can be used. Examples of typical organic peroxides include ketone peroxide, hydroperoxide, diacyl peroxide, dialkyl peroxide, peroxyketal, peroxyester, and peroxydicarbonate.
  • ketone peroxide used as the chemical polymerization initiator examples include methyl ethyl ketone peroxide, methyl isobutyl ketone peroxide, methylcyclohexanone peroxide, and cyclohexanone peroxide.
  • hydroperoxide used as the chemical polymerization initiator examples include 2,5-dimethylhexane-2,5-dihydroperoxide, diisopropylbenzene hydroperoxide, cumene hydroperoxide, t-butyl hydroperoxide, and 1,1,3,3-tetramethylbutyl hydroperoxide.
  • diacyl peroxide used as the chemical polymerization initiator examples include acetyl peroxide, isobutyryl peroxide, benzoyl peroxide, decanoyl peroxide, 3,5,5-trimethylhexanoyl peroxide, 2,4-dichlorobenzoyl peroxide, and lauroyl peroxide.
  • dialkyl peroxide used as the chemical polymerization initiator examples include di-t-butyl peroxide, dicumyl peroxide, t-butylcumyl peroxide, 2,5-dimethyl-2,5-di(t-butylperoxy)hexane, 1,3-bis(t-butylperoxyisopropyl)benzene, and 2,5-dimethyl-2,5-di(t-butylperoxy)-3-hexyne.
  • peroxyketal used as the chemical polymerization initiator examples include 1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane, 1,1-bis(t-butylperoxy)cyclohexane, 2,2-bis(t-butylperoxy)butane, 2,2-bis(t-butylperoxy)octane, and 4,4-bis(t-butylperoxy)valeric acid-n-butyl ester.
  • peroxyester used as the chemical polymerization initiator examples include alpha-cumyl peroxyneodecanoate, t-butyl peroxyneodecanoate, t-butyl peroxypivarate, 2,2,4-trimethylpentylperoxy-2-ethyl hexanoate, t-amylperoxy-2-ethyl hexanoate, t-butylperoxy-2-ethyl hexanoate, di-t-butylperoxy isophthalate, di-t-butylperoxy hexahydroterephthalate, t-butylperoxy-3,3,5-trimethyl hexanoate, t-butylperoxy acetate, t-butylperoxy benzoate, and t-butylperoxymaleic acid.
  • peroxydicarbonate used as the chemical polymerization initiator examples include di-3-methoxy peroxydicarbonate, di-2-ethylhexyl peroxydicarbonate, bis(4-t-butylcyclohexyl)peroxydicarbonate, diisopropyl peroxydicarbonate, di-n-propyl peroxydicarbonate, di-2-ethoxyethyl peroxydicarbonate, and diallyl peroxydicarbonate.
  • diacyl peroxide is used preferably from the viewpoint of a comprehensive balance of safety, storage stability, and radical production ability, and among these, benzoyl peroxide is used particularly preferably.
  • the amount of polymerization initiator (G) to be added in the present invention is not particularly limited. However, from the viewpoint of, for example, curability of the resultant composition, it is preferable that 0.001 to 20 parts by mass of polymerization initiator (G) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of polymerization initiator (G) to be added is less than 0.001 part by mass, polymerization may not proceed sufficiently and thereby bond strength may be reduced. Therefore, the amount is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass.
  • the amount of polymerization initiator (G) to be added exceeds 20 parts by mass, in the case where the polymerization initiator itself has low polymerization performance, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Therefore, the amount is more preferably 15 parts by mass or less and further preferably 10 parts by mass or less.
  • the composition of the present invention contains a polymerization accelerator (H).
  • a polymerization accelerator (H) used in the present invention include amines, sulfinic acids and salts thereof, borate compounds, barbituric acid derivatives, triazine compounds, copper compounds, tin compounds, vanadium compounds, halogen compounds, aldehydes, thiol compounds, sulfite, bisulfite, and thiourea compounds.
  • Amines used as the polymerization accelerator (H) can be divided into aliphatic amines and aromatic amines.
  • aliphatic amines include: primary aliphatic amines such as n-butylamine, n-hexylamine, and n-octylamine; secondary aliphatic amines such as diisopropylamine, dibutylamine, and N-methylethanolamine; and tertiary aliphatic amines such as N-methyldiethanolamine, N-ethyldiethanolamine, N-n-butyldiethanolamine, N-lauryldiethanolamine, 2-(dimethylamino)ethyl methacrylate, N-methyldiethanolamine dimethacrylate, N-ethyldiethanolamine dimethacrylate, triethanolamine monomethacrylate, triethanolamine dimethacrylate, triethanolamine trimethacrylate, triethanolamine, trimethylamine, triethylamine,
  • aromatic amine examples include N,N-bis(2-hydroxyethyl)-3,5-dimethylaniline, N,N-di(2-hydroxyethyl)-p-toluidine, N,N-bis(2-hydroxyethyl)-3,4-dimethylaniline, N,N-bis(2-hydroxyethyl)-4-ethylaniline, N,N-bis(2-hydroxyethyl)-4-isopropylaniline, N,N-bis(2-hydroxyethyl)-4-t-butylaniline, N,N-bis(2-hydroxyethyl)-3,5-di-isopropylaniline, N,N-bis(2-hydroxyethyl)-3,5-di-t-butylaniline, N,N-dimethylaniline, N,N-dimethyl-p-toluidine, N,N-dimethyl-m-toluidine, N,N-diethyl-p-toluidine, N
  • At least one selected from the group consisting of N,N-di(2-hydroxyethyl)-p-toluidine, 4-N,N-dimethylaminobenzoic acid ethyl ester, N,N-dimethylaminobenzoic acid n-butoxyethyl ester, and 4-N,N-dimethylaminobenzophenone is used preferably from the viewpoint of being capable of providing the composition with excellent curability.
  • Examples of sulfinic acid and salt thereof used as the polymerization accelerator (H) include p-toluenesulfinic acid, sodium p-toluenesulfinate, potassium p-toluenesulfinate, lithium p-toluenesulfinate, calcium p-toluenesulfinate, benzenesulfinic acid, sodium benzenesulfinate, potassium benzenesulfinate, lithium benzenesulfinate, calcium benzenesulfinate, 2,4,6-trimethylbenzenesulfinic acid, sodium 2,4,6-trimethylbenzenesulfinate, potassium 2,4,6-trimethylbenzenesulfinate, lithium 2,4,6-trimethylbenzenesulfinate, calcium 2,4,6-trimethylbenzenesulfinate, 2,4,6-triethylbenzenesulfinic acid, sodium 2,4,6-triethylbenzenesulfinate, potassium
  • the borate compound used as the polymerization accelerator (H) is preferably an arylborate compound.
  • arylborate compounds that are used preferably include, as a borate compound having one aryl group in one molecule, sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of trialkylphenylboron, trialkyl(p-chlorophenyl)boron, trialkyl(p-fluorophenyl)boron, trialkyl(3,5-bistrifluoromethyl)phenylboron, trialkyl[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)pheny
  • borate compound having two aryl groups in one molecule examples include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of dialkyldiphenylboron, dialkyldi(p-chlorophenyl)boron, dialkyldi(p-fluorophenyl)boron, dialkyldi(3,5-bistrifluoromethyl)phenylboron, dialkyldi[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, dialkyldi(p-nitrophenyl)boron, dialkyldi(m-nitrophenyl
  • borate compound having three aryl groups in one molecule examples include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of monoalkyltriphenylboron, monoalkyltri(p-chlorophenyl)boron, monoalkyltri(p-fluorophenyl)boron, monoalkyltri(3,5-bistrifluoromethyl)phenylboron, monoalkyltri[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, monoalkyltri(p-nitrophenyl)boron, monoalkyltri(m-nitropheny
  • examples of the borate compound having four aryl groups in one molecule include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of tetraphenylboron, tetrakis(p-chlorophenyl)boron, tetrakis(p-fluorophenyl)boron, tetrakis(3,5-bistrifluoromethyl)phenylboron, tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, tetrakis(p-nitrophenyl)boron, tetraki
  • arylborate compounds More preferably, from the viewpoint of storage stability, among these arylborate compounds, a borate compound having three or four aryl groups in one molecule is used. Furthermore, one of these arylborate compounds can be used or two or more of them can be used in mixture.
  • Examples of a barbituric acid derivative used as the polymerization accelerator (H) include barbituric acid, 1,3-dimethylbarbituric acid, 1,3-diphenylbarbituric acid, 1,5-dimethylbarbituric acid, 5-butylbarbituric acid, 5-ethylbarbituric acid, 5-isopropylbarbituric acid, 5-cyclohexylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1,3-dimethyl-5-ethylbarbituric acid, 1,3-dimethyl-n-butylbarbituric acid, 1,3-dimethyl-5-isobutylbarbituric acid, 1,3-dimethylbarbituric acid, 1,3-dimethyl-5-cyclopentylbarbituric acid, 1,3-dimethyl-5-cyclohexylbarbituric acid, 1,3-dimethyl-5-phenylbarbituric acid, 1-cyclohexyl-1-e
  • barbituric acid derivatives examples include 5-butylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1-cyclohexyl-5-ethylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, and sodium salts of these barbituric acids.
  • Examples of the triazine compound used as the polymerization accelerator (H) include 2,4,6-tris(trichloromethyl)-s-triazine, 2,4,6-tris(tribromomethyl)-s-triazine, 2-methyl-4,6-bis(trichloromethyl)-s-triazine, 2-methyl-4,6-bis(tribromomethyl)-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methylthiophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(2,4-dichlorophenyl)-4,6-bis(trichloromethyl)-s-triazine
  • triazine compounds described above as examples are 2,4,6-tris(trichloromethyl)-s-triazine in terms of polymerization activity and 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, and 2-(4-biphenylyl)-4,6-bis(trichloromethyl)-s-triazine in terms of storage stability.
  • One of the above-mentioned triazine compounds may be used or two or more of them may be used in mixture.
  • Examples of the copper compound used preferably as the polymerization accelerator (H) include copper acetylacetonate, copper (II) acetate, copper oleate, copper (II) chloride, and copper (II) bromide.
  • tin compound used as the polymerization accelerator (H) examples include di-n-butyltin dimalate, di-n-octyltin dimalate, di-n-octyltin dilaurate, and di-n-butyltin dilaurate.
  • Particularly preferable tin compounds are di-n-octyltin dilaurate and di-n-butyltin dilaurate.
  • the vanadium compound used as the polymerization accelerator (H) is preferably one of tetravalent and/or pentavalent vanadium compounds.
  • the tetravalent and/or pentavalent vanadium compounds include compounds described in JP 2003-96122 A such as divanadium (IV) tetroxide, vanadyl (IV) acetylacetonate, vanadyl (IV) oxalate, vanadyl (IV) sulfate, oxobis(1-phenyl-1,3-butanedionate)vanadium (IV), bis(maltolato)oxovanadium (IV), vanadium (V) pentoxide, sodium metavanadate (V), and ammonium metavanadate (V).
  • halogen compound used preferably as the polymerization accelerator (H) examples include dilauryldimethylammoniumchloride, lauryldimethylbenzylammoniumchloride, benzyltrimethylammoniumchloride, tetramethylammoniumchloride, benzyldimethylcetylammoniumchloride, and dilauryldimethylammoniumbromide.
  • aldehydes used as the polymerization accelerator (H) include terephthalaldehyde and a benzaldehyde derivative.
  • examples of the benzaldehyde derivative include dimethylaminobenzaldehyde, p-methyloxybenzaldehyde, p-ethyloxybenzaldehyde, and p-n-octyloxybenzaldehyde. Among these, from the viewpoint of curability, p-n-octyloxybenzaldehyde is used preferably.
  • Examples of the thiol compound used as the polymerization accelerator (H) include 3-mercaptopropyltrimethoxysilane, 2-mercaptobenzooxazol, decanethiol, and thiobenzoic acid.
  • sulfite used as the polymerization accelerator (H) examples include sodium sulfite, potassium sulfite, calcium sulfite, and ammonium sulfite.
  • Examples of bisulfate used as the polymerization accelerator (H) include sodium bisulfate and potassium bisulfate.
  • Examples of the thiourea compound used as the polymerization accelerator (H) include 1-(2-pyridyl)-2-thiourea, thiourea, methylthiourea, ethylthiourea, N,N′-dimethylthiourea, N,N′-diethylthiourea, N,N′-di-n-propylthiourea, N,N′-dicyclohexylthiourea, trimethylthiourea, triethylthiourea, tri-n-propylthiourea, tricyclohexylthiourea, tetramethylthiourea, tetraethylthiourea, tetra-n-propylthiourea, and tetracyclohexylthiourea.
  • the amount of polymerization accelerator (H) to be added in the present invention is not particularly limited. However, from the viewpoints of, for example, curability of the resultant composition, it is preferable that 0.001 to 30 parts by mass of polymerization accelerator (H) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of polymerization accelerator (H) to be added is less than 0.001 part by mass, polymerization may not proceed sufficiently and bond strength may be reduced. Therefore, the amount is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass.
  • the amount of polymerization accelerator (H) to be added exceeds 30 parts by mass, in the case where the polymerization initiator itself has low polymerization performance, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Therefore, the amount is more preferably 20 parts by mass or less and further preferably 10 parts by mass or less.
  • a filler (I) further is mixed into a composition of the present invention depending on the embodiment.
  • such fillers are divided roughly into organic fillers, inorganic fillers, and organic-inorganic composite fillers.
  • examples of materials for the organic fillers include polymethylmethacrylate, polyethylmethacrylate, a methylmethacrylate-ethylmethacrylate copolymer, cross-linked polymethylmethacrylate, cross-linked polyethylmethacrylate, polyamide, polyvinyl chloride, polystyrene, chloroprene rubber, nitrile rubber, an ethylene-vinyl acetate copolymer, a styrene-butadiene copolymer, an acrylonitrile-styrene copolymer, and an acrylonitrile-styrene-butadiene copolymer.
  • the organic fillers are not particularly limited, and particle sizes of the fillers to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the organic fillers is preferably 0.001 to 50 ⁇ m and more preferably 0.001 to 10 ⁇ m.
  • Examples of materials for the inorganic fillers include quartz, silica, alumina, silica-titania, silica-titania-barium oxide, silica-zirconia, silica-alumina, lanthanum glass, borosilicate glass, soda glass, barium glass, strontium glass, glass ceramics, aluminosilicate glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass.
  • the inorganic fillers are not particularly limited and particle sizes of the fillers to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the inorganic fillers is preferably 0.001 to 50 ⁇ m and more preferably 0.001 to 10 ⁇ m.
  • Examples of the shapes of the inorganic fillers include amorphous fillers and spherical fillers. From the viewpoint of improving the mechanical strength of a composition, it is preferable that spherical fillers be used as the inorganic fillers. Furthermore, in the case of using the spherical fillers, when a composition of the present invention is used as a dental composite resin, there also is an advantage that a composition resin with excellent surface smoothness is obtained.
  • the spherical fillers are fillers in which when a photograph thereof is taken with a scanning electron microscope (hereinafter abbreviated as SEM), particles observed within a unit field of view are rounded and the mean uniformity obtained by dividing the particle size in the direction orthogonal to the maximum diameter by the maximum diameter is at least 0.6.
  • the mean particle size of the spherical fillers is preferably 0.1 to 5 ⁇ m. When the mean particle size is less than 0.1 ⁇ m, the filling rate of the spherical fillers in the composition decreases and thereby the mechanical strength may be reduced. On the other hand, when the mean particle size exceeds 5 ⁇ m, the surface areas of the spherical fillers are reduced and a cured product with high mechanical strength may not be obtained.
  • the inorganic fillers may be used after the surfaces thereof are treated beforehand with a known surface-treating agent such as a silane coupling agent in order to adjust fluidity of the composition as required.
  • a surface-treating agent such as a silane coupling agent
  • examples of such a surface-treating agent include vinyltrimethoxysilane, vinyltriethoxysilane, vinyltrichlorosilane, vinyltri( ⁇ -methoxyethoxy)silane, ⁇ -methacryloyloxypropyltrimethoxysilane, 11-methacryloyloxyundecyltrimethoxysilane, ⁇ -glycidoxypropyltrimethoxysilane, ⁇ -mercaptopropyltrimethoxysilane, and ⁇ -aminopropyltriethoxysilane.
  • the organic-inorganic composite fillers used in the present invention can be obtained as follows. That is, a monomer compound is added to the aforementioned inorganic filler beforehand, this is made into a paste and is then polymerized, and thereafter this is crushed.
  • the organic-inorganic composite filler that can be used is, for example, a TMPT filler (obtained by mixing trimethylolpropane methacrylate with a silica filler, polymerizing it, and then crushing it).
  • the shape of the organic-inorganic composite filler is not particularly limited, and the particle size of the filler to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the organic-inorganic composite filler is preferably 0.001 to 50 ⁇ m and more preferably 0.001 to 10 ⁇ m.
  • the amount of the filler (I) to be added in the present invention is not particularly limited, but it is preferable that 1 to 2000 parts by mass of filler (I) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the preferable amount of filler (I) to be added varies considerably depending on the embodiment to be employed. Accordingly, preferable amounts of the filler (I) to be added according to the respective embodiments are indicated together with description of specific embodiments of the composition of the present invention described later.
  • a pH adjuster for example, a pH adjuster, polymerization inhibitor, ultraviolet absorbent, thickening agent, colorant, antibacterial agent, and flavor may be added to the composition of the present invention within a range that does not inhibit the effect of the present invention.
  • the composition of the present invention is used suitably as a dental composition.
  • This dental composition can be used for dental materials such as a primer, bonding material, composite resin, cement (resin cement, glass ionomer cement, and resin-reinforced glass ionomer cement), pit and fissure sealant, and denture base resin, and particularly, it is used suitably as a primer, bonding material, composite resin, or cement.
  • the composition may be used as a two component type in which the components of the composition are divided into two.
  • a dental adhesive is used when a lost part of a tooth is filled or covered with a restorative material.
  • the dental adhesive is allowed to act on dentin.
  • a hybrid layer hereinafter also referred to as a “resin-impregnated layer”
  • a bonding system in which these three steps, “decalcifying”, “penetration”, and “curing”, are performed separately is referred to as a “three-step bonding system”.
  • a product used for the penetration step is a primer
  • a product used for the curing step is a bonding material.
  • the product is referred to as a “self-etching primer”.
  • the bonding system using a self-etching primer and a bonding material is referred to as a “two-step bonding system”.
  • the polymerizable monomer (A) used in the present invention has at least two hydroxyl groups and has high hydrophilicity. Therefore, it easily penetrates into a collagen layer of dentin. Accordingly, a composition of the present invention containing a polymerizable monomer (A) can be used as a dental primer and also can be used as a dental self-etching primer.
  • the primer using a composition of the present invention is a composition containing a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, and solvent (F). Furthermore, an embodiment containing a polymerization accelerator (H) also is used preferably.
  • the amounts of the above-mentioned (A) and (D) to be added are preferably 10 to 99 parts by mass of (A) and 1 to 90 parts by mass of (D), more preferably 15 to 98 parts by mass of (A) and 2 to 85 parts by mass of (D), and further preferably 20 to 97 parts by mass of (A) and 3 to 80 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the primer composition contains (A), (C), and (D)
  • the amounts of respective components to be added are preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass of (C), and 1 to 90 parts by mass of (D), more preferably 3 to 90 parts by mass of (A), 5 to 85 parts by mass of (C), and 2 to 80 parts by mass of (D), and further preferably 10 to 80 parts by mass of (A), 7 to 80 parts by mass of (C), and 3 to 60 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • a crosslinkable polymerizable monomer (E) further may be added.
  • the above-mentioned (E) is preferably an aliphatic compound-based bifunctional polymerizable monomer, more preferably ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, or 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and further preferably triethylene glycol di(meth)acrylate, or 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane.
  • the amount of the above-mentioned (E) to be added is preferably 0 to 30 parts by mass, more preferably 1 to 25 parts by mass, and further preferably 3 to 20 parts by mass, in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of bisacylphosphine oxide (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the use of bisacylphosphine oxide (B) and polymerization initiator (G) in combination also is a preferable embodiment.
  • the amount of (G) to be contained is preferably 0.001 to 20 parts by mass and more preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the additional use of a polymerization accelerator (H) also is a preferable embodiment and particularly amines are used suitably.
  • the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the solvent (F) be used in the form of a mixed solvent of water (J) and an organic solvent (K).
  • the amount of water (J) to be contained in the mixed solvent is not particularly limited but is preferably at least 10 mass %, more preferably at least 30 mass %, and further preferably at least 50 mass %.
  • the organic solvent (K) may not need to be added depending on the embodiment.
  • the amount of the aforementioned solvent (F) to be added is preferably 5 to 4000 parts by mass, preferably 10 to 3000 parts by mass, and further preferably 15 to 2000 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amounts of the aforementioned (J) and (K) to be added are preferably 4 to 2000 parts by mass of (J) and 1 to 2000 parts by mass of (K), more preferably 8 to 1500 parts by mass of (J) and 2 to 1500 parts by mass of (K), and further preferably 12 to 1000 parts by mass of (J) and 3 to 1000 parts by mass of (K), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the composition of the present invention is used preferably as a bonding material.
  • the bonding material in the aforementioned “two-step bonding system” is a composition containing the aforementioned polymerizable monomer (A), bisacylphosphine oxide (B), and filler (I). More preferably, such a composition further contains a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group and/or crosslinkable polymerizable monomer (E). Furthermore, an embodiment containing a polymerization initiator (G) and polymerization accelerator (H) also is used preferably.
  • the amounts of respective components to be added are preferably 1 to 99 parts by mass of (A), 0 to 90 parts by mass of (C), and 0 to 90 parts by mass of (E) and more preferably 2 to 96 parts by mass of (A), 1 to 80 parts by mass of (C), and 1 to 80 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the use of a compound having at least two polymerizable groups allows a cured product to have increased mechanical strength.
  • the aforementioned (E) is more preferably a polymerizable monomer having at least two polymerizable groups, and from a viewpoint of obtaining a cured product with particularly high strength, it is further preferable that the aforementioned (E) contain an aromatic compound-based bifunctional polymerizable monomer.
  • the use of an aliphatic bifunctional polymerizable monomer and aromatic compound-based bifunctional polymerizable monomer in combination as the aforementioned (E) also is a preferable embodiment.
  • the amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the use of a bisacylphosphine oxide (B) and polymerization initiator (G) in combination also is a preferable embodiment.
  • the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably.
  • the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of filler (I) to be added is preferably 1 to 20 parts by mass, more preferably 2 to 17 parts by mass, and further preferably 3 to 15 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • One-step bonding systems Two typical products of the bonding material used in such a one-step bonding system are a bonding material in which two separate liquids of liquid A and liquid B are mixed together immediately before use and a bonding material that is provided in the form of one liquid from the beginning and that is a so-called one-component one-step bonding system.
  • the one-component type product further simplifies the process and therefore has a greater advantage in use.
  • the composition is preferably a composition containing a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, filler (I), and solvent (F), and further preferably, such a composition further contains a crosslinkable polymerizable monomer (E).
  • the amounts of respective components to be added are preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass (D), and 0 to 90 parts by mass of (E), more preferably 2 to 94 parts by mass of (A), 2 to 80 parts by mass of (D), and 2 to 80 parts by mass of (E), and further preferably 7 to 90 parts by mass of (A), 3 to 70 parts by mass of (D), and 7 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group it is preferable that a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group further be contained.
  • the amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 95 parts by mass of (D), and 3 to 97 parts by mass of (E), more preferably 3 to 90 parts by mass of (A), 3 to 85 parts by mass of (C), 2 to 80 parts by mass of (D), and 5 to 80 parts by mass of (E), and further preferably 5 to 80 parts by mass of (A), 5 to 80 parts by mass of (C), 3 to 60 parts by mass of (D), and 8 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • a combined use of a bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment.
  • the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of filler (I) to be added is preferably 1 to 20 parts by mass, more preferably 1.5 to 15 parts by mass, and further preferably 2 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of solvent (F) to be added is preferably 6 to 4000 parts by mass, more preferably 12 to 3000 parts by mass, and further preferably 15 to 2000 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the one-component one-step bonding system needs to perform all the processes of decalcifying, penetration, and curing with one liquid in one step. Therefore, from the viewpoint that penetrability is considered important, it is preferable that water (J) be contained as the solvent (F). On the other hand, from the viewpoint that curability is considered important, it is preferable that the bonding system contain a suitable amount of crosslinkable polymerizable monomer (E).
  • an organic solvent (K) be contained as the aforementioned solvent (F).
  • a more preferable embodiment is the use of the solvent (F) in the form of a mixed solvent of water (J) and an organic solvent (K).
  • the amounts of the aforementioned (J) and (K) to be added are preferably 2 to 2000 parts by mass of (J) and 4 to 2000 parts by mass of (K), more preferably 4 to 1500 parts by mass of (J) and 8 to 1500 parts by mass of (K), and further preferably 5 to 1000 parts by mass of (J) and 10 to 1000 parts by mass of (K), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the composition of the present invention is used preferably as composite resin.
  • the composition is preferably one containing a polymerizable monomer (A), bisacylphosphine oxide (B), crosslinkable polymerizable monomer (E), and filler (I).
  • A polymerizable monomer
  • B bisacylphosphine oxide
  • E crosslinkable polymerizable monomer
  • I filler
  • the composite resin is used in the form of filling a cavity after the cavity is formed by cutting a site of caries incidence. Thereafter, generally, the composite resin filling the cavity is cured through photopolymerization. Therefore, the use of the bisacylphosphine oxide (B), a photopolymerization initiator, has significance.
  • the content of the filler (I) in the composition is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the content of the filler (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient.
  • the amounts of respective components to be added are preferably 1 to 99 parts by mass of (A) and 1 to 99 parts by mass of (E), more preferably 10 to 95 parts by mass of (A) and 5 to 90 parts by mass of (E), and further preferably 15 to 90 parts by mass of (A) and 10 to 85 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 15 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the combined use of the bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment.
  • the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably.
  • the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the polymerizable monomer (A) in the present invention has both excellent curability and penetrability into a tooth structure, it is preferable that it be used particularly as a self-adhesive composite resin among composite resins.
  • the composition of the present invention it is preferable that the composition contain a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, crosslinkable polymerizable monomer (E), and filler (I).
  • the amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (D), and 4 to 90 parts by mass of (E), more preferably 5 to 80 parts by mass of (A), 2 to 85 parts by mass of (D), and 6 to 85 parts by mass of (E), and further preferably 10 to 80 parts by mass of (A), 3 to 80 parts by mass of (D), and 8 to 80 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the composition further contain a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group.
  • the amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 90 parts by mass of (D), and 3 to 90 parts by mass (E), more preferably 3 to 90 parts by mass of (A), 3 to 85 parts by mass of (C), 2 to 85 parts by mass of (D), and 5 to 85 parts by mass of (E), and further preferably 5 to 80 parts by mass of (A), 5 to 70 parts by mass of (C), 3 to 60 parts by mass of (D), and 8 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the same amounts as those used in the aforementioned general composite resin can be employed. Furthermore, in the same manner as in the case of the aforementioned general composite resin, the combined use of the bisacylphosphine oxide (B), polymerization initiator (G), and polymerization accelerator (H) also is a preferable embodiment.
  • the amounts of the aforementioned (B), (G), and (H) to be added are as described above.
  • a solvent (F) when particularly the penetrability into a tooth structure is considered important, it also is possible to add a solvent (F), and it is further preferable that the solvent (F) contain water (J).
  • the amount of solvent (F) to be added is preferably 0 to 15 parts by mass and more preferably 1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • a composition of the present invention as a dental cement also is one of preferable embodiments.
  • preferable cements include a resin cement, glass ionomer cement, and resin-reinforced glass ionomer cement.
  • the composition of the present invention is preferably one containing a polymerizable monomer (A), bisacylphosphine oxide (B), crosslinkable polymerizable monomer (E), polymerization accelerator (H), filler (I), and water (J) to serve as a solvent (F).
  • a composition further can contain a polymerizable monomer (D) having an acidic group.
  • the dental cement is used suitably as, for example, a luting material that is used in fixing a metal or ceramics dental crown restorative material, which is referred to as an “inlay” or “crown”, to a tooth.
  • a luting material that is used in fixing a metal or ceramics dental crown restorative material, which is referred to as an “inlay” or “crown”, to a tooth.
  • the resultant cured product has increased mechanical strength and can withstand, for example, occlusal pressure.
  • the aforementioned (E) be a polymerizable monomer having at least two polymerizable groups.
  • a chemical polymerization initiator be used as the aforementioned (G).
  • the use of amines and/or sulfinic acid and salt thereof as the aforementioned (H) is preferable and the simultaneous use of amines and sulfinic acid and salt thereof is more preferable.
  • the filler (I) used is not particularly limited.
  • the cement is intended to be provided with a property of sustained-release of fluoride
  • at least one selected from the group consisting of fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass be used as the filler (I)
  • fluoroaluminosilicate glass and/or barium fluoroaluminosilicate glass be used as the filler (I).
  • the cement when the cement is intended to be provided with radiopacity, it is preferable that at least one selected from the group consisting of barium glass, strontium glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, strontium fluoroaluminosilicate glass, and barium fluoroaluminosilicate glass be used as the filler (I), and it is more preferable that barium glass and/or barium fluoroaluminosilicate glass be used as the filler (I).
  • the aforementioned (G) and (H) be stored in separate containers, respectively. That is, in a preferred embodiment, the resin cement is used in the form of a two component type. In a more preferred embodiment, the resin cement is used in the form of two paste type. Preferably, the respective pastes are stored while being separated from each other, the two pastes are mixed together immediately before use, and thereby chemical polymerization is allowed to proceed to cure the mixture.
  • the aforementioned pastes each are prepared by mixing a liquid component of, for example, polymerizable monomer with a filler (I) (powder) together.
  • the aforementioned (D) and (H) be stored in separate containers, respectively.
  • the aforementioned two pastes are referred to as a paste A and a paste B, respectively, an embodiment in which the paste A contains (A), (D), (B), (G), and (I) and the paste B contains (A), (H), and (I) is used particularly suitably.
  • the amounts of respective components to be added are not particularly limited. However, in 100 parts by mass of the whole amount of polymerizable monomer components, the composition contains preferably 1 to 98 parts by mass of (A), 0 to 90 parts by mass of (C), 1 to 90 parts by mass of (D), and 1 to 90 parts by mass of (E), and more preferably 2 to 96 parts by mass of (A), 0 to 85 parts by mass of (C), 2 to 85 parts by mass of (D), and 2 to 85 parts by mass of (E).
  • the amounts of the aforementioned (B), (G), and (H) to be added are preferably 0.01 to 20 parts by mass of (B), 0.001 to 20 parts by mass of (G), and 0.001 to 30 parts by mass of (H) and more preferably 0.05 to 15 parts by mass of (B), 0.05 to 15 parts by mass of (G), and 0.05 to 20 parts by mass of (H), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the content of (I) is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass.
  • the content of (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient.
  • the content of (I) exceeds 2000 parts by mass, when the resin cement is used as a two-paste-type cement, which is a preferred embodiment, the pastes lack fluidity, which makes it difficult to carry out sufficient mixing, and therefore the cured product may have reduced strength.
  • the composition of the present invention is used preferably as a glass ionomer cement and more preferably as a resin-reinforced glass ionomer cement.
  • the glass ionomer cement is typically one in which an inorganic filler such as fluoroaluminosilicate glass and polyalkenoic acid such as polyacrylic acid are reacted with each other through an acid-base reaction to be cured.
  • an inorganic filler such as fluoroaluminosilicate glass and polyalkenoic acid such as polyacrylic acid
  • the polyacrylic acid interacts with calcium contained in hydroxyapatite composing a tooth structure and thereby a bonding function is exhibited.
  • compositions of the present invention are used as a glass ionomer cement, particularly preferably as a resin-reinforced glass ionomer cement, the composition is preferably one containing (A), (B), (H), (I), (F), and polyalkenoic acid, and more preferably one containing (A), (E), (B), (H), (I), (F), and polyalkenoic acid, one containing (A), (C), (B), (H), (I), (F), and polyalkenoic acid, or one containing (A), (C), (E), (B), (H), (I), (F), and polyalkenoic acid.
  • Such compositions further can contain (D).
  • the polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group to be used is not particularly limited. As described later, from the viewpoint that an acid-base reaction is allowed to proceed smoothly, it is preferable that the solvent (F) contain water (J). Therefore, from the viewpoints of maintaining the uniformity of the composition and obtaining consistent performance, it is more preferable that a monomer with high affinity for water (J) be used as the aforementioned (C).
  • Such a monomer with high affinity for water (J) is preferably 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, glycerol mono(meth)acrylate, or erythritol mono(meth)acrylate and particularly preferably 2-hydroxyethylmethacrylate.
  • the crosslinkable polymerizable monomer (E) to be used is not particularly limited, but as described above, the use of a monomer with high affinity for water (J) as the aforementioned (E) is more preferable from the viewpoints of maintaining the uniformity of the composition and obtaining consistent performance.
  • the aforementioned (E) is preferably an aliphatic compound-based bifunctional polymerizable monomer and more preferably triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, or 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl) dimethacrylate (commonly known as “UDMA”).
  • UDMA 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl) dimethacrylate
  • the aforementioned polyalkenoic acid is a polymer of unsaturated monocarboxylic acid or unsaturated dicarboxylic acid.
  • Specific examples of the polyalkenoic acid include homopolymers of, for example, acrylic acid, methacrylic acid, 2-chloroacrylic acid, 2-cyanoacrylic acid, aconitic acid, mesaconic acid, maleic acid, itaconic acid, fumaric acid, glutaconic acid, citraconic acid, and utraconic acid, or copolymers of these unsaturated carboxylic acids and monomers copolymerizable therewith.
  • the ratio of the unsaturated carboxylic acid unit is preferably at least 50 mol % with respect to the total structure unit.
  • An ethylenically unsaturated polymerizable monomer is preferable as the copolymerizable monomer, and examples thereof include styrene, acrylamide, acrylonitrile, methyl methacrylate, acrylic acid salts, vinyl chloride, allyl chloride, vinyl acetate, and 1,1,6-trimethylhexamethylene dimethacrylate ester.
  • a homopolymer or copolymer of acrylic acid or maleic acid is preferable.
  • a weight-average molecular weight of the polyalkenoic acid When these polyalkenoic acids have a weight-average molecular weight of less than 5,000, the cured product of the dental cement composition may have reduced strength and poor durability. On the other hand, when it has a weight-average molecular weight exceeding 40,000, it may have high consistency during mixing of the dental cement composition and therefore may have lower operability. Accordingly, a preferable weight-average molecular weight of the polyalkenoic acid is 5,000 to 40,000.
  • the filler (I) to be used is preferably at least one selected from the group consisting of fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass, and more preferably fluoroaluminosilicate glass and/or barium fluoroaluminosilicate glass.
  • the solvent (F) to be used is not particularly limited. However, from the viewpoint that an acid-base reaction is allowed to proceed smoothly, it is preferable that the solvent (F) contain water (J).
  • the content of water (J) in the mixed solvent is preferably at least 50 mass %, more preferably at least 70 mass %, and further preferably at least 90 mass %.
  • the solvent (F) consist substantially of water (J) alone.
  • the amounts of respective components to be added are not particularly limited.
  • the composition contains (A) and (C), it contains preferably 1 to 99 parts by mass of (A), 1 to 90 parts by mass of (C), and 0 to 50 parts by mass of (D) and more preferably 2 to 95 parts by mass of (A), 5 to 85 parts by mass of (C), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • composition contains (A) and (E), it contains preferably 1 to 99 parts by mass of (A), 1 to 90 parts by mass of (E), and 0 to 50 parts by mass of (D) and more preferably 2 to 95 parts by mass of (A), 5 to 98 parts by mass of (E), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the composition contains (A), (C), and (E), it contains preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 90 parts by mass of (E), and 0 to 50 parts by mass of (D) and more preferably 2 to 90 parts by mass of (A), 5 to 85 parts by mass of (C), 5 to 85 parts by mass of (E), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • the combined use of bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment.
  • the content of (G) is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably.
  • the content of (H) is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the content of (I) is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • the content of (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient.
  • the content of (I) exceeds 2000 parts by mass, the composition paste has lower fluidity, which makes sufficient mixing difficult, and therefore the acid-base reaction may not proceed smoothly. As a result, the cured product may have reduced strength.
  • the content of solvent (F) is preferably 7 to 500 parts by mass, more preferably 10 to 300 parts by mass, and further preferably 20 to 100 parts by mass.
  • the acid-base reaction can proceed smoothly, and the resultant cured product has excellent mechanical strength and excellent adhesive properties to a tooth structure.
  • the content of the aforementioned polyalkenoic acid is preferably 1 to 200 parts by mass, more preferably 5 to 100 parts by mass, and further preferably 10 to 50 parts by mass.
  • the polyalkenoic acid is contained in such ranges, curing through the acid-base reaction proceeds smoothly and decay of the resultant cured product inside an oral cavity by, for example, hydrolysis can be diminished.
  • a basic filler (I) and polyalkenoic acid be packed in separate containers and be used after being mixed immediately before use.
  • the preferable types of products to be employed include a so-called powder-liquid type, but from the viewpoint of improving handling ability, the form of so-called two past-type glass ionomer cement containing two types of pastes is more preferable.
  • the type of product is the two paste type
  • the paste A contains (A), (B), (F), (I), and polyalkenoic acid and the paste B contains (C) and (I).
  • the paste A contains (A), (B), (F), (I), and polyalkenoic acid and the paste B contains (E) and (I) also is used preferably.
  • the paste A contains (E), (B), (I), and polyalkenoic acid and the paste B contains (A), (G), (I), and (F) also is used preferably.
  • the paste A further contain (D), and from the similar viewpoint, it also is preferable that the paste B further contain (C).
  • the paste A contains polyalkenoic acid
  • the filler (I) contained in the paste A to be used is preferably one that exhibits no reactivity with polyalkenoic acid, and particularly preferably quartz.
  • These dental materials can be prepared and used according to a conventional method. These dental materials exhibit excellent bond strength and bond durability with respect to a tooth structure (particularly dentin).
  • the present invention is described in further detail using examples but is not limited thereto.
  • Respective components were mixed together at an ordinary temperature and thereby a one-component bonding material composition was produced.
  • the composition thereof is indicated in Table 1.
  • the bond strength with respect to bovine teeth dentin was measured according to the following procedure.
  • MDMA is a new compound and it was synthesized by the following method.
  • the resultant organic layer was subjected to vacuum concentration using an evaporator and thus an oily material was obtained.
  • the yield amount was 36.3 g, and the yield rate was 37%.
  • the oily material was purified using silica gel column chromatography (diluent:ethyl acetate 100%) and was concentrated. As a result, white crystals were precipitated. It was confirmed by NMR that these crystals were a target compound. The yield amount was 8.7 g and the yield rate was 60%.
  • the labial surface of a bovine mandibular incisor was ground with #80 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water, and thereby a sample with an exposed flat surface of dentin was obtained.
  • the sample thus obtained further was ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water. After completion of grinding, water on the surface was air-blown to be dried.
  • An adhesive tape with a thickness of about 150 ⁇ m having a circular hole whose diameter was 3 mm was attached to the smooth surface that had been dried and thereby the adhesive area was defined.
  • Each one-component bonding material composition produced above was applied into the above-mentioned circular hole using a brush and was then allowed to stand for 20 seconds. Thereafter, the surface thereof was air-blown with a dental air syringe and thereby the one-component bonding material composition thus applied was dried until it lost fluidity. Subsequently, it was irradiated with light using a dental visible light unit “JET LITE 3000” (manufactured by J. Morita USA) for 10 seconds. Thus, the one-component bonding material composition that had been applied was cured.
  • a dental filling composite resin (manufactured by Kuraray Medical Inc., “CLEARFILAP-X” (trade name, registered trademark)) was applied to the surface of each resultant cured product of the one-component bonding material compositions, and it was then covered with a mold release film (polyester). Next, slide glass was placed on the mold release film to press it, and thereby the surface of the applied composite resin was smoothed. Subsequently, the composite resin was irradiated with light for 20 seconds using the aforementioned unit “JET LITE 3000” through the mold release film. Thus, the composite resin was cured.
  • One end face (circular section) of a stainless-steel cylindrical rod (with a diameter of 5 mm and a length of 1.5 cm) was bonded to the surface of the resultant cured product of the dental filling composite resin using a commercially available dental resin cement (manufactured by Kuraray Medical Inc., “PANAVIA21” (trade name)). After bonding, this sample was allowed to stand still at room temperature for 30 minutes and was then immersed in distilled water. The resultant sample that had been immersed in distilled water was allowed to stand still for 24 hours inside a thermostat whose temperature was maintained at 37° C. Thus, a bonding test sample was produced.
  • the labial surface of a bovine mandibular incisor was ground with #80 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water, and thereby a sample with an exposed flat surface of dentin was obtained.
  • the sample thus obtained further was ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water. After completion of grinding, water on the surface was air-blown to be dried.
  • An adhesive tape with a thickness of about 150 ⁇ m having a circular hole whose diameter was 3 mm was attached to the smooth surface that had been dried and thereby the adhesive area was defined.
  • Each primer produced above was applied into the above-mentioned circular hole using a brush and was then allowed to stand for 20 seconds. Thereafter, the surface thereof was air-blown and thereby the primer thus applied was dried until it lost fluidity.
  • the bonding material having a composition indicated in Table 3 was applied over the tooth surface where the primer had been applied and dried. Subsequently, it was irradiated with light using a dental visible light unit “JET LITE 3000” (manufactured by J. Morita USA) for 10 seconds. Thus, the primer and bonding material that had been applied were cured.
  • a dental filling composite resin (manufactured by Kuraray Medical Inc., “CLEARFIL AP-X” (trade name, registered trademark)) was applied to the surface of the resultant cured product of the bonding material, and it was then covered with a mold release film (polyester). Next, slide glass was placed on the mold release film to press it, and thereby the surface of the applied composite resin was smoothed. Subsequently, the composite resin was irradiated with light for 20 seconds using the aforementioned unit “JET LITE 3000” through the mold release film. Thus, the composite resin was cured.
  • the tensile bond strengths of the above-mentioned bonding test samples were measured with a universal testing machine (manufactured by Shimadzu Corporation), with the crosshead speed being set at 2 mm/min, and the average value thereof was taken as tensile bond strength.
  • the inorganic particles and polymerizable monomer compositions indicated in Table 4 were mixed together, respectively, and thereby paste-like dental composite resins were prepared.
  • the bond strength with respect to dentin is indicated together.
  • Barium glass (manufactured by STEC, Product Code: “Raysorb E-3000”) was crushed with a ball mill and thus barium glass powder was obtained.
  • the mean particle size of the barium glass powder thus obtained was measured with a laser diffraction particle size distribution analyzer (manufactured by Shimadzu Corporation, Type “SALD-2100”) and it was 2.4 ⁇ m.
  • the surface treatment was performed by a conventional method using 3 parts by weight of 3-methacryloyloxypropyltrimethoxysilane with respect to 100 parts by weight of this barium glass powder.
  • silane-treated barium glass powder was obtained.
  • Inorganic filler 4 Silane-treated colloidal silica powder
  • a bovine incisor was wet-ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) to be smooth and thereby an enamel surface or dentin surface was exposed. Thereafter, water on the surface was blown away using a dental air syringe.
  • Each self-adhesive composite resin composition produced above was placed in the circular hole and this was covered with a mold release film (manufactured by Kuraray Co., Ltd., “EVAL” (trade name)).
  • the tensile bond strengths of the above-mentioned bonding test samples were measured with a universal testing machine (manufactured by Shimadzu Corporation), with the crosshead speed being set at 2 mm/min, and the average value thereof was taken as tensile bond strength.
  • Example 1-1 where the polymerizable monomer (A) and bisacylphosphine oxide (B) were used in combination
  • Comparative Example 1-1 where only the polymerizable monomer (A) was used
  • Comparative Examples 1-7 to 1-9 where only the bisacylphosphine oxide (B) was used
  • Comparative Example 1-10 where neither the polymerizable monomer (A) nor the bisacylphosphine oxide (B) was used
  • higher effect of improving adhesive properties was obtained as compared to the total of the effect of improving adhesive properties obtained using only the polymerizable monomer (A) and that obtained using only the bisacylphosphine oxide (B).
  • the composition of the present invention contains a polymerizable monomer (A) having a plurality of polymerizable groups and a plurality of hydroxyl groups and bisacylphosphine oxide (B) with excellent performance and therefore is useful for applications that require curability and those that require hydrophilicity.
  • This composition can be used for various applications including dental applications. Particularly, this composition is suitable for dental materials such as a primer, bonding material, cement, and composite resin.

Abstract

The present invention provides a composition that exhibits excellent adhesive properties to tooth structure (particularly dentin) when applied as a dental material. The present invention is a composition containing a polymerizable monomer (A) having an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups, and a bisacylphosphine oxide (B) represented by the following formula (1):
Figure US20100048762A1-20100225-C00001
where the respective symbols are as defined in the specification.

Description

    TECHNICAL FIELD
  • The present invention relates to compositions that are particularly suitable for dental materials and that contain polymerizable monomers and polymerization initiators. The present invention also relates to dental materials using the compositions, such as dental primers, bonding materials, composite resins, and cements.
  • BACKGROUND ART
  • When a lost part of a tooth is filled or covered with a restorative material, generally a dental adhesive is used. A known dental adhesive is one containing a polymerizable monomer having a polymerizable group and a hydroxyl group. For example, WO 2004/047773 describes a dental adhesive composition characterized by containing a polyfunctional polymerizable monomer that is an ester compound of polyhydric alcohol having 3 to 6 carbon atoms and a plurality of (meth)acrylic acids and that has one to two hydroxyl groups, a monofunctional (meth)acrylate having no hydroxyl group in the molecule, a polymerizable monomer having an acidic group in the molecule, an organoboron compound as a curing agent, and a filling material. This describes that the addition of a small amount of the above polyfunctional polymerizable monomer to the composition can improve the cure rate considerably almost without affecting the adhesive properties of the composition, physical properties of the cured product, or operable time. Recently, however, higher bond strength to a tooth structure is desired, and therefore there may be a problem in bond strength in some cases.
  • When such a dental adhesive is allowed to act on dentin, it is important for the dental adhesive to have an decalcifying effect that allows a dentin surface to be dissolved with an acidic component, a penetration effect that allows a monomer component to penetrate into a collagen layer of dentin, and a curing effect that allows the monomer component thus penetrated to solidify to form a hybrid layer (hereinafter also referred to as a “resin-impregnated layer”) with collagen.
  • It has been studied so far to simplify the form of application of the dental adhesive from a three-component three-step type in which the aforementioned decalcifying effect, penetration effect, and curing effect are applied sequentially, to a two-component two-step type in which the decalcifying effect and the penetration effect are integrated, and further to a one-component one-step type in which the decalcifying effect, penetration effect, and curing effect are all combined together. All the forms of application require compositions that can be used for dental adhesives that are excellent in adhesive properties.
  • DISCLOSURE OF INVENTION
  • The present invention is intended to provide a composition that exhibits excellent adhesive properties to a tooth structure (particularly dentin) when it is applied as a dental material. The present invention also is intended to provide a dental material that is excellent in adhesive properties to a tooth structure (particularly dentin).
  • The present invention that has achieved the above-mentioned objects is a composition including a polymerizable monomer (A) having an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups, and a bisacylphosphine oxide (B) represented by formula (1):
  • Figure US20100048762A1-20100225-C00002
  • where R4 indicates an alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group, and R5 to R14 are each independently a hydrogen atom, halogen atom, alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group.
  • Preferably, the polymerizable monomer (A) includes a group represented by formula (2):
  • Figure US20100048762A1-20100225-C00003
  • where G is a hydroxyl group or polymerizable group and “*” indicates a bond.
  • Preferably, the polymerizable groups each are a group represented by formula (3), (4), or (5):
  • Figure US20100048762A1-20100225-C00004
  • where R1 indicates a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and “*” indicates a bond.
  • Preferably, the polymerizable monomer (A) is a compound represented by formula (6):
  • Figure US20100048762A1-20100225-C00005
  • where Gs are hydroxyl groups or polymerizable groups, n is an integer of 2 or more, at least two of the Gs are hydroxyl groups, and at least two of the Gs are polymerizable groups. An example of more preferable polymerizable monomers (A) is a compound represented by formula (7):
  • Figure US20100048762A1-20100225-C00006
  • where R1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms, m denotes an integer of 2 or more, k denotes an integer of 1 or more, and the sequence order of m units having an ester group and k units having a hydroxyl group is arbitrary. In this case, it is preferable that m be 2 to 5 and k be 1 to 5.
  • Another example of more preferable polymerizable monomers (A) is a compound represented by formula (8):
  • Figure US20100048762A1-20100225-C00007
  • where R1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and p denotes an integer of 2 or more. In this case, it is preferable that p be 2 to 4.
  • In the above, it is preferable that R1 be a hydrogen atom or methyl group.
  • With respect to the bisacylphosphine oxide (B), it is preferable that R4 be an alkyl group or aryl group, and R5 to R14 be each independently a hydrogen atom, halogen atom, alkyl group, or alkoxy group.
  • Preferably, depending on the embodiment, the composition of the present invention further includes, as a polymerizable monomer component, at least one polymerizable monomer selected from the group consisting of a polymerizable monomer (C) having one polymerizable functional group and at least one hydroxyl group, a polymerizable monomer (D) having an acidic group, and a crosslinkable polymerizable monomer (E). Furthermore, preferably, depending on the embodiment, the composition of the present invention includes at least one selected from the group consisting of a solvent (F), a polymerization accelerator (H), and a filler (I). Moreover, preferably, the composition of the present invention further includes at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxides.
  • Preferably, the composition of the present invention contains 0.01 to 20 parts by mass of bisacylphosphine oxide (B) with respect to 100 parts by mass of the whole amount of polymer monomer components.
  • The composition of the present invention is suitable for dental applications.
  • Furthermore, the present invention includes a dental primer, dental bonding material, dental composite resin, and dental cement, each of which contains the above-mentioned composition.
  • Since the composition of the present invention contains a polymerizable monomer having a plurality of polymerizable groups and hydrophilic groups as well as a polymerization initiator having excellent performance, it is useful for the applications that require curability and those that require hydrophilicity and it is particularly suitable for dental applications. Dental materials (such as a dental primer, bonding material, composite resin, and cement) using the compositions of the present invention exhibit excellent curability and are exceptionally excellent in adhesive properties to tooth structures.
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • First, essential components of the composition of the present invention are described.
  • Polymerizable Monomer (A)
  • The polymerizable monomer (A) has an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups. For the polymerizable monomer (A), polymerizable monomers that satisfy such a definition can be used independently or two or more of them can be used in combination.
  • The polymerizable monomer (A) has at least two polymerizable groups. When a composition of the present invention is used for a dental application, these polymerizable groups are polymerized and thereby the composition is cured to be able to function as, for example, a primer, bonding material, composite resin, or cement. Furthermore, since the number of the polymerizable groups is two or more, the polymerizable monomer (A) has crosslinkability. Accordingly, the composition has high curability and the cured product has high mechanical strength.
  • With respect to the polymerizable monomer (A), the polymerizable group denotes a group including a radical polymerizable functional group and examples thereof include a group including a vinyl group. Particularly, from the viewpoint of polymerization reactivity, the group represented by the following formula (3), (4), or (5) is preferable as the polymerizable group. Among these, from the viewpoint of ease of introduction into the polymerizable monomer (A), a group represented by formula (3) is most preferable.
  • Figure US20100048762A1-20100225-C00008
  • In the above formulae, R1, R2, and R3 each indicate a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and “*” indicates a bond. Examples of the aliphatic hydrocarbon group having 1 to 10 carbon atoms include an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, and an alkynyl group having 2 to 10 carbon atoms.
  • The alkyl group having 1 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include a methyl group, ethyl group, n-propyl group, isopropyl group, cyclopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, cyclobutyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, cyclopentyl group, n-hexyl group, isohexyl group, cyclohexyl group, n-heptyl group, cycloheptanyl group, n-octyl group, 2-ethylhexyl group, cyclooctanyl group, n-nonyl group, cyclononanyl group, and n-decyl group.
  • The alkenyl group having 2 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include a vinyl group, allyl group, methylvinyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, and cyclohexenyl group.
  • The alkynyl group having 2 to 10 carbon atoms may be any one of linear, branched, and cyclic, and examples thereof include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-hexynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl, and 1-ethyl-3-butynyl.
  • When the polymerizable monomer (A) is used in, for example, dental applications, radical polymerization is performed. Accordingly, it is preferable from the viewpoint of radical polymerization reactivity of the final product that R1, R2, and R3 each be a hydrogen atom or a methyl group. Furthermore, when the polymerizable monomer (A) is used in a dental composition, the polymerizable group may be detached from the polymerizable monomer (A) by, for example, hydrolysis. When the stimulativeness of the detached polymerizable group to a biological body is taken into account, it is preferable that the polymerizable group include a methacryloyloxy group. Therefore, it is more preferable that R1, R2, and R3 each be a methyl group.
  • The polymerizable monomer (A) includes at least two polymerizable groups, and the at least two polymerizable groups may be identical to or different from each other.
  • The polymerizable monomer (A) has at least two hydroxyl groups. These hydroxyl groups allow the polymerizable monomer (A) to be provided with high hydrophilicity to have high penetrability into a collagen layer of dentin, which results in high adhesive properties of the composition to a tooth structure.
  • The polymerizable monomer (A) has an unconjugated carbon chain with at least four carbon atoms bonded continuously. Preferably, this carbon chain composes the whole or a part of the skeleton of the polymerizable monomer (A), and the polymerizable groups and hydroxyl groups are bonded to the carbon chain.
  • An example of the polymerizable monomer (A) is a compound in which a part of hydroxyl groups of a tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously is substituted by polymerizable groups so that the number of each of the hydroxyl groups and the polymerizable groups is two or more. Examples of the tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously are not particularly limited. Preferable examples thereof include sugar alcohol, monosaccharides, disaccharides, and trisaccharides, each of which has 4 to 20 carbon atoms. Examples of the sugar alcohol that is used preferably include erythritol, a sugar alcohol having 4 carbon atoms, xylitol, ribitol, and arabinitol, each of which is a sugar alcohol having 5 carbon atoms, mannitol, sorbitol, and iditol, each of which is a sugar alcohol having 6 carbon atoms, and maltitol, a sugar alcohol having 12 carbon atoms. Furthermore, glucamine, a sugar alcohol containing an amino group, also is used preferably. Examples of monosaccharides that are used preferably include xylose, ribose, arabinose, and lyxose, each of which is a monosaccharide having 5 carbon atoms, as well as glucose, mannose, galactose, sorbose, and fructose, each of which is a monosaccharide having 6 carbon atoms. Furthermore, glucosamine, mannosamine, galactosamine, N-acetylglucosamine, N-acetylmannosamine, and N-acetylgalactosamine that are monosaccharides, each of which contains an amino group and a derivative thereof, also are used preferably. Examples of disaccharides that are used preferably include trehalose, sucrose, maltose, lactose, and cellobiose. Examples of trisaccharides that are used preferably include Coupling Sugar (registered trademark), lactosucrose, maltotriose, and isomaltotriose. The composition of the present invention is used preferably as a dental composition and more preferably as a dental adhesive composition. From the viewpoint of adhesive properties to a tooth structure (particularly dentin), it is preferable that it have high penetrability into the tooth structure (particularly dentin). From such a viewpoint, the carbon number of the aforementioned alcohol compound is more preferably 4 to 15, further preferably 4 to 9, and particularly preferably 4 to 7. Moreover, from the same viewpoint, the number of the hydroxyl groups of the alcohol compound is preferably 4 to 15, more preferably 4 to 9, and particularly preferably 4 to 7. Specific examples of preferable alcohol compounds include: erythritol, mannitol, sorbitol, and maltitol as sugar alcohols; glucose and glucosamine as monosaccharides; trehalose and maltose as disaccharides; and maltotriose as trisaccharides. Among these, erythritol, mannitol, glucose, and trehalose are further preferable and erythritol and mannitol are particularly preferable.
  • Preferably, the polymerizable monomer (A) has a group represented by the following formula (2). This group is a structure that is characteristic to the compounds indicated above as examples.
  • Figure US20100048762A1-20100225-C00009
  • In the above formula, G indicates a hydroxyl group or polymerizable group and “*” indicates a bond.
  • With respect to the structure of the polymerizable monomer (A), specifically, the polymerizable monomer (A) is preferably a compound represented by formula (6).
  • Figure US20100048762A1-20100225-C00010
  • In the above formula, Gs are hydroxyl groups or polymerizable groups, n is an integer of 2 or more, at least two of the Gs are hydroxyl groups, and at least two of the Gs are polymerizable groups.
  • In this structure, the polymerizable group or the hydroxyl group is bonded to each carbon atom of the carbon chain, and therefore the polymerizable groups and hydroxyl groups are closely-located with a high density. Accordingly, when a composition containing this polymerizable monomer (A) is applied as a dental material, it exhibits excellent curability and adhesive properties. Furthermore, it also has an advantage that it can be produced easily using sugar alcohol.
  • From the viewpoints of curability and adhesive properties to a tooth structure of the composition as well as availability of raw materials, n is preferably an integer of 2 to 18, more preferably an integer of 2 to 9, and most preferably an integer of 2 to 4.
  • When adhesive properties to a tooth structure of the composition is considered important, the polymerizable monomer (A) is preferably a compound represented by the following formula (7).
  • Figure US20100048762A1-20100225-C00011
  • In the above formula, R1 denotes the same as described above, m denotes an integer of 2 or more, k denotes an integer of 1 or more, and the sequence order of m units having an ester group and k units having a hydroxyl group is arbitrary.
  • From the viewpoints of curability and adhesive properties to a tooth structure of the composition as well as availability of raw materials, m is preferably 2 to 5, more preferably 2 to 4, and most preferably 2. Furthermore, k is preferably 1 to 5, more preferably 2 to 4, and most preferably 2. The total of m and k is preferably 3 to 18, more preferably 3 to 9, further preferably 4 to 8, and most preferably 4.
  • The compound represented by formula (7) has at least three hydroxyl groups, two of which are primary hydroxyl groups. These primary hydroxyl groups are highly advantageous for interaction with a tooth structure (particularly dentin). Accordingly, when a composition containing a compound represented by formula (7) is applied as dental applications, a composition with particularly high adhesive properties to a tooth structure (particularly dentin) is obtained. Moreover, since at least two groups represented by formula (3) are included as polymerizable groups, curability also is excellent.
  • Furthermore, among the compounds represented by formula (7), compounds represented by formulae (9) and (10) are preferable from the viewpoints of curability and adhesive properties to a tooth structure of the composition.
  • Figure US20100048762A1-20100225-C00012
  • On the other hand, when curability of the composition is considered important, the polymerizable monomer (A) is preferably a compound represented by the following formula (8).
  • Figure US20100048762A1-20100225-C00013
  • In the above formula, R1 denotes the same as described above, and p denotes an integer of 2 or more.
  • The compound represented by formula (8) has polymerizable groups represented by formula (3) at the both ends of an unconjugated carbon chain with at least four carbon atoms bonded continuously and has particularly high polymerization performance due to a steric factor. Accordingly, when a composition containing a compound represented by formula (8) is applied as a dental application, it serves as a composition with particularly high curability. Moreover, since it has a plurality of hydroxyl groups, it has excellent penetrability into a collagen layer of dentin as well as excellent adhesive properties to a tooth structure.
  • p is preferably 2 to 4. This is because when a decomposition product is produced by an action such as hydrolysis inside an oral cavity, the decomposition product is a highly safe compound such as erythritol, xylitol, sorbitol, or mannitol. Examples of compounds in which p is 2 to 4 include erythritol di(meth)acrylate, xylitol di(meth)acrylate, and sorbitol di(meth)acrylate. Furthermore, erythritol di(meth)acrylate in which p is 2 is more preferable, and when the aforementioned viewpoints of polymerizability and stimulativeness to a biological body also are taken into consideration, erythritol dimethacrylate represented by the following general formula (11) is most preferable.
  • Figure US20100048762A1-20100225-C00014
  • The polymerizable monomer (A) can be obtained through production by a known method. Specifically, for example, a carboxylic acid having a polymerizable group (for instance, a carboxylic acid in which a hydrogen atom is bonded to a bond of a group represented by formula (3)) or a derivative thereof and the tetravalent or more alcohol compound having an unconjugated carbon chain with at least four carbon atoms bonded continuously may be allowed to undergo an esterification reaction according to a conventional method and this may then be purified by a separation means such as chromatography. In order to improve the yield, the esterification reaction may be carried out after the carboxylic acid having a polymerizable group is converted into a derivative such as an acid halide.
  • When the polymerizable monomer (A) is particularly a compound represented by formula (7), especially a compound represented by formula (9) or (10), it is preferable that the polymerizable monomer (A) be produced by performing a step (a) where using a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand, as a raw material, the compound and carboxylic acid having a polymerizable group (in this case, carboxylic acid in which a hydrogen atom is bonded to a bond of a group represented by formula (3)) or a derivative thereof are esterified, and a step (b) where the protecting groups of the primary hydroxyl groups of the resultant ester compound are deprotected. The derivative of the carboxylic acid having a polymerizable group is not particularly limited but an acid halide or acid anhydride is used preferably. When the reactivity with the alcohol compound is taken into account, an acid halide is used more preferably. Furthermore, among the acid halides, acid chloride is used particularly preferably when availability and storage stability of the compound are taken into account. The production process including these steps allows a polymerizable monomer to be obtained with high yield and therefore is suitable for industrial production.
  • The compound in which primary hydroxyl groups of the alcohol compound are protected beforehand can be obtained as a commercially available product, for example, 1,2:5,6-di-O-isopropylidene-D-mannitol and 1,3:4,6-di-O-benzylidene-D-mannitol. Furthermore, it also can be produced by carrying out a step of protecting the primary hydroxyl groups of the alcohol compound. In a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand, it is preferable that a part of hydroxyl groups other than the primary hydroxyl groups be protected while a plurality of hydroxyl groups are allowed to remain. In this manner, a structure having at least three hydroxyl groups is obtained easily.
  • The step of protecting the primary hydroxyl groups of the alcohol compound can be carried out by performing a known reaction for introducing protecting groups.
  • It is advantageous to select a group that is introduced preferentially into a primary hydroxyl group, as a protecting group for the primary hydroxyl groups of the alcohol compound. Furthermore, for the protecting group, it is advantageous to select one that tends not to undergo a deprotection reaction during the esterification reaction and tends not to allow the ester bond to be cleaved during the deprotection reaction. From these viewpoints, protecting groups that are used preferably are ether protecting groups, silyl ether protecting groups, and acetal protecting groups. Ether protecting groups that are used more preferably are a 1-ethoxyethyl ether group and triphenylmethyl ether group. Silyl ether protecting groups that are used more preferably are a triisopropylsilyl ether group, t-butyldimethylsilyl ether group, and t-butyldiphenylsilyl ether group. Each of these protecting groups can be introduced preferentially into a primary hydroxyl group and can be deprotected under a mild acidic condition, and therefore it has an advantage that deprotection can be achieved without cleaving the ester bond. On the other hand, acetal protecting groups that are used more preferably are an isopropylidene group, cycloheptylidene group, benzylidene group, and p-methoxybenzylidene group. When using an acetal protecting group, it not only can be introduced preferentially into a primary hydroxyl group but also can protect two or more hydroxyl groups including the primary hydroxyl group at the same time. Accordingly, the acetal protecting group is especially suitable for synthesis of the polymerizable monomer (A). Therefore, among the ether protecting groups, silyl ether protecting groups, and acetal protecting groups, the acetal protecting groups are used further preferably. Moreover, from the viewpoints that deprotection is possible under a particularly mild acidic condition and a byproduct produced at the time of deprotection can be removed easily, an isopropylidene group is used particularly preferably.
  • The step of esterifying a compound in which primary hydroxyl groups of the alcohol compound are protected beforehand and a carboxylic acid having a polymerizable group or a derivative thereof can be carried out according to a known method. For the esterification reaction, it is important to select suitable reaction conditions (particularly, the temperature condition and the type of catalyst) under which a deprotection reaction tends not to occur, with consideration given to the type of the protecting group. Furthermore, it is important to select the reaction conditions (particularly, the amounts of the compound in which primary hydroxyl groups of the alcohol compound are protected beforehand and the carboxylic acid having a polymerizable group or a derivative thereof to be used) so that after the esterification reaction, a plurality of ester bonds are formed and the total number of the protected hydroxyl groups and unreacted hydroxyl groups is at least three, in one molecule.
  • The step of deprotecting the protecting groups of the primary hydroxyl groups of the resultant ester compound may be carried out according to a known method depending on the type of the protecting group. In this case, it is important to select reaction conditions (particularly, the temperature condition and the type of catalyst) under which the ester bond tends not to be cleaved. As described above, when the ether protecting groups, silyl ether protecting groups, and acetal protecting groups that are preferable as the protecting group of the primary hydroxyl group are used, all of them can be deprotected under mild acidic conditions and therefore deprotection can be performed without allowing the ester bond to be cleaved. Furthermore, the silyl ether protecting groups can be deprotected with extremely high selectivity by the use of a fluorine-containing compound such as TBAF (tetrabutylammonium fluoride) and thus are highly useful. In the case of deprotection under an acidic condition, for example, mineral acids such as hydrochloric acid and sulfuric acid and aqueous solutions thereof; organic acids such as formic acid, acetic acid, and trifluoroacetic acid and aqueous solutions thereof; and cation exchange resin are used preferably. Among these, since the acidity is suitable and deprotection can be performed with cleavage of the ester bond being prevented efficiently, organic acids such as formic acid, acetic acid, and trifluoroacetic acid and aqueous solutions thereof are more preferable, and formic acid, acetic acid, and aqueous solutions thereof are further preferable.
  • Since the polymerizable monomer (A) has a plurality of polymerizable groups and a plurality of hydroxyl groups, it is excellent in crosslinking reactivity and can interact strongly with a compound having a hydrophilic group. Accordingly, when the polymerizable monomer is mixed with a suitable component into a composition, the composition thus obtained exhibits excellent curability and adhesive properties in various applications including dental applications. From the viewpoint of obtaining both curability and adhesive properties to a tooth structure of the composition in a balanced manner, compounds represented by the aforementioned formulae (7) and (8) can be used in combination.
  • The amount of polymerizable monomer (A) to be added may be determined appropriately according to the application of the composition. Preferably, 1 to 99 parts by mass of polymerizable monomer (A) is contained in 100 parts by mass of the whole amount of polymerizable monomer components (other polymerizable monomer components will be described later). When a composition in which the amount of the polymerizable monomer (A) to be added is in such a range is used as a dental composition, there are advantages that penetrability into a collagen layer of dentin is excellent and bond strength is high. When the amount of polymerizable monomer (A) to be added is less than 1 part by mass, bond strength may be reduced and bond durability also may be reduced. Therefore, the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass. On the other hand, the amount of polymerizable monomer (A) to be added exceeding 99 parts by mass results in insufficient decalcification and sufficiently high bond strength may not be obtained. Therefore the amount is more preferably 98 parts by mass or less and further preferably 95 parts by mass or less.
  • Bisacylphosphine oxide (B) represented by formula (1)
  • Figure US20100048762A1-20100225-C00015
  • In the above formula, R4 indicates an alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group, and R5 to R14 are each independently a hydrogen atom, halogen atom, alkyl group, alkenyl group, alkynyl group, aryl group, alkoxy group, acyl group, or acyloxy group.
  • The bisacylphosphine oxide (B) acts as a photopolymerization initiator. As a result of studies made by the present inventors, they found that when bisacylphosphine oxide (B) combined with the polymerizable monomer (A) was used for a dental application, a composition was obtained that was exceptionally excellent in adhesive properties to a tooth structure. The reason why the adhesive properties increase considerably when bisacylphosphine oxide (B) is used in combination is surmised as follows. A composition containing a polymerizable monomer (A) has high penetrability into a collagen layer of dentin. However, in the portion where this polymerizable monomer (A) has penetrated into the collagen layer, light for initiating polymerization tends not to reach and therefore polymerization tends not to occur. Accordingly, it is considered that in the case of initiators used widely such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide(TMDPO) and camphorquinone (CQ), the cure degree is not so high in the portion where the polymerizable monomer (A) has penetrated into the collagen layer, and the effect of improving penetrability by the polymerizable monomer (A) cannot be fully used. However, conceivably, the bisacylphosphine oxide (B) makes it possible to cure the polymerizable monomer (A) sufficiently even in the portion where the polymerizable monomer (A) has penetrated into the collagen layer and as a result, adhesive properties improve surprisingly.
  • Alkyl groups having 1 to 10 carbon atoms are preferable as the alkyl groups indicated with R4 to R14, and examples thereof include a methyl group, ethyl group, n-propyl group, isopropyl group, cyclopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, cyclobutyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 2,4,4-trimethylpentyl group, cyclopentyl group, n-hexyl group, isohexyl group, cyclohexyl group, n-heptyl group, cycloheptanyl group, n-octyl group, 2-ethylhexyl group, cyclooctanyl group, n-nonyl group, cyclononanyl group, and n-decyl group.
  • Alkenyl groups having 2 to 10 carbon atoms are preferable as the alkenyl groups indicated with R4 to R14, and examples thereof include a vinyl group, allyl group, methylvinyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, and cyclohexenyl group.
  • Alkynyl groups having 2 to 10 carbon atoms are preferable as the alkynyl groups indicated with R4 to R14, and examples thereof include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-hexynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl, and 1-ethyl-3-butynyl.
  • Aryl groups having 6 to 30 carbon atoms are preferable as the aryl groups indicated with R4 to R14, and examples thereof include a phenyl group, o-tolyl group, m-tolyl group, p-tolyl group, xylyl group, mesityl group, naphthyl group, and anthracenyl group. These aryl groups further may include an alkyl group, alkoxy group, alkenyl group, and alkynyl group.
  • Alkoxy groups having 1 to 10 carbon atoms are preferable as the alkoxy groups indicated with R4 to R14, and examples thereof include a methoxy group, ethoxy group, n-propoxy group, isopropoxy group, cyclopropyropoxy group, n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group, cyclobutoxy group, and cyclohexyloxy group.
  • Acyl groups having 1 to 10 carbon atoms are preferable as the acyl groups indicated with R4 to R14, and examples thereof include: formyl groups; alkylcarbonyl groups having 2 to 10 carbon atoms such as an acetyl group, propionyl group, butyryl group, isobutyryl group, valeryl group, pivaloyl group, hexanoyl group, heptanoyl group, octanoyl group, and decenoyl group; arylcarbonyl groups having 7 to 10 carbon atoms such as a benzoyl group; and arylalkylcarbonyl groups having 8 to 10 carbon atoms such as a benzylcarbonyl group.
  • Acyloxy groups having 1 to 10 carbon atoms are preferable as the acyloxy groups indicated with R4 to R14, and examples thereof include groups in which one oxygen atom is bonded to each of the groups described above as examples of the acyl groups.
  • Examples of halogen atoms indicated with R5 to R14 include a fluorine atom, chlorine atom, and bromine atom. Among these, a chlorine atom is preferable.
  • An alkyl group and aryl group each are preferable as R4. A hydrogen atom, halogen atom, alkyl group, and alkoxy group are preferable as R5 to R14. Examples of the bisacylphosphine oxide (B) represented by formula (1) include bis-(2,6-dichlorobenzoyl)phenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-2,5-dimethylphenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-4-propylphenylphosphine oxide, bis-(2,6-dichlorobenzoyl)-1-naphthylphosphine oxide, bis-(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis-(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, bis-(2,6-dimethoxybenzoyl)-2,5-dimethylphenylphosphine oxide, bis-(2,4,6-trimethylbenzoyl)phenylphosphine oxide, and (2,5,6-trimethylbenzoyl)-2,4,4-trimethylpentylphosphine oxide.
  • Preferably, 0.01 to 20 parts by mass of bisacylphosphine oxide (B) is contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of bisacylphosphine oxide (B) to be added is less than 0.01 part by mass, polymerization may not proceed sufficiently, which may result in a reduction in bond strength. Accordingly, it is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass. On the other hand, when the amount of bisacylphosphine oxide (B) to be added exceeds 20 parts by mass, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Accordingly, it is more preferably 18 parts by mass or less, further preferably 15 parts by mass or less, and most preferably 10 parts by mass or less.
  • Next, arbitrary components of the composition according to the present invention are described. The composition of the present invention may contain components other than the polymerizable monomer (A) and bisacylphosphine oxide (B) depending on the application of the composition. For instance, the composition of the present invention may contain, as a polymerizable monomer component other than the polymerizable monomer (A), polymerizable monomer components such as a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group, a polymerizable monomer (D) having an acidic group, and a crosslinkable polymerizable monomer (E). Furthermore, the composition of the present invention may contain a solvent (F), a polymerization accelerator (H), and a filler (I). Moreover, the composition may contain at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxides.
  • In the present invention, the phrase “the whole amount of polymerizable monomer components” denotes the total amount of the polymerizable monomer (A) and polymerizable monomers (C) to (E).
  • In the following description, terms “monofunctional”, “bifunctional”, and “trifunctional” are used and the terms “monofunctional”, “bifunctional”, and “trifunctional” indicate that one, two, and three polymerizable groups each are contained in one molecule. Preferably, these polymerizable groups are groups that are radical-copolymerizable with polymerizable groups of the polymerizable monomer (A).
  • Polymerizable Monomer (C) Having One Polymerizable Group and at Least One Hydroxyl Group
  • Preferably, the composition of the present invention contains a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group. When the composition of the present invention contains a polymerizable monomer (C), particularly when it is used as a dental composition, excellent bond strength is obtained. Since the polymerizable monomer (C) has a polymerizable group, not only radical polymerization can occur but also copolymerization with another monomer can occur. The polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group is not particularly limited. The polymerizable group of the polymerizable monomer (C) is preferably a group that is radical-copolymerizable with a polymerizable group of the polymerizable monomer (A). From the viewpoint of ease of radical polymerization, the polymerizable group of the polymerizable monomer (C) is preferably a (meth)acrylic group or (meth)acrylamide group. The polymerizable monomer (C) is used preferably as a component of a dental composition. However, since the inside of an oral cavity has a humid environment, the polymerizable group may be detached by, for example, hydrolysis. When consideration is given to stimulativeness of a detached polymerizable group to a biological body, the polymerizable group of the polymerizable monomer (C) is preferably a methacrylic group or methacrylamide group.
  • The polymerizable monomer (C) has at least one hydroxyl group and therefore has excellent hydrophilicity, and it is a monofunctional polymer monomer having one polymerizable group. Accordingly, when a composition of the present invention containing a polymerizable monomer (A) and a polymerizable monomer (C) is used as a dental composition, an effect that the penetrability into a collagen layer of dentin is further excellent also is obtained.
  • Polymerizable monomers (C) can be used independently or two or more of them can be used in suitable combination. Examples of the polymerizable monomers (C) include 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, 4-hydroxybutyl(meth)acrylate, 6-hydroxyhexyl(meth)acrylate, 10-hydroxydecyl(meth)acrylate, propylene glycol mono(meth)acrylate, glycerol mono(meth)acrylate, erythritol mono(meth)acrylate, N-methylol(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, and N,N-(dihydroxyethyl)(meth)acrylamide. Among these, from the viewpoint of improving the penetrability into a collagen layer of dentin, 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, glycerol mono(meth)acrylate, and erythritol mono(meth)acrylate are preferable and 2-hydroxyethylmethacrylate is particularly preferable.
  • The amount of polymerizable monomer (C) to be added is not particularly limited, but it is preferable that 1 to 90 parts by mass of polymerizable monomer (C) be contained in 100 parts by mass of the whole amount of polymerizable monomer components. When a composition in which the amount of polymerizable monomer (C) to be added is in such a range is used as a dental composition, both excellent penetrability into a collagen layer of dentin and excellent bond strength are obtained. When the amount of polymerizable monomer (C) to be added is less than 1 part by mass, contribution of the polymerizable monomer (C) to penetration into a collagen layer of dentin may not be obtained and the bond strength may be reduced. The amount of polymerizable monomer (C) to be added is more preferably at least 3 parts by mass, further preferably at least 5 parts by mass, and particularly preferably at least 7 parts by mass. On the other hand, when the amount of polymerizable monomer (C) to be added exceeds 90 parts by mass, sufficiently high curability cannot be obtained and therefore the mechanical strength of the cured product may be reduced. Accordingly, the bond strength may be reduced. The amount of polymerizable monomer (C) to be added is more preferably 80 parts by mass or less, further preferably 75 parts by mass or less, and particularly preferably 70 parts by mass or less.
  • Polymerizable Monomer (D) Having Acidic Group
  • Preferably, the composition of the present invention contains a polymerizable monomer (D) having an acidic group. When a composition containing a polymerizable monomer (D) having an acidic group is used as a dental composition, the polymerizable monomer (D) itself that has an acidic group has an acid-etching effect and a primer treatment effect. Therefore, it has advantages that, for example, pretreatments such as an acid etching treatment and a primer treatment are not necessary. Accordingly, a combination with a polymerizable monomer (D) having an acidic group makes it possible to provide a bonding material that is simple to use and has high bond strength and excellent bond durability, particularly preferably a one-component bonding material.
  • Polymerizable monomers (D) having acidic groups can be used independently or two or more of them can be used in suitable combination. The polymerizable monomers (D) having acidic groups are not particularly limited. Examples thereof include a monofunctional polymerizable monomer having one carboxyl group or an acid anhydride group thereof in the molecule, a monofunctional polymerizable monomer having a plurality of carboxyl groups or an acid anhydride group thereof in the molecule, and a monofunctional polymerizable monomer having a phosphinyloxy group or phosphonooxy group in the molecule (also referred to as a monofunctional radical polymerizable phosphoric acid ester).
  • Examples of the monofunctional polymerizable monomer having one carboxyl group or an acid anhydride group thereof in the molecule include (meth)acrylic acid, N-(meth)acryloylglycine, N-(meth)acryloylaspartic acid, N-(meth)acryloyl-5-aminosalicylic acid, 2-(meth)acryloyloxyethyl hydrogen succinate, 2-(meth)acryloyloxyethyl hydrogen phthalate, 2-(meth)acryloyloxyethyl hydrogen malate, 6-(meth)acryloyloxyethyl naphthalene-1,2,6-tricarboxylic acid, O-(meth)acryloyltyrosine, N-(meth)acryloyltyrosine, N-(meth)acryloylphenylalanine, N-(meth)acryloyl-p-aminobenzoic acid, N-(meth)acryloyl-o-aminobenzoic acid, p-vinylbenzoic acid, 2-(meth)acryloyloxybenzoic acid, 3-(meth)acryloyloxybenzoic acid, 4-(meth)acryloyloxybenzoic acid, N-(meth)acryloyl-4-aminosalicylic acid, and compounds obtained by converting the carboxyl group of these compounds into an acid anhydride group.
  • Examples of the monofunctional polymerizable monomer having a plurality of carboxyl groups or an acid anhydride group thereof in the molecule include 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, 10-(meth)acryloyloxydecane-1,1-dicarboxylic acid, 12-(meth)acryloyloxydodecane-1,1-dicarboxylic acid, 6-(meth)acryloyloxyhexane-1,1-dicarboxylic acid, 2-(meth)acryloyloxyethyl-3′-methacryloyloxy-2′-(3,4-dicarboxybenzoyloxy)-propyl succinate, 4-(2-(meth)acryloyloxyethyl)trimeritate anhydride, 4-(2-(meth)acryloyloxyethyl)trimeritate, 4-(meth)acryloyloxyethyl trimeritate, 4-(meth)acryloyloxybutyl trimeritate, 4-(meth)acryloyloxyhexyl trimeritate, 4-(meth)acryloyloxydecyl trimeritate, 6-(meth)acryloyloxyethylnaphthalene-1,2,6-tricarboxylic acid anhydride, 6-(meth)acryloyloxyethylnaphthalene-2,3,6-tricarboxylic acid anhydride, 4-(meth)acryloyloxyethylcarbonylpropionoyl-1,8-naphthalic acid anhydride, 4-(meth)acryloyloxyethylnaphthalene-1,8-tricarboxylic acid anhydride, 9-(meth)acryloyloxynonane-1,1-dicarboxylic acid, 13-(meth)acryloyloxytridecane-1,1-dicarboxylic acid, and 11-(meth)acrylamideundecane-1,1-dicarboxylic acid.
  • Examples of the monofunctional polymerizable monomer having a phosphinyloxy group or phosphonooxy group in the molecule (also referred to as a monofunctional radical polymerizable phosphoric acid ester) include 2-(meth)acryloyloxyethyl dihydrogenphosphate, 2-(meth)acryloyloxyethylphenyl hydrogenphosphate, 10-(meth)acryloyloxydecyl dihydrogenphosphate, 6-(meth)acryloyloxyhexyl dihydrogenphosphate, 2-(meth)acryloyloxyethyl-2-bromoethyl hydrogenphosphate, and 2-(meth)acrylamideethyl dihydrogenphosphate.
  • Examples of other monofunctional polymerizable monomer having an acidic group include a monofunctional polymerizable monomer having a sulfo group in the molecule such as 2-(meth)acrylamide-2-methylpropanesulfonic acid and 10-sulfodecyl(meth)acrylate.
  • The amount of polymerizable monomer (D) having an acidic group to be added is not particularly limited but it is preferable that 1 to 90 parts by mass of polymerizable monomer (D) having an acidic group be contained in 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of polymerizable monomer (D) having an acidic group to be added is less than 1 part by mass, the acid-etching effect or primer treatment effect may not be obtained. Therefore, the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass. On the other hand, when the amount of polymerizable monomer (D) having an acidic group to be added exceeds 90 parts by mass, sufficiently high curability may not be obtained and therefore the adhesive properties may be deteriorated. Accordingly, the amount is more preferably 80 parts by mass or less and further preferably 70 parts by mass or less.
  • Crosslinkable Polymerizable Monomer (E)
  • Preferably, the composition of the present invention contains a crosslinkable polymerizable monomer (E). When a composition containing a crosslinkable polymerizable monomer (E) is used as a dental composition, it has advantages such as a further improvement in bond strength.
  • Crosslinkable polymerizable monomers (E) can be used independently or two or more of them can be used in suitable combination. The crosslinkable polymerizable monomers (E) are not particularly limited. Examples thereof include an aromatic compound-based bifunctional polymerizable monomer, an aliphatic compound-based bifunctional polymerizable monomer, and trifunctional or higher polymerizable monomers.
  • Examples of the aromatic compound-based bifunctional polymerizable monomer include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy)-2-hydroxypropoxyphenyl]propane (commonly known as “Bis-GMA”), 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytetraethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydipropoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxyethoxyphenyl)-propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxytriethoxy-phenyl)propane, 2-(4-(meth)acryloyloxydipropoxyphenyl)-2-(4-(meth)acryloyloxytriethoxy-phenyl)propane, 2,2-bis(4-(meth)acryloyloxypropoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxyisopropoxyphenyl)propane, and 1,4-bis(2-(meth)acryloyloxyethyl)pyromeritate.
  • Examples of the aliphatic compound-based bifunctional polymerizable monomer include ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)dimethacrylate (commonly known as “UDMA”).
  • Examples of the trifunctional or higher polymerizable monomers include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate, and 1,7-diacryloyloxy-2,2,6,6-tetraacryloyloxymethyl-4-oxyheptane.
  • The amount of crosslinkable polymerizable monomer (E) to be added is not particularly limited, but it is preferable that 1 to 90 parts by mass of crosslinkable polymerizable monomer (E) be contained in 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of crosslinkable polymerizable monomer (E) to be added is less than 1 part by mass, sufficiently high bond strength may not be obtained. Therefore, the amount is more preferably at least 2 parts by mass and further preferably at least 5 parts by mass. On the other hand, when the amount of crosslinkable polymerizable monomer (E) to be added exceeds 90 parts by mass, the composition may not penetrate sufficiently into a collagen layer of dentin and thereby high bond strength may not be obtained. Therefore, the amount is more preferably 80 parts by mass or less and further preferably 70 parts by mass or less.
  • The composition of the present invention may contain a polymerizable monomer other than the aforementioned (A), (C), (D), and (E) as required.
  • Solvent (F)
  • Preferably, the composition of the present invention contains a solvent (F) depending on the specific embodiment. Examples of the solvent include water (J), an organic solvent (K), and a mixed solvent thereof.
  • When the composition of the present invention contains water (J), it exhibits both excellent bond strength and excellent bond durability. Preferably, the content of water (J) is 6 to 2000 parts by mass with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the content of water (J) is less than 6 parts by mass, the monomer may not penetrate sufficiently into a collagen layer and the bond strength may be reduced. On the other hand, when the content of water (I) exceeds 2000 parts by mass, the polymerizability of the monomer may be deteriorated and both the bond strength and bond durability may be reduced. The content of water (J) is more preferably at least 7 parts by mass and further preferably at least 10 parts by mass. Furthermore, the content of water (J) is more preferably 1500 parts by mass or less. Preferably, water (J) is free of impurities that have adverse effects, and distilled water or ion exchanged water is preferable.
  • Organic solvents (K) can be used independently or two or more of them can be used in suitable combination. Examples of the organic solvent (K) include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-methyl-2-propanol, acetone, methyl ethyl ketone, tetrahydrofuran, diethyl ether, diisopropyl ether, hexane, toluene, chloroform, ethyl acetate, and butyl acetate. Particularly, when both safety to biological bodies and easy removal based on volatility are taken into consideration, the organic solvent (E) is preferably a water-soluble organic solvent. Specifically, ethanol, 2-propanol, 2-methyl-2-propanol, acetone, and tetrahydrofuran are used preferably. The content of organic solvent (K) is not particularly limited and the organic solvent (K) may not need to be added depending on the embodiment. In an embodiment using the organic solvent, it is preferable that 1 to 2000 parts by mass of organic solvent (K) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. The preferable amount of the organic solvent (K) to be added varies considerably depending on the embodiment in which it is used. Therefore, preferable amounts of organic solvents (K) to be added according to respective embodiments are indicated together with description of specific embodiments of the composition of the present invention described later.
  • Polymerization Initiator (G)
  • The composition of the present invention further may contain a polymerization initiator (G) other than the bisacylphosphine oxide (B), preferably at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxide. This polymerization initiator (G) may be either a photopolymerization initiator or a chemical polymerization initiator. Examples of the photopolymerization initiator include acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, and alpha-amino ketone compounds.
  • Examples of acylphosphine oxides used as the photopolymerization initiator include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, 2,6-dichlorobenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, 2,4,6-trimethylbenzoylethoxyphenylphosphine oxide, 2,3,5,6-tetramethylbenzoyldiphenylphosphine oxide, and benzoyl di-(2,6-dimethylphenyl) phosphonate.
  • Preferably, the water-soluble acylphosphine oxides used as the photopolymerization initiator have alkali metal ions, alkaline earth metal ions, pyridinium ions, or ammonium ions in the acylphosphine oxide molecules. For instance, the water-soluble acylphosphine oxides can be synthesized by the method disclosed in EP 0009348 or JP 57(1982)-197289 A.
  • Specific examples of the aforementioned water-soluble acylphosphine oxides include sodium monomethylacetylphosphonate, sodium monomethyl(1-oxopropyl)phosphonate, sodium monomethylbenzoylphosphonate, sodium monomethyl(1-oxobutyl)phosphonate, sodium monomethyl(2-methyl-1-oxopropyl)phosphonate, sodium acetylphosphonate, sodium monomethylacetylphosphonate, sodium acetylmethylphosphonate, methyl-4-(hydroxymethoxyphosphinyl)-4-oxobutanoate sodium salt, methyl-4-oxophosphonobutanoate monosodium salt, acetylphenylphosphinate sodium salt, sodium (1-oxopropyl)pentylphosphinate, methyl-4-(hydroxypentylphosphinyl)-4-oxobutanoate sodium salt, sodium acetylpentylphosphinate, sodium acetylethylphosphinate, sodium methyl(1,1-dimethyl)methylphosphinate, sodium (1,1-diethoxyethyl)methylphosphinate, sodium (1,1-diethoxyethyl)methylphosphinate, methyl-4-(hydroxymethylphosphinyl)-4-oxobutanoate lithium salt, 4-(hydroxymethylphosphinyl)-4-oxobutanoic acid dilithium salt, methyl(2-methyl-1,3-dioxolan-2-yl)phosphinate sodium salt, methyl(2-methyl-1,3-thiazolidin-2-yl)phosphonite sodium salt, (2-methylperhydro-1,3-diazin-2-yl)phosphonite sodium salt, acetylphosphinate sodium salt, (1,1-diethoxyethyl)phosphonite sodium salt, (1,1-diethoxyethyl)methylphosphonite sodium salt, methyl(2-methyloxathiolane-2-yl)phosphinate sodium salt, methyl(2,4,5-trimethyl-1,3-dioxolan-2-yl)phosphinate sodium salt, methyl(1,1-propoxyethyl)phosphinate sodium salt, (1-methoxyvinyl)methylphosphinate sodium salt, (1-ethylthiovinyl)methylphosphinate sodium salt, methyl(2-methylperhydro-1,3-diazin-2-yl)phosphinate sodium salt, methyl(2-methylperhydro-1,3-thiazin-2-yl)phosphinate sodium salt, methyl(2-methyl-1,3-diazolidin-2-yl)phosphinate sodium salt, methyl(2-methyl-1,3-thiazolidin-2-yl)phosphinate sodium salt, (2,2-dicyano-1-methylethynyl)phosphinate sodium salt, acetylmethylphosphinate oxime sodium salt, acetylmethylphosphinate-O-benzyloxime sodium salt, 1-[(N-ethoxyimino)ethyl]methylphosphinate sodium salt, methyl(1-phenyliminoethyl)phosphinate sodium salt, methyl(1-phenylhydrazone ethyl)phosphinate sodium salt, [1-(2,4-dinitrophenylhydrazono)ethyl]methylphosphinate sodium salt, acetylmethylphosphinate semicarbazone sodium salt, (1-cyano-1-hydroxyethyl)methylphosphinate sodium salt, (dimethoxymethyl)methyl phosphinate sodium salt, formylmethylphosphinate sodium salt, (1,1-dimethoxypropyl)methylphosphinate sodium salt, methyl(1-oxopropyl)phosphinate sodium salt, dodecylguanidine salt of (1,1-dimethoxypropyl)methylphosphinate, isopropylamine salt of (1,1-dimethoxypropyl)methylphosphinate, acetylmethylphosphinate thiosemicarbazone sodium salt, 1,3,5-tributyl-4-methylamino-1,2,4-triazolium (1,1-dimethoxyethyl)-methylphosphinate, 1-butyl-4-butylaminomethylamino-3,5-dipropyl-1,2,4-triazolium (1,1-dimethoxyethyl)-methylphosphinate, 2,4,6-trimethylbenzoylphenylphosphine oxide sodium salt, 2,4,6-trimethylbenzoylphenylphosphine oxide potassium salt, and ammonium salt of 2,4,6-trimethylbenzoylphenylphosphine oxide. Furthermore, examples thereof also include compounds described in JP 2000-159621 A.
  • Among these acylphosphine oxides and water-soluble acylphosphine oxides, particularly preferable ones are 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, and 2,4,6-trimethylbenzoylphenylphosphine oxide sodium salt.
  • Examples of thioxanthones or the quaternary ammonium salts of thioxanthones that are used as the above-mentioned photopolymerization initiators include thioxanthone, 2-chlorothioxanthen-9-one, 2-hydroxy-3-(9-oxy-9H-thioxanthen-4-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(1-methyl-9-oxy-9H-thioxanthen-4-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(9-oxo-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-propaneaminium chloride, 2-hydroxy-3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride, 2-hydroxy-3-(3,4-dimethyl-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride, and 2-hydroxy-3-(1,3,4-trimethyl-9-oxo-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride.
  • Among the thioxanthones or the quaternary ammonium salts of thioxanthones, a particularly preferable thioxanthone is 2-chlorothioxanthen-9-one, and a particularly preferable quaternary ammonium salt of thioxanthone is 2-hydroxy-3-(3,4-dimethyl-9H-thioxanthen-2-yloxy)-N,N,N-trimethyl-1-propaneaminium chloride.
  • Examples of ketals used as the photopolymerization initiator include benzyl dimethyl ketal and benzyl diethyl ketal.
  • Examples of the alpha-diketones used as the photopolymerization initiator include diacetyl, dibenzyl, camphorquinone, 2,3-pentadione, 2,3-octadione, 9,10-phenanthrenequinone, 4,4′-oxybenzyl, and acenaphthenequinone. Among these, camphorquinone is particularly preferable from the viewpoint of having the maximum absorption wavelength in the visible light range.
  • Examples of the coumarin compound used as the aforementioned photopolymerization initiator include compounds described in JP 9(1997)-3109 A and JP 10(1998)-245525 A such as 3,3′-carbonylbis(7-diethylamino)coumarin, 3-(4-methoxybenzoyl)coumarin, 3-thienoyl coumarin, 3-benzoyl-5,7-dimethoxycoumarin, 3-benzoyl-7-methoxycoumarin, 3-benzoyl-6-methoxycoumarin, 3-benzoyl-8-methoxycoumarin, 3-benzoylcoumarin, 7-methoxy-3-(p-nitrobenzoyl)coumarin, 3-(p-nitrobenzoyl)coumarin, 3,5-carbonylbis(7-methoxycoumarin), 3-benzoyl-6-bromocoumarin, 3,3′-carbonylbiscoumarin, 3-benzoyl-7-dimethylaminocoumarin, 3-benzoylbenzo[f]coumarin, 3-carboxycoumarin, 3-carboxy-7-methoxycoumarin, 3-ethoxycarbonyl-6-methoxycoumarin, 3-ethoxycarbonyl-8-methoxycoumarin, 3-acetylbenzo[f]coumarin, 7-methoxy-3-(p-nitrobenzoyl)coumarin, 3-(p-nitrobenzoyl)coumarin, 3-benzoyl-6-nitrocoumarin, 3-benzoyl-7-diethylaminocoumarin, 7-dimethylamino-3-(4-methoxybenzoyl)coumarin, 7-diethylamino-3-(4-methoxybenzoyl)coumarin, 7-diethylamino-3-(4-diethylamino)coumarin, 7-methoxy-3-(4-methoxybenzoyl)coumarin, 3-(4-nitrobenzoyl)benzo[f]coumarin, 3-(4-ethoxycinnamoyl)-7-methoxycoumarin, 3-(4-dimethylaminocinnamoyl)coumarin, 3-(4-diphenylaminocinnamoyl)coumarin, 3-[(3-dimethylbenzothiazole-2-ilidene)acetyl]coumarin, 3-[(1-methylnaphtho[1,2-d]thiazole-2-ilidene)acetyl]coumarin, 3,3′-carbonylbis(6-methoxycoumarin), 3,3′-carbonylbis(7-acetoxycoumarin), 3,3′-carbonylbis(7-dimethylaminocoumarin), 3-(2-benzothiazoyl)-7-(diethylamino)coumarin, 3-(2-benzothiazoyl)-7-(dibutylamino)coumarin, 3-(2-benzimidazoyl)-7-(diethylamino)coumarin, 3-(2-benzothiazoyl)-7-(dioctylamino)coumarin, 3-acetyl-7-(dimethylamino)coumarin, 3,3′-carbonylbis(7-dibutylaminocoumarin), 3,3′-carbonyl-7-diethylaminocoumarin-7′-bis(butoxyethyl)aminocoumarin, 10-[3-[4-(dimethylamino)phenyl]-1-oxo-2-propenyl]-2,3,6,7-1,1,7,7-tetramethyl 1H, 5H, 11H-[1]benzopyrano[6,7,8-ij]quinolizine-11-one, and 10-(2-benzothiazoyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl 1H, 5H, 11H-[1]-benzopyrano[6,7,8-ij]quinolizin-11-one.
  • Among the above-mentioned coumarin compounds, particularly 3,3′-carbonylbis(7-diethylaminocoumarin) and 3,3′-carbonylbis(7-dibutylaminocoumarin) are suitable.
  • Examples of the anthraquinones used as the aforementioned photopolymerization initiator include anthraquinone, 1-chloroanthraquinone, 2-chloroanthraquinone, 1-bromoanthraquinone, 1,2-benzanthraquinone, 1-methylanthraquinone, 2-ethylanthraquinone, and 1-hydroxyanthraquinone.
  • Examples of the benzoin alkyl ethers used as the aforementioned photopolymerization initiator include benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether.
  • Examples of the alpha-aminoketones used as the aforementioned photopolymerization initiator include 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one.
  • Preferably, among these photopolymerization initiators, at least one selected from the group consisting of acylphosphine oxides, salts thereof, alpha-diketones, and coumarin compounds is used in combination with the aforementioned bisacylphosphine oxide (B). This makes it possible to obtain a composition that has excellent photocurability in visible and near-ultraviolet ranges and sufficiently high photocurability regardless of which light source among a halogen lamp, light-emitting diode (LED), and xenon lamp is used.
  • Among the polymerization initiators (G) used in the present invention, a chemical polymerization initiator that is used preferably is organic peroxide. The organic peroxide used as the chemical polymerization initiator is not particularly limited and a known one can be used. Examples of typical organic peroxides include ketone peroxide, hydroperoxide, diacyl peroxide, dialkyl peroxide, peroxyketal, peroxyester, and peroxydicarbonate.
  • Examples of ketone peroxide used as the chemical polymerization initiator include methyl ethyl ketone peroxide, methyl isobutyl ketone peroxide, methylcyclohexanone peroxide, and cyclohexanone peroxide.
  • Examples of hydroperoxide used as the chemical polymerization initiator include 2,5-dimethylhexane-2,5-dihydroperoxide, diisopropylbenzene hydroperoxide, cumene hydroperoxide, t-butyl hydroperoxide, and 1,1,3,3-tetramethylbutyl hydroperoxide.
  • Examples of diacyl peroxide used as the chemical polymerization initiator include acetyl peroxide, isobutyryl peroxide, benzoyl peroxide, decanoyl peroxide, 3,5,5-trimethylhexanoyl peroxide, 2,4-dichlorobenzoyl peroxide, and lauroyl peroxide.
  • Examples of dialkyl peroxide used as the chemical polymerization initiator include di-t-butyl peroxide, dicumyl peroxide, t-butylcumyl peroxide, 2,5-dimethyl-2,5-di(t-butylperoxy)hexane, 1,3-bis(t-butylperoxyisopropyl)benzene, and 2,5-dimethyl-2,5-di(t-butylperoxy)-3-hexyne.
  • Examples of peroxyketal used as the chemical polymerization initiator include 1,1-bis(t-butylperoxy)-3,3,5-trimethylcyclohexane, 1,1-bis(t-butylperoxy)cyclohexane, 2,2-bis(t-butylperoxy)butane, 2,2-bis(t-butylperoxy)octane, and 4,4-bis(t-butylperoxy)valeric acid-n-butyl ester.
  • Examples of peroxyester used as the chemical polymerization initiator include alpha-cumyl peroxyneodecanoate, t-butyl peroxyneodecanoate, t-butyl peroxypivarate, 2,2,4-trimethylpentylperoxy-2-ethyl hexanoate, t-amylperoxy-2-ethyl hexanoate, t-butylperoxy-2-ethyl hexanoate, di-t-butylperoxy isophthalate, di-t-butylperoxy hexahydroterephthalate, t-butylperoxy-3,3,5-trimethyl hexanoate, t-butylperoxy acetate, t-butylperoxy benzoate, and t-butylperoxymaleic acid.
  • Examples of peroxydicarbonate used as the chemical polymerization initiator include di-3-methoxy peroxydicarbonate, di-2-ethylhexyl peroxydicarbonate, bis(4-t-butylcyclohexyl)peroxydicarbonate, diisopropyl peroxydicarbonate, di-n-propyl peroxydicarbonate, di-2-ethoxyethyl peroxydicarbonate, and diallyl peroxydicarbonate.
  • Among these organic peroxides, diacyl peroxide is used preferably from the viewpoint of a comprehensive balance of safety, storage stability, and radical production ability, and among these, benzoyl peroxide is used particularly preferably.
  • The amount of polymerization initiator (G) to be added in the present invention is not particularly limited. However, from the viewpoint of, for example, curability of the resultant composition, it is preferable that 0.001 to 20 parts by mass of polymerization initiator (G) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of polymerization initiator (G) to be added is less than 0.001 part by mass, polymerization may not proceed sufficiently and thereby bond strength may be reduced. Therefore, the amount is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass. On the other hand, when the amount of polymerization initiator (G) to be added exceeds 20 parts by mass, in the case where the polymerization initiator itself has low polymerization performance, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Therefore, the amount is more preferably 15 parts by mass or less and further preferably 10 parts by mass or less.
  • Polymerization Accelerator (H)
  • Preferably, the composition of the present invention contains a polymerization accelerator (H). Examples of the polymerization accelerator (H) used in the present invention include amines, sulfinic acids and salts thereof, borate compounds, barbituric acid derivatives, triazine compounds, copper compounds, tin compounds, vanadium compounds, halogen compounds, aldehydes, thiol compounds, sulfite, bisulfite, and thiourea compounds.
  • Amines used as the polymerization accelerator (H) can be divided into aliphatic amines and aromatic amines. Examples of aliphatic amines include: primary aliphatic amines such as n-butylamine, n-hexylamine, and n-octylamine; secondary aliphatic amines such as diisopropylamine, dibutylamine, and N-methylethanolamine; and tertiary aliphatic amines such as N-methyldiethanolamine, N-ethyldiethanolamine, N-n-butyldiethanolamine, N-lauryldiethanolamine, 2-(dimethylamino)ethyl methacrylate, N-methyldiethanolamine dimethacrylate, N-ethyldiethanolamine dimethacrylate, triethanolamine monomethacrylate, triethanolamine dimethacrylate, triethanolamine trimethacrylate, triethanolamine, trimethylamine, triethylamine, and tributylamine. Among these, tertiary aliphatic amines are preferable from the viewpoint of curability and storage stability of the composition, and particularly, N-methyldiethanolamine and triethanolamine are used more preferably.
  • Examples of aromatic amine include N,N-bis(2-hydroxyethyl)-3,5-dimethylaniline, N,N-di(2-hydroxyethyl)-p-toluidine, N,N-bis(2-hydroxyethyl)-3,4-dimethylaniline, N,N-bis(2-hydroxyethyl)-4-ethylaniline, N,N-bis(2-hydroxyethyl)-4-isopropylaniline, N,N-bis(2-hydroxyethyl)-4-t-butylaniline, N,N-bis(2-hydroxyethyl)-3,5-di-isopropylaniline, N,N-bis(2-hydroxyethyl)-3,5-di-t-butylaniline, N,N-dimethylaniline, N,N-dimethyl-p-toluidine, N,N-dimethyl-m-toluidine, N,N-diethyl-p-toluidine, N,N-dimethyl-3,5-dimethylaniline, N,N-dimethyl-3,4-dimethylaniline, N,N-dimethyl-4-ethylaniline, N,N-dimethyl-4-isopropylaniline, N,N-dimethyl-4-t-butylaniline, N,N-dimethyl-3,5-di-t-butylaniline, 4-N,N-dimethylaminobenzoic acid ethyl ester, 4-N,N-dimethylaminobenzoic acid methyl ester, N,N-dimethylaminobenzoic acid n-butoxyethyl ester, 4-N,N-dimethylaminobenzoic acid 2-(methacryloyloxy)ethyl ester, 4-N,N-dimethylaminobenzophenone, and butyl 4-dimethylaminobenzoate. Among these, at least one selected from the group consisting of N,N-di(2-hydroxyethyl)-p-toluidine, 4-N,N-dimethylaminobenzoic acid ethyl ester, N,N-dimethylaminobenzoic acid n-butoxyethyl ester, and 4-N,N-dimethylaminobenzophenone is used preferably from the viewpoint of being capable of providing the composition with excellent curability.
  • Examples of sulfinic acid and salt thereof used as the polymerization accelerator (H) include p-toluenesulfinic acid, sodium p-toluenesulfinate, potassium p-toluenesulfinate, lithium p-toluenesulfinate, calcium p-toluenesulfinate, benzenesulfinic acid, sodium benzenesulfinate, potassium benzenesulfinate, lithium benzenesulfinate, calcium benzenesulfinate, 2,4,6-trimethylbenzenesulfinic acid, sodium 2,4,6-trimethylbenzenesulfinate, potassium 2,4,6-trimethylbenzenesulfinate, lithium 2,4,6-trimethylbenzenesulfinate, calcium 2,4,6-trimethylbenzenesulfinate, 2,4,6-triethylbenzenesulfinic acid, sodium 2,4,6-triethylbenzenesulfinate, potassium 2,4,6-triethylbenzenesulfinate, lithium 2,4,6-triethylbenzenesulfinate, calcium 2,4,6-triethylbenzenesulfinate, 2,4,6-triisopropylbenzenesulfinic acid, sodium 2,4,6-triisopropylbenzenesulfinate, potassium 2,4,6-triisopropylbenzenesulfinate, lithium 2,4,6-triisopropylbenzenesulfinate, and calcium 2,4,6-triisopropylbenzenesulfinate. Sodium benzenesulfinate, sodium p-toluenesulfinate, and sodium 2,4,6-triisopropylbenzenesulfinate are particularly preferable.
  • The borate compound used as the polymerization accelerator (H) is preferably an arylborate compound. Specific examples of arylborate compounds that are used preferably include, as a borate compound having one aryl group in one molecule, sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of trialkylphenylboron, trialkyl(p-chlorophenyl)boron, trialkyl(p-fluorophenyl)boron, trialkyl(3,5-bistrifluoromethyl)phenylboron, trialkyl[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, trialkyl(p-nitrophenyl)boron, trialkyl(m-nitrophenyl)boron, trialkyl(p-butylphenyl)boron, trialkyl(m-butylphenyl)boron, trialkyl(p-butyloxyphenyl)boron, trialkyl(m-butyloxyphenyl)boron, trialkyl(p-octyloxyphenyl)boron, and trialkyl(m-octyloxyphenyl)boron (each alkyl group is at least one selected from the group consisting of, for example, an n-butyl group, an n-octyl group, and an n-dodecyl group).
  • Examples of the borate compound having two aryl groups in one molecule include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of dialkyldiphenylboron, dialkyldi(p-chlorophenyl)boron, dialkyldi(p-fluorophenyl)boron, dialkyldi(3,5-bistrifluoromethyl)phenylboron, dialkyldi[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, dialkyldi(p-nitrophenyl)boron, dialkyldi(m-nitrophenyl)boron, dialkyldi(p-butylphenyl)boron, dialkyldi(m-butylphenyl)boron, dialkyldi(p-butyloxyphenyl)boron, dialkyldi(m-butyloxyphenyl)boron, dialkyldi(p-octyloxyphenyl)boron, and dialkyldi(m-octyloxyphenyl)boron (each alkyl group is at least one selected from the group consisting of, for example, an n-butyl group, an n-octyl group, and an n-dodecyl group).
  • Examples of the borate compound having three aryl groups in one molecule include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of monoalkyltriphenylboron, monoalkyltri(p-chlorophenyl)boron, monoalkyltri(p-fluorophenyl)boron, monoalkyltri(3,5-bistrifluoromethyl)phenylboron, monoalkyltri[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, monoalkyltri(p-nitrophenyl)boron, monoalkyltri(m-nitrophenyl)boron, monoalkyltri(p-butylphenyl)boron, monoalkyltri(m-butylphenyl)boron, monoalkyltri(p-butyloxyphenyl)boron, monoalkyltri(m-butyloxyphenyl)boron, monoalkyltri(p-octyloxyphenyl)boron, and monoalkyltri(m-octyloxyphenyl)boron (each alkyl group is one selected from, for example, an n-butyl group, an n-octyl group, and an n-dodecyl group).
  • Furthermore, examples of the borate compound having four aryl groups in one molecule include sodium salt, lithium salt, potassium salt, magnesium salt, tetrabutylammonium salt, tetramethylammonium salt, tetraethylammonium salt, methylpyridinium salt, ethylpyridinium salt, butylpyridinium salt, methylquinolinium salt, ethylquinolinium salt, and butylquinolinium salt of tetraphenylboron, tetrakis(p-chlorophenyl)boron, tetrakis(p-fluorophenyl)boron, tetrakis(3,5-bistrifluoromethyl)phenylboron, tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]boron, tetrakis(p-nitrophenyl)boron, tetrakis(m-nitrophenyl)boron, tetrakis(p-butylphenyl)boron, tetrakis(m-butylphenyl)boron, tetrakis(p-butyloxyphenyl)boron, tetrakis(m-butyloxyphenyl)boron, tetrakis(p-octyloxyphenyl)boron, tetrakis(m-octyloxyphenyl)boron, (p-fluorophenyl)triphenylboron, (3,5-bistrifluoromethyl)phenyltriphenylboron, (p-nitrophenyl)triphenylboron, (m-butyloxyphenyl)triphenylboron, (p-butyloxyphenyl)triphenylboron, (m-octyloxyphenyl)triphenylboron, and (p-octyloxyphenyl)triphenylboron.
  • More preferably, from the viewpoint of storage stability, among these arylborate compounds, a borate compound having three or four aryl groups in one molecule is used. Furthermore, one of these arylborate compounds can be used or two or more of them can be used in mixture.
  • Examples of a barbituric acid derivative used as the polymerization accelerator (H) include barbituric acid, 1,3-dimethylbarbituric acid, 1,3-diphenylbarbituric acid, 1,5-dimethylbarbituric acid, 5-butylbarbituric acid, 5-ethylbarbituric acid, 5-isopropylbarbituric acid, 5-cyclohexylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1,3-dimethyl-5-ethylbarbituric acid, 1,3-dimethyl-n-butylbarbituric acid, 1,3-dimethyl-5-isobutylbarbituric acid, 1,3-dimethylbarbituric acid, 1,3-dimethyl-5-cyclopentylbarbituric acid, 1,3-dimethyl-5-cyclohexylbarbituric acid, 1,3-dimethyl-5-phenylbarbituric acid, 1-cyclohexyl-1-ethylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, 5-methylbarbituric acid, 5-propylbarbituric acid, 1,5-diethylbarbituric acid, 1-ethyl-5-methylbarbituric acid, 1-ethyl-5-isobutylbarbituric acid, 1,3-diethyl-5-butylbarbituric acid, 1-cyclohexyl-5-methylbarbituric acid, 1-cyclohexyl-5-ethylbarbituric acid, 1-cyclohexyl-5-octylbarbituric acid, 1-cyclohexyl-5-hexylbarbituric acid, 5-butyl-1-cyclohexylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, and thiobarbituric acids, as well as salts thereof (particularly, alkali metals or alkaline earth metals are preferable). Examples of salts of these barbituric acids include sodium 5-butylbarbiturate, sodium 1,3,5-trimethylbarbiturate, and sodium 1-cyclohexyl-5-ethylbarbiturate.
  • Examples of particularly preferable barbituric acid derivatives include 5-butylbarbituric acid, 1,3,5-trimethylbarbituric acid, 1-cyclohexyl-5-ethylbarbituric acid, 1-benzyl-5-phenylbarbituric acid, and sodium salts of these barbituric acids.
  • Examples of the triazine compound used as the polymerization accelerator (H) include 2,4,6-tris(trichloromethyl)-s-triazine, 2,4,6-tris(tribromomethyl)-s-triazine, 2-methyl-4,6-bis(trichloromethyl)-s-triazine, 2-methyl-4,6-bis(tribromomethyl)-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methylthiophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(2,4-dichlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-bromophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis(trichloromethyl)-s-triazine, 2-n-propyl-4,6-bis(trichloromethyl)-s-triazine, 2-(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-s-triazine, 2-styryl-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-methoxyphenyl)ethenyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(o-methoxyphenyl)ethenyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(p-butoxyphenyl)ethenyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4-dimethoxyphenyl)ethenyl]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-(3,4,5-trimethoxyphenyl)ethenyl]-4,6-bis(trichloromethyl)-s-triazine, 2-(1-naphthyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-biphenylyl)-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N,N-bis(2-hydroxyethyl)amino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-ethylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, 2-[2-{N-hydroxyethyl-N-methylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine, and 2-[2-{N,N-diallylamino}ethoxy]-4,6-bis(trichloromethyl)-s-triazine.
  • Particularly preferable ones among the triazine compounds described above as examples are 2,4,6-tris(trichloromethyl)-s-triazine in terms of polymerization activity and 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, and 2-(4-biphenylyl)-4,6-bis(trichloromethyl)-s-triazine in terms of storage stability. One of the above-mentioned triazine compounds may be used or two or more of them may be used in mixture.
  • Examples of the copper compound used preferably as the polymerization accelerator (H) include copper acetylacetonate, copper (II) acetate, copper oleate, copper (II) chloride, and copper (II) bromide.
  • Examples of the tin compound used as the polymerization accelerator (H) include di-n-butyltin dimalate, di-n-octyltin dimalate, di-n-octyltin dilaurate, and di-n-butyltin dilaurate. Particularly preferable tin compounds are di-n-octyltin dilaurate and di-n-butyltin dilaurate.
  • The vanadium compound used as the polymerization accelerator (H) is preferably one of tetravalent and/or pentavalent vanadium compounds. Examples of the tetravalent and/or pentavalent vanadium compounds include compounds described in JP 2003-96122 A such as divanadium (IV) tetroxide, vanadyl (IV) acetylacetonate, vanadyl (IV) oxalate, vanadyl (IV) sulfate, oxobis(1-phenyl-1,3-butanedionate)vanadium (IV), bis(maltolato)oxovanadium (IV), vanadium (V) pentoxide, sodium metavanadate (V), and ammonium metavanadate (V).
  • Examples of the halogen compound used preferably as the polymerization accelerator (H) include dilauryldimethylammoniumchloride, lauryldimethylbenzylammoniumchloride, benzyltrimethylammoniumchloride, tetramethylammoniumchloride, benzyldimethylcetylammoniumchloride, and dilauryldimethylammoniumbromide.
  • Examples of aldehydes used as the polymerization accelerator (H) include terephthalaldehyde and a benzaldehyde derivative. Examples of the benzaldehyde derivative include dimethylaminobenzaldehyde, p-methyloxybenzaldehyde, p-ethyloxybenzaldehyde, and p-n-octyloxybenzaldehyde. Among these, from the viewpoint of curability, p-n-octyloxybenzaldehyde is used preferably.
  • Examples of the thiol compound used as the polymerization accelerator (H) include 3-mercaptopropyltrimethoxysilane, 2-mercaptobenzooxazol, decanethiol, and thiobenzoic acid.
  • Examples of sulfite used as the polymerization accelerator (H) include sodium sulfite, potassium sulfite, calcium sulfite, and ammonium sulfite.
  • Examples of bisulfate used as the polymerization accelerator (H) include sodium bisulfate and potassium bisulfate.
  • Examples of the thiourea compound used as the polymerization accelerator (H) include 1-(2-pyridyl)-2-thiourea, thiourea, methylthiourea, ethylthiourea, N,N′-dimethylthiourea, N,N′-diethylthiourea, N,N′-di-n-propylthiourea, N,N′-dicyclohexylthiourea, trimethylthiourea, triethylthiourea, tri-n-propylthiourea, tricyclohexylthiourea, tetramethylthiourea, tetraethylthiourea, tetra-n-propylthiourea, and tetracyclohexylthiourea.
  • The amount of polymerization accelerator (H) to be added in the present invention is not particularly limited. However, from the viewpoints of, for example, curability of the resultant composition, it is preferable that 0.001 to 30 parts by mass of polymerization accelerator (H) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the amount of polymerization accelerator (H) to be added is less than 0.001 part by mass, polymerization may not proceed sufficiently and bond strength may be reduced. Therefore, the amount is more preferably at least 0.05 part by mass and further preferably at least 0.1 part by mass. On the other hand, when the amount of polymerization accelerator (H) to be added exceeds 30 parts by mass, in the case where the polymerization initiator itself has low polymerization performance, sufficiently high bond strength may not be obtained and further precipitation from the composition may occur. Therefore, the amount is more preferably 20 parts by mass or less and further preferably 10 parts by mass or less.
  • Filler (I)
  • Preferably, a filler (I) further is mixed into a composition of the present invention depending on the embodiment. Generally, such fillers are divided roughly into organic fillers, inorganic fillers, and organic-inorganic composite fillers. Examples of materials for the organic fillers include polymethylmethacrylate, polyethylmethacrylate, a methylmethacrylate-ethylmethacrylate copolymer, cross-linked polymethylmethacrylate, cross-linked polyethylmethacrylate, polyamide, polyvinyl chloride, polystyrene, chloroprene rubber, nitrile rubber, an ethylene-vinyl acetate copolymer, a styrene-butadiene copolymer, an acrylonitrile-styrene copolymer, and an acrylonitrile-styrene-butadiene copolymer. These may be used independently or a mixture of two or more of them may be used. The shapes of the organic fillers are not particularly limited, and particle sizes of the fillers to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the organic fillers is preferably 0.001 to 50 μm and more preferably 0.001 to 10 μm.
  • Examples of materials for the inorganic fillers include quartz, silica, alumina, silica-titania, silica-titania-barium oxide, silica-zirconia, silica-alumina, lanthanum glass, borosilicate glass, soda glass, barium glass, strontium glass, glass ceramics, aluminosilicate glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass. Similarly, these can be used independently or two or more of them can be used in mixture. The shapes of the inorganic fillers are not particularly limited and particle sizes of the fillers to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the inorganic fillers is preferably 0.001 to 50 μm and more preferably 0.001 to 10 μm.
  • Examples of the shapes of the inorganic fillers include amorphous fillers and spherical fillers. From the viewpoint of improving the mechanical strength of a composition, it is preferable that spherical fillers be used as the inorganic fillers. Furthermore, in the case of using the spherical fillers, when a composition of the present invention is used as a dental composite resin, there also is an advantage that a composition resin with excellent surface smoothness is obtained. In this case, the spherical fillers are fillers in which when a photograph thereof is taken with a scanning electron microscope (hereinafter abbreviated as SEM), particles observed within a unit field of view are rounded and the mean uniformity obtained by dividing the particle size in the direction orthogonal to the maximum diameter by the maximum diameter is at least 0.6. The mean particle size of the spherical fillers is preferably 0.1 to 5 μm. When the mean particle size is less than 0.1 μm, the filling rate of the spherical fillers in the composition decreases and thereby the mechanical strength may be reduced. On the other hand, when the mean particle size exceeds 5 μm, the surface areas of the spherical fillers are reduced and a cured product with high mechanical strength may not be obtained.
  • The inorganic fillers may be used after the surfaces thereof are treated beforehand with a known surface-treating agent such as a silane coupling agent in order to adjust fluidity of the composition as required. Examples of such a surface-treating agent include vinyltrimethoxysilane, vinyltriethoxysilane, vinyltrichlorosilane, vinyltri(β-methoxyethoxy)silane, γ-methacryloyloxypropyltrimethoxysilane, 11-methacryloyloxyundecyltrimethoxysilane, γ-glycidoxypropyltrimethoxysilane, γ-mercaptopropyltrimethoxysilane, and γ-aminopropyltriethoxysilane.
  • The organic-inorganic composite fillers used in the present invention can be obtained as follows. That is, a monomer compound is added to the aforementioned inorganic filler beforehand, this is made into a paste and is then polymerized, and thereafter this is crushed. The organic-inorganic composite filler that can be used is, for example, a TMPT filler (obtained by mixing trimethylolpropane methacrylate with a silica filler, polymerizing it, and then crushing it). The shape of the organic-inorganic composite filler is not particularly limited, and the particle size of the filler to be used can be selected appropriately. From the viewpoints of, for example, handling ability and mechanical strength of the resultant composition, the mean particle size of the organic-inorganic composite filler is preferably 0.001 to 50 μm and more preferably 0.001 to 10 μm.
  • The amount of the filler (I) to be added in the present invention is not particularly limited, but it is preferable that 1 to 2000 parts by mass of filler (I) be contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components. The preferable amount of filler (I) to be added varies considerably depending on the embodiment to be employed. Accordingly, preferable amounts of the filler (I) to be added according to the respective embodiments are indicated together with description of specific embodiments of the composition of the present invention described later.
  • In addition, for example, a pH adjuster, polymerization inhibitor, ultraviolet absorbent, thickening agent, colorant, antibacterial agent, and flavor may be added to the composition of the present invention within a range that does not inhibit the effect of the present invention.
  • The composition of the present invention is used suitably as a dental composition. This dental composition can be used for dental materials such as a primer, bonding material, composite resin, cement (resin cement, glass ionomer cement, and resin-reinforced glass ionomer cement), pit and fissure sealant, and denture base resin, and particularly, it is used suitably as a primer, bonding material, composite resin, or cement. In this case, the composition may be used as a two component type in which the components of the composition are divided into two.
  • With respect to a dental material, generally, a dental adhesive is used when a lost part of a tooth is filled or covered with a restorative material. Typically, the dental adhesive is allowed to act on dentin. In this case, when such a dental adhesive is allowed to act on dentin, it is important for the dental adhesive to have an decalcifying effect that allows a dentin surface to be dissolved with an acidic component, a penetration effect that allows a monomer component to penetrate into a collagen layer of the dentin, and a curing effect that allows the monomer component thus penetrated to solidify to form a hybrid layer (hereinafter also referred to as a “resin-impregnated layer”) with collagen. Generally, a bonding system in which these three steps, “decalcifying”, “penetration”, and “curing”, are performed separately is referred to as a “three-step bonding system”. Basically, a product used for the penetration step is a primer, and a product used for the curing step is a bonding material.
  • Recently, in order to simplify the operation process, a product that allows the decalcifying step and the penetration step to be performed together in one step has been developed and has been used practically. The product is referred to as a “self-etching primer”. Generally, the bonding system using a self-etching primer and a bonding material is referred to as a “two-step bonding system”. The polymerizable monomer (A) used in the present invention has at least two hydroxyl groups and has high hydrophilicity. Therefore, it easily penetrates into a collagen layer of dentin. Accordingly, a composition of the present invention containing a polymerizable monomer (A) can be used as a dental primer and also can be used as a dental self-etching primer.
  • Preferably, the primer using a composition of the present invention is a composition containing a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, and solvent (F). Furthermore, an embodiment containing a polymerization accelerator (H) also is used preferably. The amounts of the above-mentioned (A) and (D) to be added are preferably 10 to 99 parts by mass of (A) and 1 to 90 parts by mass of (D), more preferably 15 to 98 parts by mass of (A) and 2 to 85 parts by mass of (D), and further preferably 20 to 97 parts by mass of (A) and 3 to 80 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • Furthermore, when penetrability of a primer composition into a tooth structure (particularly dentin) is considered important, it is preferable that further a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group be contained. When the primer composition contains (A), (C), and (D), the amounts of respective components to be added are preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass of (C), and 1 to 90 parts by mass of (D), more preferably 3 to 90 parts by mass of (A), 5 to 85 parts by mass of (C), and 2 to 80 parts by mass of (D), and further preferably 10 to 80 parts by mass of (A), 7 to 80 parts by mass of (C), and 3 to 60 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • When particularly the strength of the cured product of a primer containing a composition of the present invention is intended to be improved, a crosslinkable polymerizable monomer (E) further may be added. When consideration is given to penetrability into a tooth structure (particularly dentin), the above-mentioned (E) is preferably an aliphatic compound-based bifunctional polymerizable monomer, more preferably ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, or 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, and further preferably triethylene glycol di(meth)acrylate, or 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane. The amount of the above-mentioned (E) to be added is preferably 0 to 30 parts by mass, more preferably 1 to 25 parts by mass, and further preferably 3 to 20 parts by mass, in 100 parts by mass of the whole amount of polymerizable monomer components.
  • Furthermore, the amount of bisacylphosphine oxide (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. In the primer containing a composition of the present invention, the use of bisacylphosphine oxide (B) and polymerization initiator (G) in combination also is a preferable embodiment. In this case, the amount of (G) to be contained is preferably 0.001 to 20 parts by mass and more preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, the additional use of a polymerization accelerator (H) also is a preferable embodiment and particularly amines are used suitably. In this case, the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • In the primer containing a composition of the present invention, since the polymerizable monomer (A) has at least two hydroxyl groups in the molecule, hydrophilicity of the composition of the present invention can be improved and thereby penetrability into a collagen layer of dentin can be improved. Furthermore, it is preferable that the solvent (F) be used in the form of a mixed solvent of water (J) and an organic solvent (K). The amount of water (J) to be contained in the mixed solvent is not particularly limited but is preferably at least 10 mass %, more preferably at least 30 mass %, and further preferably at least 50 mass %. Moreover, the organic solvent (K) may not need to be added depending on the embodiment. The amount of the aforementioned solvent (F) to be added is preferably 5 to 4000 parts by mass, preferably 10 to 3000 parts by mass, and further preferably 15 to 2000 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, when the solvent (F) is used in the form of a mixed solvent of water (J) and the organic solvent (K), the amounts of the aforementioned (J) and (K) to be added are preferably 4 to 2000 parts by mass of (J) and 1 to 2000 parts by mass of (K), more preferably 8 to 1500 parts by mass of (J) and 2 to 1500 parts by mass of (K), and further preferably 12 to 1000 parts by mass of (J) and 3 to 1000 parts by mass of (K), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • The composition of the present invention is used preferably as a bonding material. Preferably, the bonding material in the aforementioned “two-step bonding system” is a composition containing the aforementioned polymerizable monomer (A), bisacylphosphine oxide (B), and filler (I). More preferably, such a composition further contains a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group and/or crosslinkable polymerizable monomer (E). Furthermore, an embodiment containing a polymerization initiator (G) and polymerization accelerator (H) also is used preferably. The amounts of respective components to be added are preferably 1 to 99 parts by mass of (A), 0 to 90 parts by mass of (C), and 0 to 90 parts by mass of (E) and more preferably 2 to 96 parts by mass of (A), 1 to 80 parts by mass of (C), and 1 to 80 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components. As in the case of the above-mentioned (A) used in the present invention, the use of a compound having at least two polymerizable groups allows a cured product to have increased mechanical strength. From such a viewpoint, the aforementioned (E) is more preferably a polymerizable monomer having at least two polymerizable groups, and from a viewpoint of obtaining a cured product with particularly high strength, it is further preferable that the aforementioned (E) contain an aromatic compound-based bifunctional polymerizable monomer. The use of an aliphatic bifunctional polymerizable monomer and aromatic compound-based bifunctional polymerizable monomer in combination as the aforementioned (E) also is a preferable embodiment.
  • Furthermore, the amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. In the bonding material containing a composition of the present invention, the use of a bisacylphosphine oxide (B) and polymerization initiator (G) in combination also is a preferable embodiment. In this case, the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably. In this case, the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Moreover, the amount of filler (I) to be added is preferably 1 to 20 parts by mass, more preferably 2 to 17 parts by mass, and further preferably 3 to 15 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • Recently, since there are demands for further simplification in operations, products that allow three steps of “decalcifying”, “penetration”, and “curing” to be performed together in one step also have been developed and are referred to as “one-step bonding systems”. Two typical products of the bonding material used in such a one-step bonding system are a bonding material in which two separate liquids of liquid A and liquid B are mixed together immediately before use and a bonding material that is provided in the form of one liquid from the beginning and that is a so-called one-component one-step bonding system. Among these, the one-component type product further simplifies the process and therefore has a greater advantage in use. When a composition of the present invention is used as the bonding material of the aforementioned one-component one-step bonding system, the composition is preferably a composition containing a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, filler (I), and solvent (F), and further preferably, such a composition further contains a crosslinkable polymerizable monomer (E). The amounts of respective components to be added are preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass (D), and 0 to 90 parts by mass of (E), more preferably 2 to 94 parts by mass of (A), 2 to 80 parts by mass of (D), and 2 to 80 parts by mass of (E), and further preferably 7 to 90 parts by mass of (A), 3 to 70 parts by mass of (D), and 7 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components. In the one-component one-step bonding system, since the “penetration” and “curing” are performed at one time, the use of a polymerizable monomer having at least two hydroxyl groups and at least two polymerizable groups like the aforementioned (A) is of great significance.
  • In the one-component one-step bonding system, when penetrability into a tooth structure (particularly dentin) is considered important, it is preferable that a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group further be contained. When the one-component one-step bonding system contains (A), (C), (D), and (E), the amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 95 parts by mass of (D), and 3 to 97 parts by mass of (E), more preferably 3 to 90 parts by mass of (A), 3 to 85 parts by mass of (C), 2 to 80 parts by mass of (D), and 5 to 80 parts by mass of (E), and further preferably 5 to 80 parts by mass of (A), 5 to 80 parts by mass of (C), 3 to 60 parts by mass of (D), and 8 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • The amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. In the one-component one-step bonding system containing a composition of the present invention, a combined use of a bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment. In this case, the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, an additional use of a polymerization accelerator (H) also is a preferable embodiment and particularly amine is used suitably. In this case, the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, the amount of filler (I) to be added is preferably 1 to 20 parts by mass, more preferably 1.5 to 15 parts by mass, and further preferably 2 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • The amount of solvent (F) to be added is preferably 6 to 4000 parts by mass, more preferably 12 to 3000 parts by mass, and further preferably 15 to 2000 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. The one-component one-step bonding system needs to perform all the processes of decalcifying, penetration, and curing with one liquid in one step. Therefore, from the viewpoint that penetrability is considered important, it is preferable that water (J) be contained as the solvent (F). On the other hand, from the viewpoint that curability is considered important, it is preferable that the bonding system contain a suitable amount of crosslinkable polymerizable monomer (E). From the viewpoints of increasing the solubility of the aforementioned (E) and obtaining a uniform solution, it is preferable that an organic solvent (K) be contained as the aforementioned solvent (F). A more preferable embodiment is the use of the solvent (F) in the form of a mixed solvent of water (J) and an organic solvent (K). In such an embodiment, the amounts of the aforementioned (J) and (K) to be added are preferably 2 to 2000 parts by mass of (J) and 4 to 2000 parts by mass of (K), more preferably 4 to 1500 parts by mass of (J) and 8 to 1500 parts by mass of (K), and further preferably 5 to 1000 parts by mass of (J) and 10 to 1000 parts by mass of (K), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • The composition of the present invention is used preferably as composite resin. When the composition of the present invention is used as composite resin, the composition is preferably one containing a polymerizable monomer (A), bisacylphosphine oxide (B), crosslinkable polymerizable monomer (E), and filler (I). Generally, the composite resin is used in the form of filling a cavity after the cavity is formed by cutting a site of caries incidence. Thereafter, generally, the composite resin filling the cavity is cured through photopolymerization. Therefore, the use of the bisacylphosphine oxide (B), a photopolymerization initiator, has significance. Furthermore, since the composite resin that has filled the cavity and that has been cured as described above is subjected to occlusal pressure inside an oral cavity, high mechanical strength is required. Accordingly, the content of the filler (I) in the composition is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the content of the filler (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient. On the other hand, when the content of the filler (I) exceeds 2000 parts by mass, it may become difficult to disperse the filler (I) uniformly throughout the whole amount of polymerizable monomer components, which may result in a composition that is insufficient in mechanical strength and handling ability. The amounts of respective components to be added are preferably 1 to 99 parts by mass of (A) and 1 to 99 parts by mass of (E), more preferably 10 to 95 parts by mass of (A) and 5 to 90 parts by mass of (E), and further preferably 15 to 90 parts by mass of (A) and 10 to 85 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, the amount of (B) to be contained is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 15 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. The combined use of the bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment. In this case, the amount of (G) to be contained is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Further, the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably. In this case, the amount of (H) to be contained is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • Since the polymerizable monomer (A) in the present invention has both excellent curability and penetrability into a tooth structure, it is preferable that it be used particularly as a self-adhesive composite resin among composite resins. When the composition of the present invention is used as a self-adhesive composite resin, it is preferable that the composition contain a polymerizable monomer (A), bisacylphosphine oxide (B), polymerizable monomer (D) having an acidic group, crosslinkable polymerizable monomer (E), and filler (I). The amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (D), and 4 to 90 parts by mass of (E), more preferably 5 to 80 parts by mass of (A), 2 to 85 parts by mass of (D), and 6 to 85 parts by mass of (E), and further preferably 10 to 80 parts by mass of (A), 3 to 80 parts by mass of (D), and 8 to 80 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, when the penetrability into a tooth structure (particularly dentin) is considered important, it is preferable that the composition further contain a polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group. When the self-adhesive composite resin contains (A), (C), (D), and (E), the amounts of respective components to be added are preferably 1 to 95 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 90 parts by mass of (D), and 3 to 90 parts by mass (E), more preferably 3 to 90 parts by mass of (A), 3 to 85 parts by mass of (C), 2 to 85 parts by mass of (D), and 5 to 85 parts by mass of (E), and further preferably 5 to 80 parts by mass of (A), 5 to 70 parts by mass of (C), 3 to 60 parts by mass of (D), and 8 to 70 parts by mass of (E), in 100 parts by mass of the whole amount of polymerizable monomer components. With respect to the amounts of bisacylphosphine oxide (B) and filler (H) to be added, the same amounts as those used in the aforementioned general composite resin can be employed. Furthermore, in the same manner as in the case of the aforementioned general composite resin, the combined use of the bisacylphosphine oxide (B), polymerization initiator (G), and polymerization accelerator (H) also is a preferable embodiment. The amounts of the aforementioned (B), (G), and (H) to be added are as described above. Moreover, when particularly the penetrability into a tooth structure is considered important, it also is possible to add a solvent (F), and it is further preferable that the solvent (F) contain water (J). The amount of solvent (F) to be added is preferably 0 to 15 parts by mass and more preferably 1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • Furthermore, the use of a composition of the present invention as a dental cement also is one of preferable embodiments. Examples of preferable cements include a resin cement, glass ionomer cement, and resin-reinforced glass ionomer cement. When the composition of the present invention is used as a resin cement, the composition is preferably one containing a polymerizable monomer (A), bisacylphosphine oxide (B), crosslinkable polymerizable monomer (E), polymerization accelerator (H), filler (I), and water (J) to serve as a solvent (F). Such a composition further can contain a polymerizable monomer (D) having an acidic group. The dental cement is used suitably as, for example, a luting material that is used in fixing a metal or ceramics dental crown restorative material, which is referred to as an “inlay” or “crown”, to a tooth. As in the case of the aforementioned (A) used in the present invention, when at least two polymerizable groups are included, the resultant cured product has increased mechanical strength and can withstand, for example, occlusal pressure. From such a viewpoint, it is more preferable that the aforementioned (E) be a polymerizable monomer having at least two polymerizable groups. Furthermore, in the case of the form of usage as described above, since many of the dental crown restorative materials have optical opacity, it is not easy to cure the cement by only photopolymerization. Therefore, it is preferable that a chemical polymerization initiator be used as the aforementioned (G). Furthermore, when polymerization is performed by using a chemical polymerization initiator, in order to improve the reactivity thereof, the use of amines and/or sulfinic acid and salt thereof as the aforementioned (H) is preferable and the simultaneous use of amines and sulfinic acid and salt thereof is more preferable. The filler (I) used is not particularly limited.
  • When the cement is intended to be provided with a property of sustained-release of fluoride, it is preferable that at least one selected from the group consisting of fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass be used as the filler (I), and it is more preferable that fluoroaluminosilicate glass and/or barium fluoroaluminosilicate glass be used as the filler (I). On the other hand, when the cement is intended to be provided with radiopacity, it is preferable that at least one selected from the group consisting of barium glass, strontium glass, barium boroaluminosilicate glass, strontium boroaluminosilicate glass, strontium fluoroaluminosilicate glass, and barium fluoroaluminosilicate glass be used as the filler (I), and it is more preferable that barium glass and/or barium fluoroaluminosilicate glass be used as the filler (I).
  • When a chemical polymerization initiator is used, from the viewpoint of storage stability, it is preferable that the aforementioned (G) and (H) be stored in separate containers, respectively. That is, in a preferred embodiment, the resin cement is used in the form of a two component type. In a more preferred embodiment, the resin cement is used in the form of two paste type. Preferably, the respective pastes are stored while being separated from each other, the two pastes are mixed together immediately before use, and thereby chemical polymerization is allowed to proceed to cure the mixture. The aforementioned pastes each are prepared by mixing a liquid component of, for example, polymerizable monomer with a filler (I) (powder) together. Furthermore, when sulfinic acid and salt thereof are used as the aforementioned (H), from the viewpoint of storage stability, it is preferable that the aforementioned (D) and (H) be stored in separate containers, respectively. Suppose that the aforementioned two pastes are referred to as a paste A and a paste B, respectively, an embodiment in which the paste A contains (A), (D), (B), (G), and (I) and the paste B contains (A), (H), and (I) is used particularly suitably.
  • When the composition of the present invention is used as a dental cement, the amounts of respective components to be added are not particularly limited. However, in 100 parts by mass of the whole amount of polymerizable monomer components, the composition contains preferably 1 to 98 parts by mass of (A), 0 to 90 parts by mass of (C), 1 to 90 parts by mass of (D), and 1 to 90 parts by mass of (E), and more preferably 2 to 96 parts by mass of (A), 0 to 85 parts by mass of (C), 2 to 85 parts by mass of (D), and 2 to 85 parts by mass of (E). When consideration is given to obtaining a suitable setting time, the amounts of the aforementioned (B), (G), and (H) to be added are preferably 0.01 to 20 parts by mass of (B), 0.001 to 20 parts by mass of (G), and 0.001 to 30 parts by mass of (H) and more preferably 0.05 to 15 parts by mass of (B), 0.05 to 15 parts by mass of (G), and 0.05 to 20 parts by mass of (H), with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
  • Furthermore, with respect to 100 parts by mass of the whole amount of polymerizable monomer components, the content of (I) is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass. When the content of (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient. On the other hand, in the case where the content of (I) exceeds 2000 parts by mass, when the resin cement is used as a two-paste-type cement, which is a preferred embodiment, the pastes lack fluidity, which makes it difficult to carry out sufficient mixing, and therefore the cured product may have reduced strength. The composition of the present invention is used preferably as a glass ionomer cement and more preferably as a resin-reinforced glass ionomer cement. The glass ionomer cement is typically one in which an inorganic filler such as fluoroaluminosilicate glass and polyalkenoic acid such as polyacrylic acid are reacted with each other through an acid-base reaction to be cured. Conceivably, the polyacrylic acid interacts with calcium contained in hydroxyapatite composing a tooth structure and thereby a bonding function is exhibited. When a composition of the present invention is used as a glass ionomer cement, particularly preferably as a resin-reinforced glass ionomer cement, the composition is preferably one containing (A), (B), (H), (I), (F), and polyalkenoic acid, and more preferably one containing (A), (E), (B), (H), (I), (F), and polyalkenoic acid, one containing (A), (C), (B), (H), (I), (F), and polyalkenoic acid, or one containing (A), (C), (E), (B), (H), (I), (F), and polyalkenoic acid. Such compositions further can contain (D).
  • The polymerizable monomer (C) having one polymerizable group and at least one hydroxyl group to be used is not particularly limited. As described later, from the viewpoint that an acid-base reaction is allowed to proceed smoothly, it is preferable that the solvent (F) contain water (J). Therefore, from the viewpoints of maintaining the uniformity of the composition and obtaining consistent performance, it is more preferable that a monomer with high affinity for water (J) be used as the aforementioned (C). Such a monomer with high affinity for water (J) is preferably 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, glycerol mono(meth)acrylate, or erythritol mono(meth)acrylate and particularly preferably 2-hydroxyethylmethacrylate.
  • The crosslinkable polymerizable monomer (E) to be used is not particularly limited, but as described above, the use of a monomer with high affinity for water (J) as the aforementioned (E) is more preferable from the viewpoints of maintaining the uniformity of the composition and obtaining consistent performance. In terms of a balance between such affinity for water (J) and the mechanical strength of the cured product, the aforementioned (E) is preferably an aliphatic compound-based bifunctional polymerizable monomer and more preferably triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, or 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl) dimethacrylate (commonly known as “UDMA”).
  • The aforementioned polyalkenoic acid is a polymer of unsaturated monocarboxylic acid or unsaturated dicarboxylic acid. Specific examples of the polyalkenoic acid include homopolymers of, for example, acrylic acid, methacrylic acid, 2-chloroacrylic acid, 2-cyanoacrylic acid, aconitic acid, mesaconic acid, maleic acid, itaconic acid, fumaric acid, glutaconic acid, citraconic acid, and utraconic acid, or copolymers of these unsaturated carboxylic acids and monomers copolymerizable therewith. In the case of the copolymers, the ratio of the unsaturated carboxylic acid unit is preferably at least 50 mol % with respect to the total structure unit. An ethylenically unsaturated polymerizable monomer is preferable as the copolymerizable monomer, and examples thereof include styrene, acrylamide, acrylonitrile, methyl methacrylate, acrylic acid salts, vinyl chloride, allyl chloride, vinyl acetate, and 1,1,6-trimethylhexamethylene dimethacrylate ester. Among those polyalkenoic acids, a homopolymer or copolymer of acrylic acid or maleic acid is preferable. When these polyalkenoic acids have a weight-average molecular weight of less than 5,000, the cured product of the dental cement composition may have reduced strength and poor durability. On the other hand, when it has a weight-average molecular weight exceeding 40,000, it may have high consistency during mixing of the dental cement composition and therefore may have lower operability. Accordingly, a preferable weight-average molecular weight of the polyalkenoic acid is 5,000 to 40,000.
  • From the viewpoints of curability in the acid-base reaction and the property of sustained-release of fluoride of the composition, the filler (I) to be used is preferably at least one selected from the group consisting of fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass, and more preferably fluoroaluminosilicate glass and/or barium fluoroaluminosilicate glass.
  • Furthermore, the solvent (F) to be used is not particularly limited. However, from the viewpoint that an acid-base reaction is allowed to proceed smoothly, it is preferable that the solvent (F) contain water (J). When a mixed solvent of water (J) and an organic solvent (K) is used as the solvent (F), the content of water (J) in the mixed solvent is preferably at least 50 mass %, more preferably at least 70 mass %, and further preferably at least 90 mass %. In an embodiment in which particularly progress of the acid-base reaction is considered important, it is particularly preferable that the solvent (F) consist substantially of water (J) alone.
  • When a composition of the present invention is used as a glass ionomer cement, particularly preferably as a resin-reinforced glass ionomer cement, the amounts of respective components to be added are not particularly limited. When the composition contains (A) and (C), it contains preferably 1 to 99 parts by mass of (A), 1 to 90 parts by mass of (C), and 0 to 50 parts by mass of (D) and more preferably 2 to 95 parts by mass of (A), 5 to 85 parts by mass of (C), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components. When the composition contains (A) and (E), it contains preferably 1 to 99 parts by mass of (A), 1 to 90 parts by mass of (E), and 0 to 50 parts by mass of (D) and more preferably 2 to 95 parts by mass of (A), 5 to 98 parts by mass of (E), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, when the composition contains (A), (C), and (E), it contains preferably 1 to 98 parts by mass of (A), 1 to 90 parts by mass of (C), 1 to 90 parts by mass of (E), and 0 to 50 parts by mass of (D) and more preferably 2 to 90 parts by mass of (A), 5 to 85 parts by mass of (C), 5 to 85 parts by mass of (E), and 0 to 30 parts by mass of (D), in 100 parts by mass of the whole amount of polymerizable monomer components.
  • The combined use of bisacylphosphine oxide (B) and polymerization initiator (G) also is a preferable embodiment. In this case, the content of (G) is preferably 0.001 to 20 parts by mass, more preferably 0.05 to 15 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Furthermore, the additional use of a polymerization accelerator (H) also is a preferable embodiment, and particularly amine is used suitably. In this case, the content of (H) is preferably 0.001 to 30 parts by mass, more preferably 0.05 to 20 parts by mass, and further preferably 0.1 to 10 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. Moreover, the content of (I) is preferably 30 to 2000 parts by mass and more preferably 50 to 1500 parts by mass, with respect to 100 parts by mass of the whole amount of polymerizable monomer components. When the content of (I) is less than 30 parts by mass, mechanical strength of the cured product may be insufficient. On the other hand, when the content of (I) exceeds 2000 parts by mass, the composition paste has lower fluidity, which makes sufficient mixing difficult, and therefore the acid-base reaction may not proceed smoothly. As a result, the cured product may have reduced strength.
  • With respect to 100 parts by mass of the whole amount of polymerizable monomer components, the content of solvent (F) is preferably 7 to 500 parts by mass, more preferably 10 to 300 parts by mass, and further preferably 20 to 100 parts by mass. When the solvent (F) is contained in such ranges, the acid-base reaction can proceed smoothly, and the resultant cured product has excellent mechanical strength and excellent adhesive properties to a tooth structure.
  • With respect to 100 parts by mass of the whole amount of polymerizable monomer components, the content of the aforementioned polyalkenoic acid is preferably 1 to 200 parts by mass, more preferably 5 to 100 parts by mass, and further preferably 10 to 50 parts by mass. When the polyalkenoic acid is contained in such ranges, curing through the acid-base reaction proceeds smoothly and decay of the resultant cured product inside an oral cavity by, for example, hydrolysis can be diminished.
  • As described above, since curing of a glass ionomer cement occurs through progress of an acid-base reaction, from the viewpoint of storage stability, it is preferable that a basic filler (I) and polyalkenoic acid be packed in separate containers and be used after being mixed immediately before use. The preferable types of products to be employed include a so-called powder-liquid type, but from the viewpoint of improving handling ability, the form of so-called two past-type glass ionomer cement containing two types of pastes is more preferable. In the case where the type of product is the two paste type, when the aforementioned two pastes are referred to as a paste A and a paste B, respectively, an embodiment is preferable in which the paste A contains (A), (B), (F), (I), and polyalkenoic acid and the paste B contains (C) and (I). Furthermore, an embodiment in which the paste A contains (A), (B), (F), (I), and polyalkenoic acid and the paste B contains (E) and (I) also is used preferably. In addition, an embodiment in which the paste A contains (E), (B), (I), and polyalkenoic acid and the paste B contains (A), (G), (I), and (F) also is used preferably. In this case, when particularly adhesive properties are considered important, it is preferable that the paste A further contain (D), and from the similar viewpoint, it also is preferable that the paste B further contain (C). In all of the embodiments, since the paste A contains polyalkenoic acid, it is preferable that at least one selected from the group consisting of fluoroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, and strontium calcium fluoroaluminosilicate glass be used as the filler (I) contained in the paste B, and it is more preferable that fluoroaluminosilicate glass and/or barium fluoroaluminosilicate glass be used as the filler (I). On the other hand, the filler (I) contained in the paste A to be used is preferably one that exhibits no reactivity with polyalkenoic acid, and particularly preferably quartz.
  • These dental materials can be prepared and used according to a conventional method. These dental materials exhibit excellent bond strength and bond durability with respect to a tooth structure (particularly dentin). Hereinafter, the present invention is described in further detail using examples but is not limited thereto.
  • Example 1 Application to One-Step Bonding System (One-Component Bonding Material) (1) Production of One-Component Bonding Material
  • Respective components were mixed together at an ordinary temperature and thereby a one-component bonding material composition was produced. The composition thereof is indicated in Table 1. The bond strength with respect to bovine teeth dentin was measured according to the following procedure.
  • TABLE 1
    One-Component Bonding Material Compositions and Bonding Evaluation Results
    Ex. Ex. Ex. Ex. Ex. Ex. Ex. C. Ex. C. Ex. C. Ex.
    Components 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-1 1-2 1-3
    Polymerizable monomer EDMA 15 15 15 15 15
    (A) XDMA 15 15
    SDMA 15 15
    MDMA 15
    Polymerizable monomer #801
    for comparison with (A) GDMA
    Polymerizable monomer HEMA 15 15 15 15 15 15 15 15 15 15
    (C) having one
    polymerizable group and
    at least one hydroxyl
    group
    Polymerizable monomer MDP 10 10 10 10 10 10 10 10 10 10
    (D) having acidic group
    Crosslinkable Bis-GMA 30 30 30 30 30 30 30 30 30 30
    polymerizable monomer
    (E)
    Solvent (F) Distilled 15 15 15 15 15 15 15 15 15 15
    water
    Ethanol 15 15 15 15 15 15 15 15 15 15
    Polymerization initiator BAPO-1 5 5 5 5 0.5 3
    (B) BAPO-2 5
    Polymerization initiator TMDPO 5 5 5
    (G) CQ 1
    Polymerization DBB 0.9
    accelerator (H)
    Filler (I) Inorganic 5 5 5 5 5 5 5 5 5 5
    filler 1
    Bond strength with After 24 24.7 22.2 22.3 23.9 22.5 22.1 24.3 18.7 16.5 17.5
    respect to dentin (MPa) hours
    After 24.8 21.0 21.2 23.5 22.9 21.1 24.5 19.0 18.2 18.4
    thermal
    cycles load
    C. Ex. C. Ex. C. Ex. C. Ex. C. Ex. C. Ex. C. Ex.
    Components 1-4 1-5 1-6 1-7 1-8 1-9 1-10
    Polymerizable monomer EDMA 15 15
    (A) XDMA
    SDMA
    MDMA 15
    Polymerizable monomer #801 15
    for comparison with (A) GDMA 15 15
    Polymerizable monomer HEMA 15 15 15 30 15 15 15
    (C) having one
    polymerizable group and
    at least one hydroxyl
    group
    Polymerizable monomer MDP 10 10 10 10 10 10 10
    (D) having acidic group
    Crosslinkable Bis-GMA 30 30 30 30
    polymerizable monomer
    (E)
    Solvent (F) Distilled 15 15 15 15 15 15 15
    water
    Ethanol 15 15 15 15 15 15 15
    Polymerization initiator BAPO-1 5 5 5
    (B) BAPO-2
    Polymerization initiator TMDPO 5 5 5
    (G) CQ 2 2
    Polymerization DBB 1 1
    accelerator (H)
    Filler (I) Inorganic 5 5 5 5 5 5 5
    filler 1
    Bond strength with After 24 19.9 18.5 18.7 15.7 15.2 15.8 12.8
    respect to dentin (MPa) hours
    After 19.5 18.6 18.7 16.1 14.8 14.6 9.8
    thermal
    cycles load
    (The amounts of respective components added each are indicated in the unit of parts by mass.)
    EDMA: erythritol dimethacrylate [1,4-bis(methacryloyloxy)-2,3-butanediol]
    XDMA: xylitol dimethacrylate [1,5-bis(methacryloyloxy)-2,3,4-pentanetriol]
    SDMA: sorbitol dimethacrylate [1,6-bis(methacryloyloxy)-2,3,4,5-hexanetetraol]
    MDMA: mannitol dimethacrylate (3,4-di-O-methacryloyl-D-mannitol)
    #801: 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane
    GDMA: glycerol dimethacrylate [polymerizable monomer for comparative examples that does not correspond to polymerizable monomer (A)]
    MDP: 10-methacryloyloxydecyldihydrogenphosphate
    HEMA: 2-hydroxyethylmethacrylate
    Bis-GMA: 2,2-bis[4-(3-methacryloyloxy)-2-hydroxypropoxyphenyl]-propane (bisphenol A diglycidyl methacrylate)
    BAPO-1: bis-(2,4,6-trimethylbenzoyl)phenylphosphine oxide
    BAPO-2: bis-(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide
    TMDPO: 2,4,6-trimethylbenzoyldiphenylphosphine oxide
    CQ: camphorquinone
    DBB: N,N-dimethylaminobenzoic acid n-butoxyethyl ester
    Inorganic filler 1: “R972” manufactured by Japan Aerosil Inc.
  • MDMA is a new compound and it was synthesized by the following method.
  • Reference Example Synthesis of MDMA
  • (i) Synthesis of 1,2 :5,6-Di-O-isopropylidene-3, 4-di-O-methacryloyl-D-mannitol
  • After 700 mL of anhydrous pyridine was added to a 2 L separable flask equipped with a condenser tube, 65 g of 1,2:5,6-Di-O-isopropylidene-D-mannitol (manufactured by Wako Pure Chemical Industries, Ltd.) was added into the flask gradually and was dissolved completely. An ice bath was set for the reaction system and the reaction system was cooled to 0° C. Subsequently, while the temperature of the reaction system was maintained around 0° C. and the reaction system was stirred, 60 g of methacryloyl chloride (manufactured by Wako Pure Chemical Industries, Ltd.) was dropped into the reaction system in a nitrogen atmosphere using a dropping funnel over approximately one hour. The dropping funnel was replaced by a glass stopper, and the reaction system was heated to 70° C. using an oil bath. This heating was continued for eight hours. After completion of heating, the oil bath was removed and the reaction system was then cooled to room temperature. Subsequently, the reaction system was poured into a beaker containing 1 L of ice water and thereby the reaction was stopped. After the reaction was stopped, extraction was performed five times using 1500 mL of diethyl ether. Thereafter, the resultant organic layer was subjected to vacuum concentration using an evaporator and thus an oily material was obtained. The oily material was purified using silica gel column chromatography (diluents: hexane:diethyl ether=7:3). After concentration, hexane was added and thereby recrystallization was carried out. Thus, a target compound was obtained. The yield amount was 36.3 g, and the yield rate was 37%.
  • 1H-NMR (400 MHz, CDCl3, δ) 1.31 (s, 6H), 1.36 (s, 6H), 1.96 (s, 6H), 3.85-3.96 (m, 4H), 4.21-4.27 (m, 2H), 5.43 (dd, 2H), 5.64 (s, 2H), 6.15 (s, 2H) (ppm).
  • 13C-NMR (100 MHz, CDCl3, δ) 18.2, 25.1, 26.3, 65.5, 71.6, 74.7, 109.3, 126.6, 135.6, 166.0 (ppm).
  • (ii) Synthesis of MDMA (3,4-di-O-methacryloyl-D-mannitol)
  • 540 mL of acetic acid and 180 mL of water were added to a 2 L round-bottom flask. While the resultant acetic acid aqueous solution was stirred, 18 g of 1,2:5,6-Di-O-isopropylidene-3,4-di-O-methacryloyl-D-mannitol synthesized above was added gradually thereto and was dissolved completely. The solution thus prepared was stirred for 18 hours, with the temperature thereof being maintained at 25° C. After completion of stirring, the solution was subjected to vacuum concentration using an evaporator and thus an oily material was obtained. The oily material was purified using silica gel column chromatography (diluent:ethyl acetate 100%) and was concentrated. As a result, white crystals were precipitated. It was confirmed by NMR that these crystals were a target compound. The yield amount was 8.7 g and the yield rate was 60%.
  • 1H-NMR (400 MHz, CD3OD, δ) 1.84 (s, 6H), 3.39 (dd, 2H), 3.51 (dd, 2H), 3.59-3.66 (m, 2H), 5.28 (d, 2H), 5.56 (s, 2H), 6.03 (s, 2H) (ppm).
  • 13C-NMR (100 MHz, CD3OD, δ) 18.4, 64.2, 71.6, 73.1, 126.8, 137.4, 167.9 (ppm).
  • (2) Method of Evaluating Bonding to Bovine Teeth Dentin
  • The labial surface of a bovine mandibular incisor was ground with #80 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water, and thereby a sample with an exposed flat surface of dentin was obtained. The sample thus obtained further was ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water. After completion of grinding, water on the surface was air-blown to be dried. An adhesive tape with a thickness of about 150 μm having a circular hole whose diameter was 3 mm was attached to the smooth surface that had been dried and thereby the adhesive area was defined.
  • Each one-component bonding material composition produced above was applied into the above-mentioned circular hole using a brush and was then allowed to stand for 20 seconds. Thereafter, the surface thereof was air-blown with a dental air syringe and thereby the one-component bonding material composition thus applied was dried until it lost fluidity. Subsequently, it was irradiated with light using a dental visible light unit “JET LITE 3000” (manufactured by J. Morita USA) for 10 seconds. Thus, the one-component bonding material composition that had been applied was cured.
  • A dental filling composite resin (manufactured by Kuraray Medical Inc., “CLEARFILAP-X” (trade name, registered trademark)) was applied to the surface of each resultant cured product of the one-component bonding material compositions, and it was then covered with a mold release film (polyester). Next, slide glass was placed on the mold release film to press it, and thereby the surface of the applied composite resin was smoothed. Subsequently, the composite resin was irradiated with light for 20 seconds using the aforementioned unit “JET LITE 3000” through the mold release film. Thus, the composite resin was cured.
  • One end face (circular section) of a stainless-steel cylindrical rod (with a diameter of 5 mm and a length of 1.5 cm) was bonded to the surface of the resultant cured product of the dental filling composite resin using a commercially available dental resin cement (manufactured by Kuraray Medical Inc., “PANAVIA21” (trade name)). After bonding, this sample was allowed to stand still at room temperature for 30 minutes and was then immersed in distilled water. The resultant sample that had been immersed in distilled water was allowed to stand still for 24 hours inside a thermostat whose temperature was maintained at 37° C. Thus, a bonding test sample was produced. Ten bonding test samples were produced in total, and all the samples that had been immersed in distilled water were allowed to stand still for 24 hours inside the thermostat whose temperature was maintained at 37° C. With respect to five samples out of the ten samples, in order to evaluate the bond strength in the early bonding stage, the bond strength was measured immediately after they were allowed to stand still for 24 hours. With respect to the other five samples, in order to evaluate bond durability, bond strength was measured after 4000 thermal cycles had been performed, with one cycle being a process for further immersing each sample in 4° C. cold water and 60° C. warm water alternately for one minute.
  • (3) Measurement of Bond Strength
  • The tensile bond strengths of the above-mentioned five bonding test samples were measured with a universal testing machine (manufactured by Instron Inc.), with the crosshead speed being set at 2 mm/min, and the average value thereof was taken as tensile bond strength. The results thus obtained are indicated together in Table 1.
  • Example 2 Application to Two-Step Bonding System (Two-Component Bonding Material) (1) Production of Primer Using Polymerizable Composition Containing Polymerizable Monomer (A)
  • The respective components were mixed together at ordinary temperature and thereby primer compositions were produced. The compositions thereof are indicated in Table 2.
  • TABLE 2
    Primer Compositions and Bonding Evaluation Results
    Ex. Ex. Ex. Ex. Ex. Ex. Ex. Ex. Ex.
    Components 2-1 2-2 2-3 2-4 2-5 2-6 2-7 2-8 2-9
    Polymerizable EDMA 35 35 35 35 35
    monomer (A) XDMA 35
    SDMA 35
    MDMA 35 35
    Polymerizable GDMA
    monomer for ErMA
    comparison with (A)
    Polymerizable MDP 20 20 20 20 20 20 20 20 20
    monomer (D) having
    acidic group
    Polymerizable HEMA 35 35 35 35 35 35 35 35 35
    monomer (C) having
    one polymerizable
    group and at least
    one hydroxyl group
    Crosslinkable #801 10 10 10 10 10 10 10 10 10
    polymerizable
    monomer (E)
    Solvent (F) Distilled water 50 50 50 50 50 50 50 50 50
    Ethanol 50 50 50 50 50 50 50 50 50
    Polymerization BAPO-1 0.8 0.8 0.8 0.8 0.1 3 3
    initiator (B) BAPO-2 0.8 0.8
    Polymerization TMDPO
    initiator (G) CQ 0.8
    Polymerization DBB 1
    accelerator (H)
    Bond strength with After 24 hours 26.6 25.7 25.6 26.7 26.4 26.8 25.1 25.6 25.1
    respect to dentin After thermal 26.9 25.8 25.8 26.5 26.3 25.5 24.9 26.7 25.7
    (MPa) cycles load
    C. Ex. C. Ex. C. Ex. C. Ex. C. Ex. C. Ex. C. Ex.
    Components 2-1 2-2 2-3 2-4 2-5 2-6 2-7
    Polymerizable EDMA 35 35 35
    monomer (A) XDMA 35
    SDMA
    MDMA
    Polymerizable GDMA 35
    monomer for ErMA 35
    comparison with (A)
    Polymerizable MDP 20 20 20 20 20 20 20
    monomer (D)
    having acidic group
    Polymerizable HEMA 35 35 35 35 70 35 35
    monomer (C)
    having
    one polymerizable
    group and at least
    one hydroxyl group
    Crosslinkable #801 10 10 10 10 10 10 10
    polymerizable
    monomer (E)
    Solvent (F) Distilled water 50 50 50 50 50 50 50
    Ethanol 50 50 50 50 50 50 50
    Polymerization BAPO-1 0.8 0.8 0.8
    initiator (B) BAPO-2
    Polymerization TMDPO 0.8 0.8 3
    initiator (G) CQ 0.8
    Polymerization DBB 1
    accelerator (H)
    Bond strength with After 24 hours 23.6 22.6 23.8 23.9 22.2 20.2 19.9
    respect to dentin After thermal 23.9 22.5 24.0 22.4 21.9 20.9 20.1
    (MPa) cycles load
    ErMA: pentaerythritol dimethacrylate
    (The amounts of respective components added each are indicated in the unit parts by mass, and the respective abbreviations have the same meanings as described above.)
  • (2) Method of Evaluating Bonding to Bovine Teeth Dentin
  • The labial surface of a bovine mandibular incisor was ground with #80 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water, and thereby a sample with an exposed flat surface of dentin was obtained. The sample thus obtained further was ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) under running water. After completion of grinding, water on the surface was air-blown to be dried. An adhesive tape with a thickness of about 150 μm having a circular hole whose diameter was 3 mm was attached to the smooth surface that had been dried and thereby the adhesive area was defined.
  • Each primer produced above was applied into the above-mentioned circular hole using a brush and was then allowed to stand for 20 seconds. Thereafter, the surface thereof was air-blown and thereby the primer thus applied was dried until it lost fluidity. Next, the bonding material having a composition indicated in Table 3 was applied over the tooth surface where the primer had been applied and dried. Subsequently, it was irradiated with light using a dental visible light unit “JET LITE 3000” (manufactured by J. Morita USA) for 10 seconds. Thus, the primer and bonding material that had been applied were cured.
  • A dental filling composite resin (manufactured by Kuraray Medical Inc., “CLEARFIL AP-X” (trade name, registered trademark)) was applied to the surface of the resultant cured product of the bonding material, and it was then covered with a mold release film (polyester). Next, slide glass was placed on the mold release film to press it, and thereby the surface of the applied composite resin was smoothed. Subsequently, the composite resin was irradiated with light for 20 seconds using the aforementioned unit “JET LITE 3000” through the mold release film. Thus, the composite resin was cured.
  • One end face (circular section) of a stainless-steel cylindrical rod (with a diameter of 7 mm and a length of 2.5 cm) was bonded to the surface of the resultant cured product of the dental filling composite resin using a commercially available dental resin cement (manufactured by Kuraray Medical Inc., “PANAVIA21” (trade name)). After bonding, this sample was allowed to stand still at room temperature for 30 minutes and was then immersed in distilled water. Ten bonding test samples were produced in total, and all the samples that had been immersed in distilled water were allowed to stand still for 24 hours inside a thermostat whose temperature was maintained at 37° C. With respect to five samples out of the ten samples, in order to evaluate the bond strength in the early bonding stage, the bond strength was measured immediately after they were allowed to stand still for 24 hours. With respect to the other five samples, in order to evaluate bond durability, bond strength was measured after 4000 thermal cycles had been performed, with one cycle being a process for further immersing each sample in 4° C. cold water and 60° C. warm water alternately for one minute.
  • TABLE 3
    Composition of Bonding Material
    Components Amount added (parts by weight)
    HEMA 40
    Bis-GMA 40
    NPG 20
    Photoinitiator (TMDPO) 3
    Inorganic Filler 1 5.5
    Inorganic Filler 2 1.5
    NPG: neopentyl glycol dimethacrylate
    Inorganic filler 2: “Ar380” manufactured by Japan Aerosil Inc.

    (The Other Abbreviations have the Same Meanings as Described Above.)
  • (3) Bonding Evaluation Test (Evaluations of Bond Strength and Bond Durability)
  • The tensile bond strengths of the above-mentioned bonding test samples were measured with a universal testing machine (manufactured by Shimadzu Corporation), with the crosshead speed being set at 2 mm/min, and the average value thereof was taken as tensile bond strength.
  • Example 3 Application to Dental Self-Adhesive Composite Resin (1) Preparation of Dental Self-Adhesive Composite Resin
  • The inorganic particles and polymerizable monomer compositions indicated in Table 4 were mixed together, respectively, and thereby paste-like dental composite resins were prepared. The bond strength with respect to dentin is indicated together.
  • TABLE 4
    Self-Adhesive Composite Resin Compositions and Bonding Evaluation Results
    Ex. Ex Ex Ex Ex C. Ex C. Ex C. Ex C. Ex C. Ex C. Ex
    3-1 3-2 3-3 3-4 3-4 3-1 3-2 3-3 3-4 3-5 3-6
    Polymerizable EDMA 25 25 25 25
    monomer (A) MDMA 25 25
    XDMA 25
    SDMA 25
    Polymerizable GDMA 25
    monomer for #801 25
    comparison with (A)
    Polymerizable HEMA 25 25 25 25 25 25 25 25 50 25 25
    monomer (C) having
    one polymerizable
    group and at least one
    hydroxyl group
    Polymerizable MDP 10 10 10 10 10 10 10 10 10 10 10
    monomer (D) having
    acidic group
    Crosslinkable Bis-GMA 40 40 40 40 40 40 40 40 40 40 40
    polymerizable
    monomer (E)
    Polymerization BAPO-1 1 1 1 1 1
    initiator (B) BAPO-2 1
    Polymerization TMDPO 1 1
    initiator (G) CQ 0.5 1 1 0.5 1 0.5
    Polymerization PDE 0.5 1 1 0.5 1 0.5
    accelerator (H)
    Filler (I) Inorganic Filler 3 230 230 230 230 230 230 230 230 230 230 230
    Inorganic Filler 4 20 20 20 20 20 20 20 20 20 20 20
    Bond strength with respect to 14.3 14.5 14.1 14.1 14.6 12.3 11.5 11.9 9.3 9.7 8.1
    dentin (MPa)
    (No Adhesive)
    Bending Strength (MPa) 104 105 106 108 107 100 98 95 92 101 99
    PDE: ethyl p-(N,N-dimethylamino)benzoate
    Inorganic filler 3: Silane-treated barium glass powder
  • Barium glass (manufactured by STEC, Product Code: “Raysorb E-3000”) was crushed with a ball mill and thus barium glass powder was obtained. The mean particle size of the barium glass powder thus obtained was measured with a laser diffraction particle size distribution analyzer (manufactured by Shimadzu Corporation, Type “SALD-2100”) and it was 2.4 μm. The surface treatment was performed by a conventional method using 3 parts by weight of 3-methacryloyloxypropyltrimethoxysilane with respect to 100 parts by weight of this barium glass powder. Thus, silane-treated barium glass powder was obtained. Inorganic filler 4: Silane-treated colloidal silica powder
  • 0.3 part by weight of acetic acid and 3 parts by weight of 3-methacryloyloxypropyltrimethoxysilane were added to 100 parts by weight of distilled water, which was then stirred. Further 50 parts by weight of colloidal silica powder (manufactured by Japan Aerosil Inc., Product Code: “Aerosil OX50”) was added thereto, which was then stirred for one hour. After water was removed by lyophilization, this was heat-treated at 80° C. for five hours and thus silane-treated colloidal silica powder was obtained.
  • (The amounts of respective components added each are indicated in the unit of parts by mass, and the other abbreviations have the same meanings as described above.)
  • (2) Method of Evaluating Bonding to Bovine Teeth Dentin
  • A bovine incisor was wet-ground with #1000 silicon carbide paper (manufactured by Nihon Kenshi Co., Ltd.) to be smooth and thereby an enamel surface or dentin surface was exposed. Thereafter, water on the surface was blown away using a dental air syringe. An adhesive tape with a thickness of about 150 μm having a circular hole whose diameter was 3 mm was attached to the exposed enamel surface or dentin surface. Each self-adhesive composite resin composition produced above was placed in the circular hole and this was covered with a mold release film (manufactured by Kuraray Co., Ltd., “EVAL” (trade name)). Thereafter, slide glass was placed on the mold release film to press it, and this was irradiated with light for 20 seconds using the dental light unit (manufactured by MORITA Corp., “JET LITE 3000” (trade name)). Thus, the composite resin was cured. Next, one end face (circular section) of a stainless-steel cylindrical rod with a diameter of 5 mm and a length of 1.5 cm was bonded to the cured surface using a dental resin cement (manufactured by Kuraray Medical Inc., “PANAVIA21” (trade name)). This was allowed to stand still for 30 minutes and thus a test piece was obtained. Five bonding test samples were produced in total.
  • (3) Bonding Evaluation Test
  • The tensile bond strengths of the above-mentioned bonding test samples were measured with a universal testing machine (manufactured by Shimadzu Corporation), with the crosshead speed being set at 2 mm/min, and the average value thereof was taken as tensile bond strength.
  • From the results of Examples 1 to 3, it was proved that the dental materials, each of which was produced using a polymerizable composition containing a polymerizable monomer (A) and bisacylphosphine oxide (B) of the present invention, had excellent initial bond strength and bond durability with respect to dentin. It should be particularly noted that as can be judged from the results of Example 1-1 where the polymerizable monomer (A) and bisacylphosphine oxide (B) were used in combination, Comparative Example 1-1 where only the polymerizable monomer (A) was used, Comparative Examples 1-7 to 1-9 where only the bisacylphosphine oxide (B) was used, and Comparative Example 1-10 where neither the polymerizable monomer (A) nor the bisacylphosphine oxide (B) was used, when the polymerizable monomer (A) and bisacylphosphine oxide (B) were used in combination, higher effect of improving adhesive properties was obtained as compared to the total of the effect of improving adhesive properties obtained using only the polymerizable monomer (A) and that obtained using only the bisacylphosphine oxide (B).
  • INDUSTRIAL APPLICABILITY
  • The composition of the present invention contains a polymerizable monomer (A) having a plurality of polymerizable groups and a plurality of hydroxyl groups and bisacylphosphine oxide (B) with excellent performance and therefore is useful for applications that require curability and those that require hydrophilicity. This composition can be used for various applications including dental applications. Particularly, this composition is suitable for dental materials such as a primer, bonding material, cement, and composite resin.

Claims (21)

1. A composition comprising a polymerizable monomer (A) having an unconjugated carbon chain with at least four carbon atoms bonded continuously, at least two polymerizable groups, and at least two hydroxyl groups, and a bisacylphosphine oxide (B) represented by formula (1):
Figure US20100048762A1-20100225-C00016
in which R4 indicates an alkyl group, an alkenyl group, an alkynyl group, an aryl group, an alkoxy group, an acyl group, or an acyloxy group, and R5 to R14 are each independently a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, an alkoxy group, an acyl group, or an acyloxy group.
2. The composition according to claim 1, wherein the polymerizable monomer (A) has a group represented by formula (2):
Figure US20100048762A1-20100225-C00017
in which G is a hydroxyl group or a polymerizable group and “*” indicates a bond.
3. The composition according to claim 1, wherein the polymerizable groups each are a group represented by formula (3), formula (4), or formula (5):
Figure US20100048762A1-20100225-C00018
in which R1, R2, and R3 each indicate a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and “*” indicates a bond.
4. The composition according to claim 1, wherein the polymerizable monomer (A) is a compound represented by formula (6):
Figure US20100048762A1-20100225-C00019
in which the Gs are hydroxyl groups or polymerizable groups, n is an integer of 2 or more, at least two of the Gs are hydroxyl groups, and at least two of the Gs are polymerizable groups.
5. The composition according to claim 1, wherein the polymerizable monomer (A) is a compound represented by formula (7):
Figure US20100048762A1-20100225-C00020
in which R1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms, m denotes an integer of 2 or more, k denotes an integer of 1 or more, and the sequence order of m units having an ester group and k units having a hydroxyl group is arbitrary.
6. The composition according to claim 5, wherein m is 2 to 5 and k is 1 to 5.
7. The composition according to claim 1, wherein the polymerizable monomer (A) is a compound represented by formula (8):
Figure US20100048762A1-20100225-C00021
in which R1 denotes a hydrogen atom or an aliphatic hydrocarbon group having 1 to 10 carbon atoms and p denotes an integer of 2 or more.
8. The composition according to claim 7, wherein p is 2 to 4.
9. The composition according to claim 3, wherein R1 is a hydrogen atom or a methyl group.
10. The composition according to claim 1, wherein R4 is an alkyl group or an aryl group, and R5 to R14 are each independently a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group.
11. The composition according to claim 1, further comprising, as a polymerizable monomer component, at least one polymerizable monomer selected from the group consisting of a polymerizable monomer (C) having one polymerizable functional group and at least one hydroxyl group, a polymerizable monomer (D) having an acidic group, and a crosslinkable polymerizable monomer (E).
12. The composition according to claim 1, comprising a solvent (F).
13. The composition according to claim 1, further comprising at least one polymerization initiator (G) selected from the group consisting of acylphosphine oxides, water-soluble acylphosphine oxides, thioxanthones, quaternary ammonium salts of thioxanthones, ketals, alpha-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, alpha-amino ketone compounds, and organic peroxides and/or polymerization accelerator (H).
14. (canceled)
15. The composition according to claim 1, comprising a filler (I).
16. The composition according to claim 1, wherein 0.01 to 20 parts by mass of the bisacylphosphine oxide (B) is contained with respect to 100 parts by mass of the whole amount of polymerizable monomer components.
17. A dental application composition comprising the composition according to claim 1.
18. A primer comprising the composition according to claim 17.
19. A bonding material comprising the composition according to claim 17.
20. A composite resin comprising the composition according to claim 17.
21. A cement comprising the composition according to claim 17.
US12/523,591 2007-01-17 2008-01-16 Composition and dental material Abandoned US20100048762A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2007-008420 2007-01-17
JP2007-008421 2007-01-17
JP2007008421 2007-01-17
JP2007008420 2007-01-17
JP2007-073603 2007-03-20
JP2007073603 2007-03-20
PCT/JP2008/050439 WO2008087981A1 (en) 2007-01-17 2008-01-16 Composition and dental material

Publications (1)

Publication Number Publication Date
US20100048762A1 true US20100048762A1 (en) 2010-02-25

Family

ID=39635983

Family Applications (4)

Application Number Title Priority Date Filing Date
US12/523,591 Abandoned US20100048762A1 (en) 2007-01-17 2008-01-16 Composition and dental material
US12/523,538 Expired - Fee Related US7977405B2 (en) 2007-01-17 2008-01-16 Polymerizable monomer-containing composition
US12/523,554 Abandoned US20100130682A1 (en) 2007-01-17 2008-01-16 Polymerizable monomer, polymerizable composition, and dental material
US12/523,546 Abandoned US20100048761A1 (en) 2007-01-17 2008-01-16 Polymerizable monomer-containing composition

Family Applications After (3)

Application Number Title Priority Date Filing Date
US12/523,538 Expired - Fee Related US7977405B2 (en) 2007-01-17 2008-01-16 Polymerizable monomer-containing composition
US12/523,554 Abandoned US20100130682A1 (en) 2007-01-17 2008-01-16 Polymerizable monomer, polymerizable composition, and dental material
US12/523,546 Abandoned US20100048761A1 (en) 2007-01-17 2008-01-16 Polymerizable monomer-containing composition

Country Status (5)

Country Link
US (4) US20100048762A1 (en)
EP (4) EP2108663A4 (en)
JP (11) JP5300269B2 (en)
TW (5) TW200900084A (en)
WO (5) WO2008087977A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056665A1 (en) * 2007-03-20 2010-03-04 Kuraray Medical Inc. Polymerizable monomer, polymerizable composition and dental material
US9962245B2 (en) 2009-12-22 2018-05-08 3M Innovative Properties Company Dental compositions, mill blocks, and methods
US11167375B2 (en) 2018-08-10 2021-11-09 The Research Foundation For The State University Of New York Additive manufacturing processes and additively manufactured products
US11452674B2 (en) 2017-08-28 2022-09-27 Kuraray Noritake Dental Inc. Non-solvent dental adhesive composition

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008189580A (en) * 2007-02-02 2008-08-21 Kuraray Medical Inc Multifunctional hydrophilic polymerizable monomer-containing composition
JP5162137B2 (en) * 2007-02-02 2013-03-13 クラレノリタケデンタル株式会社 Polyfunctional hydrophilic polymerizable monomer-containing composition
JP5162138B2 (en) * 2007-02-02 2013-03-13 クラレノリタケデンタル株式会社 Polyfunctional hydrophilic polymerizable monomer-containing composition
EP2226061B2 (en) * 2009-03-06 2017-01-25 Ernst Mühlbauer GmbH & Co.KG Infiltrant for dental application
JP5154483B2 (en) * 2009-03-18 2013-02-27 株式会社ジーシー Polymerizable composition
EP2233123B2 (en) 2009-03-24 2020-03-11 Ivoclar Vivadent AG Self-adhesive multi-component dental material
US9289359B2 (en) * 2009-03-23 2016-03-22 Ivoclar Vivadent Ag Self-adhesive multicomponent dental material
JP5396998B2 (en) * 2009-05-07 2014-01-22 東亞合成株式会社 A curable composition containing a (meth) acrylate of a disaccharide
JP4646264B1 (en) * 2009-10-16 2011-03-09 日本歯科薬品株式会社 Dental curable composition
US8669337B2 (en) 2009-12-23 2014-03-11 Momentive Performance Materials Inc. Network copolymer crosslinked compositions and methods of making the same
GB201003552D0 (en) * 2010-03-03 2010-04-21 Kind Consumer Ltd A simulated cigarette
US9271901B2 (en) 2010-03-30 2016-03-01 Kuraray Noritake Dental Inc. One-part dental adhesive composition
JP4897124B2 (en) 2010-03-30 2012-03-14 クラレメディカル株式会社 Dental adhesive kit
EP2588140A4 (en) * 2010-06-30 2015-07-15 Univ Maryland Dental composites comprising nanoparticles of amorphous calcium phosphate
EP2616476A2 (en) 2010-09-15 2013-07-24 3M Innovative Properties Company Substituted saccharide compounds and dental compositions
JP5701716B2 (en) * 2010-10-07 2015-04-15 富士フイルム株式会社 Polarizing plate protective film, polarizing plate and liquid crystal display device
CN103007338B (en) * 2011-09-28 2014-10-22 韩冰 Application of gel material for dental cavity filling material after tooth extraction
US8932060B2 (en) * 2011-09-30 2015-01-13 Kuraray Noritake Dental Inc. Dental treatment method
US10351460B2 (en) 2012-05-22 2019-07-16 Corning Incorporated Methods of separating strengthened glass sheets by mechanical scribing
TWI501030B (en) * 2012-06-12 2015-09-21 Cheil Ind Inc Photocurable composition, protective layer including the same, and encapsulated apparatus including the same
DE102012212429A1 (en) 2012-07-16 2014-01-16 Voco Gmbh Dental handset unit i.e. polymerization lamp, for invasive curing of light-curable material in e.g. dental cavity in mouth of human patient, has removable body separable together with control unit from non-destructive autoclavable handgrip
JP5817744B2 (en) * 2013-01-17 2015-11-18 信越化学工業株式会社 Pattern forming method, resist composition, polymer compound and monomer
CN105101934B (en) * 2013-03-26 2017-09-22 可乐丽则武齿科株式会社 Curable composition for dental applications
CN105101935B (en) * 2013-03-28 2018-02-23 可乐丽则武齿科株式会社 Solidification compound
JP6244207B2 (en) * 2014-01-21 2017-12-06 株式会社トクヤマデンタル Dental adhesive composition
AU2015272902B2 (en) 2014-06-10 2018-01-18 Kuraray Noritake Dental Inc. Self-adhesive dental composite resin
CN106413666B (en) 2014-06-10 2020-07-28 可乐丽则武齿科株式会社 Dental cement
KR101647954B1 (en) * 2014-11-27 2016-08-12 (주)스피덴트 Dental composite for glass ionomer cement and method for thereof
US20170143594A1 (en) * 2015-11-20 2017-05-25 Dentsply Sirona Inc. Orthodontic cement compositions and methods of use thereof
US10478385B2 (en) 2015-12-18 2019-11-19 Kuraray Noritake Dental Inc. Dental adhesive material kit
JP6687898B2 (en) * 2016-08-31 2020-04-28 株式会社リコー Ink and its manufacturing method, ink container, ink jet recording method, ink jet recording apparatus, and recorded matter
EP3530257B1 (en) 2016-10-21 2021-09-08 Kuraray Noritake Dental Inc. Self-adhesive dental composite resin
JP2020515641A (en) 2017-04-03 2020-05-28 ゼスト、アイピー、ホールディングス、リミテッド、ライアビリティー、カンパニーZest Ip Holdings,Llc Dental cement composition and method of use
EP3424969A1 (en) 2017-07-03 2019-01-09 HILTI Aktiengesellschaft Mixture of radical curable compounds and their use
WO2019124515A1 (en) 2017-12-21 2019-06-27 クラレノリタケデンタル株式会社 Dental adhesive material kit
WO2020111142A1 (en) 2018-11-28 2020-06-04 クラレノリタケデンタル株式会社 Dental adhesive material kit
WO2020179852A1 (en) 2019-03-05 2020-09-10 クラレノリタケデンタル株式会社 Solvent-free adhesive composition for dental use
JPWO2021070875A1 (en) 2019-10-08 2021-04-15
US20230270630A1 (en) 2020-08-07 2023-08-31 Kuraray Noritake Dental Inc. Composition for dental attachment
EP4268795A1 (en) 2020-12-25 2023-11-01 Kuraray Noritake Dental Inc. Dental composition
WO2022138973A1 (en) 2020-12-25 2022-06-30 クラレノリタケデンタル株式会社 Dental composition
JP2022120710A (en) * 2021-02-05 2022-08-18 株式会社ジーシー Dental adhesive composition
JPWO2022220250A1 (en) 2021-04-13 2022-10-20
WO2022230909A1 (en) 2021-04-26 2022-11-03 クラレノリタケデンタル株式会社 Dental filling kit
JPWO2022270601A1 (en) 2021-06-23 2022-12-29
WO2024043291A1 (en) * 2022-08-25 2024-02-29 クラレノリタケデンタル株式会社 Dental adhesive composition
CN117466907A (en) * 2023-05-31 2024-01-30 江苏集萃光敏电子材料研究所有限公司 Acrylate monomer with ultralow volume shrinkage and application

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666824A (en) * 1984-04-23 1987-05-19 Hercules Incorporated Photopolymer process and composition employing a photooxidizable component capable of forming endoperoxides
US4719297A (en) * 1981-04-08 1988-01-12 Basf Aktiengesellschaft Acylphosphine compounds and their use as photoinitiators
US4737593A (en) * 1984-11-27 1988-04-12 Fabrik Pharmazeutischer Praparate Bisacylphosphine oxides, the preparation and use thereof
US5204383A (en) * 1990-03-28 1993-04-20 Kuraray Co., Ltd. Dental adhesives
US5270415A (en) * 1990-12-21 1993-12-14 Allergan Inc. Balanced charge polymer and hydrophilic contact lens manufactured therefrom
EP0615980A2 (en) * 1993-03-18 1994-09-21 Ciba-Geigy Ag Curing of compositions containing Bisacylphosphinoxide
US5399770A (en) * 1991-09-23 1995-03-21 Ciba-Geigy Corporation Alkylbisacylphosphine oxides
US5539017A (en) * 1994-01-26 1996-07-23 Ivoclar Ag Use of a thermally curable composition as dental material
US5556897A (en) * 1992-07-10 1996-09-17 Sun Medical Co., Ltd. Primer solution compositions and method of forming adhesive layer on tooth surface
US5648441A (en) * 1992-12-23 1997-07-15 Gurit-Worbla Ag Substrate and polymerizable mixture, method of manufacturing of said polymerizable mixture, and method of manufacturing of a non fogging or low fogging layer
US5932393A (en) * 1995-11-24 1999-08-03 Ciba Specialty Chemicals Corporation Borate photoinitiators from monoboranes
US5942290A (en) * 1996-08-28 1999-08-24 Ciba Specialty Chemicals Corporation Molecular complex compounds of acylphosphine oxide and α-hydroxy ketones as photoinitiators
US5965147A (en) * 1997-12-03 1999-10-12 Mycone Dental Inc. Artificial fingernails
US6107358A (en) * 1996-08-23 2000-08-22 Nippon Shokubai Co., Ltd. Water-absorbent resin and method for production thereof
US20030166737A1 (en) * 2002-01-15 2003-09-04 Karsten Dede Ternary photoinitiator system for cationically polymerizable resins
US20040005524A1 (en) * 2002-06-28 2004-01-08 Oxman Joel D. Processes for forming dental materials and device
US20040176496A1 (en) * 2003-03-04 2004-09-09 Han Dong Keun Light-curing dental adhesive compositions
US20040180983A1 (en) * 2003-03-13 2004-09-16 Tadashi Hara Photopolymerization initiator
US20050042363A1 (en) * 2003-08-18 2005-02-24 Kukhtin Alexander V. Method for fabrication of biochips with a macroporous polymer substrate
US6894144B1 (en) * 1999-09-06 2005-05-17 3M Espe Ag Two-constituent elastomer materials based on alkyl aziridine comprising a catalyst constituent that contains a boric acid complex
US20050256221A1 (en) * 2002-11-22 2005-11-17 Weiping Zeng Dental adhesive composition
US20060030013A1 (en) * 2002-11-22 2006-02-09 Basf Aktiengesellschaft Enzymatic synthesis of polyol acrylates

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339443A (en) 1978-09-22 1982-07-13 Fbc Limited Compounds and compositions
JPS63150312A (en) * 1986-12-12 1988-06-23 Osaka Soda Co Ltd Resin composition for laminate
JPS6490277A (en) 1987-09-30 1989-04-06 Kuraray Co Dental adhesive
JP2782694B2 (en) * 1990-03-28 1998-08-06 和雄 伊藤 Dental adhesive
JP2848974B2 (en) * 1991-02-26 1999-01-20 三井化学株式会社 Dental adhesive
JP3279307B2 (en) 1992-06-09 2002-04-30 ヤマハ株式会社 Keyboard instrument
JPH07316098A (en) * 1994-05-23 1995-12-05 San Medical Kk Acrylate compound and dental adhesive
DE4447164A1 (en) * 1994-12-30 1996-07-04 Voco Gmbh Adhesive contg. hydroxy-methacrylic acid ester derivs.
JP3388670B2 (en) 1995-04-19 2003-03-24 株式会社トクヤマ Visible light polymerization initiator and visible light polymerizable composition
JP3895422B2 (en) * 1997-03-17 2007-03-22 株式会社日本触媒 Method for producing hydrophilic polymer
JPH1072404A (en) * 1996-08-28 1998-03-17 Dainippon Ink & Chem Inc (meth)acrylic acid ester of sorbitol and its production
JP3520707B2 (en) 1997-03-03 2004-04-19 株式会社トクヤマ Adhesive composition
WO1998046196A2 (en) * 1997-04-16 1998-10-22 Dentsply International Inc. Method and composition for adhering to tooth structure
JP4148334B2 (en) 1998-08-06 2008-09-10 株式会社トクヤマ Light-curing dental restoration material
JP4241978B2 (en) 1998-12-02 2009-03-18 株式会社クラレ Dental photopolymerizable composition
JP4822617B2 (en) * 2001-06-28 2011-11-24 クラレメディカル株式会社 Dental cement composition
JP5224255B2 (en) 2001-09-21 2013-07-03 株式会社トクヤマ Radical polymerization catalyst
JP4231952B2 (en) 2002-05-23 2009-03-04 株式会社トクヤマ Adhesion kit
JP2004091949A (en) * 2002-08-30 2004-03-25 Kyoeisha Chem Co Ltd Composition for modifying fiber and method for modifying fiber therewith
EP1594904A1 (en) * 2003-02-20 2005-11-16 Ciba SC Holding AG Photocurable compositions
JP4663225B2 (en) * 2003-11-21 2011-04-06 株式会社ジーシー Photopolymerization type dental surface coating material
JP2005171213A (en) 2003-12-09 2005-06-30 Shiyoufuu:Kk Multi-wavelength photopolymerizable composition
JP4335100B2 (en) * 2004-09-01 2009-09-30 株式会社リコー Electrophotographic photoreceptor and image forming method using the same
WO2007040253A1 (en) * 2005-10-04 2007-04-12 Nihon University Dental composition

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719297A (en) * 1981-04-08 1988-01-12 Basf Aktiengesellschaft Acylphosphine compounds and their use as photoinitiators
US4666824A (en) * 1984-04-23 1987-05-19 Hercules Incorporated Photopolymer process and composition employing a photooxidizable component capable of forming endoperoxides
US4737593A (en) * 1984-11-27 1988-04-12 Fabrik Pharmazeutischer Praparate Bisacylphosphine oxides, the preparation and use thereof
US5204383A (en) * 1990-03-28 1993-04-20 Kuraray Co., Ltd. Dental adhesives
US5270415A (en) * 1990-12-21 1993-12-14 Allergan Inc. Balanced charge polymer and hydrophilic contact lens manufactured therefrom
US5399770A (en) * 1991-09-23 1995-03-21 Ciba-Geigy Corporation Alkylbisacylphosphine oxides
US5556897A (en) * 1992-07-10 1996-09-17 Sun Medical Co., Ltd. Primer solution compositions and method of forming adhesive layer on tooth surface
US5648441A (en) * 1992-12-23 1997-07-15 Gurit-Worbla Ag Substrate and polymerizable mixture, method of manufacturing of said polymerizable mixture, and method of manufacturing of a non fogging or low fogging layer
EP0615980A2 (en) * 1993-03-18 1994-09-21 Ciba-Geigy Ag Curing of compositions containing Bisacylphosphinoxide
US5534559A (en) * 1993-03-18 1996-07-09 Ciba-Geigy Corporation Daylight curing compositions containing bisacylphosphine oxide photoinitiators
US5539017A (en) * 1994-01-26 1996-07-23 Ivoclar Ag Use of a thermally curable composition as dental material
US5932393A (en) * 1995-11-24 1999-08-03 Ciba Specialty Chemicals Corporation Borate photoinitiators from monoboranes
US6107358A (en) * 1996-08-23 2000-08-22 Nippon Shokubai Co., Ltd. Water-absorbent resin and method for production thereof
US5942290A (en) * 1996-08-28 1999-08-24 Ciba Specialty Chemicals Corporation Molecular complex compounds of acylphosphine oxide and α-hydroxy ketones as photoinitiators
US5965147A (en) * 1997-12-03 1999-10-12 Mycone Dental Inc. Artificial fingernails
US6894144B1 (en) * 1999-09-06 2005-05-17 3M Espe Ag Two-constituent elastomer materials based on alkyl aziridine comprising a catalyst constituent that contains a boric acid complex
US20030166737A1 (en) * 2002-01-15 2003-09-04 Karsten Dede Ternary photoinitiator system for cationically polymerizable resins
US20040005524A1 (en) * 2002-06-28 2004-01-08 Oxman Joel D. Processes for forming dental materials and device
US20050256221A1 (en) * 2002-11-22 2005-11-17 Weiping Zeng Dental adhesive composition
US20060030013A1 (en) * 2002-11-22 2006-02-09 Basf Aktiengesellschaft Enzymatic synthesis of polyol acrylates
US20040176496A1 (en) * 2003-03-04 2004-09-09 Han Dong Keun Light-curing dental adhesive compositions
US20040180983A1 (en) * 2003-03-13 2004-09-16 Tadashi Hara Photopolymerization initiator
US20050042363A1 (en) * 2003-08-18 2005-02-24 Kukhtin Alexander V. Method for fabrication of biochips with a macroporous polymer substrate

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056665A1 (en) * 2007-03-20 2010-03-04 Kuraray Medical Inc. Polymerizable monomer, polymerizable composition and dental material
US9962245B2 (en) 2009-12-22 2018-05-08 3M Innovative Properties Company Dental compositions, mill blocks, and methods
US11452674B2 (en) 2017-08-28 2022-09-27 Kuraray Noritake Dental Inc. Non-solvent dental adhesive composition
US11167375B2 (en) 2018-08-10 2021-11-09 The Research Foundation For The State University Of New York Additive manufacturing processes and additively manufactured products
US11426818B2 (en) 2018-08-10 2022-08-30 The Research Foundation for the State University Additive manufacturing processes and additively manufactured products

Also Published As

Publication number Publication date
JP5300269B2 (en) 2013-09-25
JP5342786B2 (en) 2013-11-13
EP2112177A4 (en) 2012-04-25
EP2108663A1 (en) 2009-10-14
JP5398267B2 (en) 2014-01-29
JP2008260751A (en) 2008-10-30
US20100048761A1 (en) 2010-02-25
JP5335247B2 (en) 2013-11-06
WO2008087979A1 (en) 2008-07-24
US20100130682A1 (en) 2010-05-27
TW200843796A (en) 2008-11-16
JPWO2008087980A1 (en) 2010-05-06
JP2008260911A (en) 2008-10-30
JP4914428B2 (en) 2012-04-11
EP2112178A1 (en) 2009-10-28
JP2008260754A (en) 2008-10-30
EP2108664A4 (en) 2012-04-25
JP4231545B2 (en) 2009-03-04
US7977405B2 (en) 2011-07-12
TW200900084A (en) 2009-01-01
US20100036075A1 (en) 2010-02-11
JPWO2008087978A1 (en) 2010-05-06
EP2108664A1 (en) 2009-10-14
JP5300270B2 (en) 2013-09-25
WO2008087977A1 (en) 2008-07-24
JP5378804B2 (en) 2013-12-25
JP2009137960A (en) 2009-06-25
JPWO2008087981A1 (en) 2010-05-06
EP2112178A4 (en) 2012-04-25
WO2008087980A1 (en) 2008-07-24
TW200840594A (en) 2008-10-16
EP2108664B1 (en) 2016-11-16
EP2108663A4 (en) 2012-04-25
JP5300268B2 (en) 2013-09-25
JPWO2008087979A1 (en) 2010-05-06
EP2112177A1 (en) 2009-10-28
JP2008260752A (en) 2008-10-30
JP2008260753A (en) 2008-10-30
WO2008087978A1 (en) 2008-07-24
TW200848081A (en) 2008-12-16
TW200846024A (en) 2008-12-01
JP5378803B2 (en) 2013-12-25
JPWO2008087977A1 (en) 2010-05-06
WO2008087981A1 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
EP2108664B1 (en) Dental composition
US7968615B2 (en) Polymerizable monomer, polymerizable composition and dental material
EP2301975B1 (en) Polymerizable composition suitable for led light source
JP4866201B2 (en) NOVEL COMPOUND AND COMPOSITION CONTAINING THE SAME
JP5260093B2 (en) Polymerizable monomer, polymerizable composition and dental material
JP5122229B2 (en) Polymerizable adamantane derivative and dental composition
JP5207859B2 (en) Polymerizable composition and dental material
JP5306697B2 (en) Polymerizable monomer, polymerizable composition and dental material
WO2020130143A1 (en) Dental adhesive composition

Legal Events

Date Code Title Description
AS Assignment

Owner name: KURARAY MEDICAL INC.,JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ISHINO, HIROSHIGE;SEKIGUCHI, TAKAHIRO;OKADA, KOICHI;AND OTHERS;SIGNING DATES FROM 20090612 TO 20090615;REEL/FRAME:023428/0079

AS Assignment

Owner name: KURARAY NORITAKE DENTAL INC., JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:KURARAY MEDICAL INC.;REEL/FRAME:028813/0382

Effective date: 20120401

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION